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The transcription factor Pax6 is a pleiotropic player during neural development. 
In the central nervous system, Pax6 is mostly expressed by neural progenitors, 
where its functions have been most extensively studied. However, in the 
anterior diencephalon, the prethalamus, Pax6 is expressed in both neural 
progenitors and post-mitotic neurons. This distinctive expression pattern of 
Pax6 makes the prethalamus a unique place in which to explore the functions 
of Pax6 and its mechanisms of action during development. 
 
I have found that in post-mitotic prethalamic neurons, Pax6 seems to regulate 
the process of neuronal morphogenesis. Gene ontology analysis on the 
RNAseq data, which showed significant transcriptional changes of genes in 
the prethalamus when Pax6 is lost, revealed that genes involved in 
neuritogenesis, establishment of neuronal polarity, axon elongation and axon 
initial segment (AIS) were significantly differentially expressed. To further 
explore this, I performed dissociated cell cultures of the prethalamus at 
embryonic day 13.5. Various aspects of neuronal morphogenesis were 
analysed in these primary neurons cultured for 1-9 days in vitro (DIV). I found 
that Pax6-null prethalamic neurons constantly displayed fewer neurites and a 
disturbed rate of neurite elongation. Additionally, I discovered that the AISs of 
these neurons were located further away from the soma. The AIS is where the 
neurons generate action potentials, and its location and molecular composition 
can determine the amplitudes and firing frequencies of the neurons. I found 
that the components of the AISs seemed to have been altered as increased 
amount of voltage-gated sodium channels and AnkyrinG was found in the AISs 
of the Pax6-null prethalamic neurons. AnkyrinG is a cytoskeletal protein known 
to be the master regulator of AIS formation. Therefore, my analysis suggested 
that the Pax6-null prethalamic neurons might display different 
electrophysiological properties. Indeed, whole-cell patch clamping on 
dissociated prethalamic neurons showed that the Pax6-null neurons required 
a much lower amplitude of current stimuli to initiate an action potential. In the 
adult brain, derivative neurons of the prethalamus are organized into nuclei, 
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which innervate with the thalamus in a reciprocal manner and can modulate 
the activities of the thalamus. The thalamus is the relay station where all 
sensory inputs (except olfactory) are received, processed and further 
projected to the cortex. Consequently, the loss of Pax6 in the embryonic 
prethalamus might impact the functionality of entire nervous system.  
 
Additionally, I have also found that Pax6 removal from the prethalamus 
significantly deregulates the activity of various genes involved in canonical and 
non-canonical Wnt-signaling pathways. My data indicate that in the 
prethalamic ventricular zone, where neural progenitors reside, Pax6 seems to 
suppress the expression of various canonical Wnt-signalling pathway effectors 
by promoting the expression of antagonists of Wnt-signaling pathways, such 
as Sfrp2 and Dkk3. 
 
By utilising the RNAseq data and comparing the transcriptome profiles of the 
thalamus and prethalamus, I found that in the absence of Pax6, the 
prethalamus develops a thalamus-like expression profile of the voltage-gated 
ion channels and AIS component genes. During embryonic development, the 
thalamus and prethalamus reside adjacent to each other, and receive the 
same amounts of morphogens. However, the thalamus and prethalamus give 
rise to neurons with completely different morphologies and functions. Pax6 is 
expressed simultaneously by the thalamus and prethalamus. However, in the 
thalamus, Pax6 is only expressed in the progenitors, whereas in the 
prethalamus, Pax6 is expressed by both the progenitors and post-mitotic cells. 
My results thus indicated that such differential expression of Pax6 helps to 
explain the inter-regional diverse development of the thalamus and 
prethalamus. 
 
My study revealed novel and distinct functions of Pax6 in the developing 
prethalamus of the mouse embryos- suppressing the activity of canonical Wnt 
signalling pathway in the progenitor cells and regulating neuronal 
morphogenesis and functionality in a cell autonomous manner in the post-
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mitotic cells. Additionally, Pax6’s expression in the prethalamus also 
influences the prethalamic electrophysiological identities from the 
neighbouring thalamus, thus contributing to the differential development of 
these two tissues. My findings hence provide new insight into the temporal and 








My PhD project focuses on investigating how a single gene, Pax6, controls the 
way neurons are formed in an area of the brain called the prethalamus in 
mouse embryos.  
 
Pax6 is important because it controls the activities of hundreds of other genes. 
Therefore, errors in this gene can have catastrophic cascading effects. For 
example, in human patients, mutations of both copies of the Pax6 gene are 
lethal, whereas mutations in only one copy of the Pax6 gene can cause eye 
defects, structural brain defects and intellectual disabilities.  
 
In the developing central nervous system, Pax6 is very active in the newborn 
cells, where it controls the process of cell division and proliferation. As the 
newborn cells mature and become neurons, most of them lose their Pax6 
activities. However, in certain areas of the brain, such as the prethalamus, a 
structure situated deep in the brain and essential for modulating perception, 
Pax6 continues to be active in the mature neurons, and we have no clue of 
what Pax6’s functions are in these cells. 
 
I started my PhD by asking whether Pax6 continues to function in the mature 
neurons of the prethalamus and what those functions might be. I have found 
that in the prethalamus, Pax6 seems to control an important cell-cell signalling 
pathway (Wnt signalling) in the newborn cells. However, in mature neurons, it 
seems to regulate how they develop their shapes. As a neuron matures, it 
changes its original shape and sends out protrusions called axons and 
dendrites to connect with other neurons, thus forming a neural network. I have 
developed a culture system to observe this process as the neurons of the 
prethalamus mature. I found that disabling Pax6’s activities in these neurons 
results in a decrease in the number of dendrites and a disturbance in the rate 
at which these neurons send out their protrusions.  
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The above results indicate that the shapes of the prethalamus neurons change 
when Pax6 is lost. Next, I want to find out if the behaviours of these neurons 
also change when Pax6 is mutated. Interestingly, losing Pax6 seems to affect 
an important structure called the axon initial segment (AIS). The AIS is where 
the neurons generate electrical impulses and it is crucial for how they transmit 
information. My preliminary data showed that without Pax6, these neurons are 
hyperactive as they generate more electrical activity under the same amount 
of stimulation. In the adult brain, prethalamic neurons connect with and fine-
tune the activities of other brain regions. Therefore, changes in how active 
these neurons are could potentially affect the cognitive function of the whole 
nervous system.  
 
Given Pax6’s known function to control the expression of hundreds of other 
genes, to have a better understanding of the global effect of Pax6’s loss on 
development of the prethalamus, I analysed all the active genes in the 
prethalamus by big data processing. I found that when I eliminate Pax6, the 
prethalamus loses the activity of some of its signature genes but activates 
other genes that are typically active in a nearby brain region- the thalamus. 
This effect was particularly strong for genes that are involved in the AIS, and 
other genes that also function to determine how the neurons would generate 
their electrical impulses. These results indicated that Pax6 not only functions 
to control how these neurons develop their shapes and behaviours, but it is 
also essential for the distinctive development of the prethalamus itself.  
 
As most studies on Pax6 focus on its functions in the newborn cells, my results 
revealed new roles of this important gene in the maturing neurons of the 
developing nervous system. Additionally, these findings show how the same 
gene can have different functions at different developmental stages of a cell in 
the embryonic brain, providing interesting insights into the mechanisms of 
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The diencephalon is the caudal-most component of the forebrain (1). It is a 
twinned bulb-shaped structure that forms at the top of the brainstem on either 
side of the third ventricle (2).  
 
The diencephalon consists of three major alar domains- the prethalamus, the 
thalamus and the pretectum (3). As development proceeds, the neurons within 
the diencephalon are further organised into nuclei along the anterior-posterior 
(AP) and dorsal-ventral (DV) axes of the neural tube (4–6). The thalamic nuclei 
serve as morphological and functional units that filter all afferent sensory 
information (except olfactory) and connect reciprocally with the overlying 
cerebral cortex in the adult brain (2). Therefore, the thalamus is often 
described as the “the gateway to consciousness” (7). The nuclei derived from 
the prethalamus receive input from the cortex, the basal telencephalon and 
connect reciprocally with the thalamic nuclei and function to modulate the 
activities of the latter (8). The telencephalon and diencephalon are thus the 
embryonic anlage of higher cognition and information integration centres (5). 
Malformations or damage to the diencephalon has been shown to result in 
cognitive disorders such as schizophrenia, amnesia, Alzheimer’s disease, 
dementia, etc. (9). Therefore, a fully developed diencephalon with correct 
patterning is an essential prerequisite to a healthy brain, and it is of great 
importance for us to understand the genetic regulations that take place during 
diencephalic development. 
 
1.1.2 The prosomeric model and the subdivisions of the embryonic 
diencephalon 
 
During mouse embryonic development, neurulation occurs at about E8.5 as 
the neural plate folds at its dorsal midline to form the neural tube (10) (Figure 
 3 
1.1A). As development proceeds, the anterior neural tube enlarges, giving rise 
to the prosencephalon (forebrain vesicle), the mesencephalon (midbrain 
vesicle) and the rhombencephalon (hindbrain vesicle) (Figure 1.1B) (1,3,8,11).  
 
Based on a wide-ranging analysis of histological landmarks and gene 
expression patterns in the forebrain, Bergquist (1932) first theorised the 
prosomeric model, which was later revised by Puelles, Rubenstein et al (12–
14). The prosomeric model proposed that the prosencephalon can be divided 
into 6 transverse segments along its anteroposterior (AP) axis and 4 
longitudinal domains along its dorsoventral (DV) axis (13,14). The six 
transverse segments are termed Prosomeres 1-6 from posterior to anterior, 
whereas the four longitudinal subdivisions are the floor plate, basal plate, alar 
plate and roof plate from ventral to dorsal (13,14). Anteriorly, prosomeres 4-6 
(P4-P6) give rise to the secondary prosencephalon, whereas prosomeres 1-3 
(P1-P3) will give rise to the diencephalon that is situated posteriorly (Figure 
1.1C) (3,14). The secondary prosencephalon later develops into 
hypothalamus and telencephalon, whereas the telencephalon further gives 
rise to the cerebral cortex, basal ganglion and hippocampus (Figure 1.1D-E) 
(3,5,8,14). In mouse, morphological segmentation of the diencephalon starts 
at E9.5. At about E10-11, the diencephalic prosomeres P1-P3 are 
morphologically distinct (15). In their roof and alar plates, P1 gives rise to the 
pretectum that resides anteriorly adjacent to the midbrain. P2 differentiates 
into thalamus and epithalamus, whereas P3 develops into the prethalamus 
and eminentia thalamus that is situated posteriorly to the telencephalon 
(Figure 1.1D-E) (3,8,14). Figure 1.1F is the schematic representation of the 
coronal view of the neural tube, which shows the anatomy of the diencephalon 
and the telencephalon at the indicated level of sectioning (16). 
 
The prosomeric model has proved useful as it provides a topographical 
framework for studies on forebrain development (17). Additionally, it has been 
tested by numerous studies examining gene expression during neural 
development in various species, and widely supported due to its corroborated 
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capacity to attribute morphological meanings to these gene expression 
patterns (14). However, the expression domains of various forebrain markers 
were found to be highly dynamic spatially and temporally, and did not confine 
to the putative segments especially at early developmental stages before the 
appearance of morphological boundaries (17,18). Additionally, recent fate 
mapping experiments revealed that cells were able to cross the proposed 
boundaries of P1/P2, P2/P3 and the boundary between the prethalamus (P3) 
and the secondary prosencephalon, raising the question of whether these 
areas can be considered as true compartments or segments (17,19) . Finally, 
several boundaries, especially those postulated in the hypothalamus and 
telencephalon, were ambiguous (5). These concerns resulted in a revision of 
the prosomeric model that no longer includes the secondary prosencephalon 
as a prosomeric structure (5,14). Nonetheless, the prosomeric model still 
provides a comprehensible framework to interpret forebrain, especially 
diencephalon, development, which is why I used it to introduce early 
development of the prethalamus and the thalamus.  
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Figure 1.1 Schematic representation of early development of the diencephalon. (A-
E) Schematic representation of the sagittal view of early development of the central 
nervous system. (A) After neurulation, the neural primordium (NP) is a hollow tube with 
no subdivisons. (B) The anterior part of the neural tube expands, giving rise to the 
prosencephalon (forebrain vesicle, F), the mesencephalon (midbrain vesicle, M) and the 
rhombencephalon (hindbrain vesicle, H). (C) The forebrain vesicle further develops, 
giving rise to the secondary prosencephalon (SP) anteriorly and the diencephalon (D) 
posteriorly. (D-E) SP further give rise to the telencephalon, which further develops into 
the cerebral cortex, basal ganglion and hippocampus, whereas the three prosomeres (P1-
P3) of diencephalon further differentiate into the pretectum, thalamus and epithalamus, 
and prethalamus respectively. The cross made with two perpendicular double arrows 
indicates the orientation of the developing neural tube in (A)-(E). Figure adapted from 
reference (3). (F) Coronal view of the developing neural tube sectioned at the level pointed 
by an arrow in (E). The dorsal (pallium) and ventral (subpallium) telencephalon are divided 
by the cortical hem (purple) and pallium/subpallium boundary (antihem, red). The 
diencephalon contains p1, p2 and p3 from dorsal to ventral. In between p2 and p3 resides 
the secondary organiser zona limitans intrathalamica (ZLI). Figure adapted from 
reference (16). 
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1.1.3 Prepatterning of the diencephalic area and the formation of the 
zona limitans intrathalamica (ZLI) 
 
In the process of neural patterning (or regionalisation), morphogens induce 
neural patterning by providing positional information through controlling the 
expressions of transcription factors in the neural progenitor cells. By binding 
to the regulatory elements on DNA and altering the expression of specific 
genes, transcription factors can initiate cascades of various signalling 
pathways in these neural progenitor cells. As a result, the progenitor cells 
undergo a sequence of finely regulated events of proliferation, cell fate 
specification, migration and eventually acquire their specific neuronal shape 
and position within a fully developed brain (1,11,20). During neural 
development, morphogens are released by groups of cells called organisers 
(11). While the primary organisers are responsible for releasing the first 
batches of morphogens, the secondary organisers carry on this job further in 
development, fine-detailing structures in the forebrain, midbrain and the 
hindbrain (8,11). 
 
Secondary organisers (or local organisers) are small groups of cells that direct 
development of the surrounding tissues by secretion of signalling molecules 
while at the same time serve as segment boundaries that prevent mixing of 
cells with their neighbours. Loss of secondary organisers leads to loss of the 
surrounding structures. Additionally, ectopic induction of cell fates of the 
secondary organisers and ectopic provision of principle signal molecules of the 
secondary organisers can both result in the ectopic appearance of respective 
surrounding structures (1,20,21). The effectiveness of the secondary 
organisers in directing development depends on the timing of their presence, 
the efficiency of the signal molecules’ spread and also the competence of the 
target cells to respond to a particular combination of signal molecules (2,21). 
 
During development of the diencephalon, secondary organisers play critical 
roles in the execution of this AP, DV patterning. One of the most important 
secondary organisers for diencephalic AP patterning is the zona limitans 
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intrathalamica (ZLI), which is a narrow strip of cells separating the thalamus 
and prethalamus (Figure 1.2B) (2,8,11). The ZLI forms at about E9-10 in 
mouse embryos (22). It appears as a wedge-shaped lineage-restricted 
compartment with sonic hedgehog (Shh) expression that initiates ventrally 
from the basal plate and extends dorsally through the alar plate to the roof 




Figure 1.2 Schematic representation of regions where the major morphogens are 
expressed in the early and late neural tube stages in amniote embryos. (A) At early 
neural tube stage, prior to the formation of the ZLI, Shh is produced and released by the 
floor and basal plate (green). The other major morphogens being produced and released at 
this age are the Wnts at the dorsal midline (red) and the Fgfs at the commissural plate and 
midbrain-hindbrain boundary (blue). The expression of the Wnts comes in a gradient of 
caudal-high and rostral low, due to the repression of expression by Wnt antagonist such as 
Dkk1 in the rostral telecephalon. (B) At late neural tube stage, the three prosomeres of the 
diencephalon (P1-P3) had developed into the pretectum (ptec), the thalamus (th) and 
epithalamus, and prethalamus (pth). The zona limitans intrathalamica (ZLI) is a wedge-
shaped structure with its Shh expression appears to be a distinct spike, which extends from 
the floor plate through the alar plate, towards the roof plate. Shh is also produced and 
released by the floor plate and the medial ganglionic eminence at this stage. Figure adapted 
from reference: (11). 
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Similar to the other regions of the developing CNS, the morphogen Shh in the 
diencephalon is also produced and released ventrally by the floor and basal 
plate (24). However, Shh released dorsally by the wedge-shaped structure of 
the ZLI that extends into the alar and roof plate is an additional source (4,13). 
So far, the mechanisms underlying the positioning and formation of the ZLI still 
remain elusive.  
 
It is hypothesised that the ZLI initiates at the ventral midline where the 
prechordal neural plate (expressing transcription factor Six3) and the 
epichordal neural plate (expressing transcription factor Irx3) meet (20). Later, 
several studies questioned the advocated critical role of Six3 and Irx3 in 
establishing the ZLI domain. Scholpp and Lumsden thus proposed that instead 
of Six3 and Irx3, transcription factor Fez and Otx in the prechordal and 
epichordal plate should be the determinants of ZLI initiation (2). Analysis of 
expression patterns showed that the domain of Otx1 and Otx2 abut that of 
Fez’s in the developing zebrafish neural plate whereas loss of function analysis 
indicated that both Fez and Otx are required for ZLI initiation (25,26). However, 
evidence from these studies only proved that in vivo interaction of the 
prechordal and epichordal domain itself was sufficient to initiate formation of 
ZLI, indicating the possibility that transcription factors other than Fez and Otx 
might also contribute to ZLI initiation. 
 
Interestingly, the ZLI is also the only place in the neural tube where the 
expression domain of Shh expands dorsally to form a distinct spike (24). It was 
widely speculated that the mechanism underlying ZLI development was a 
progressing expansion of Shh domain from the Shh-positive basal plate to the 
roof plate (2). However, fate map analysis failed to identify the anticipated 
dorsally migrating cells, whereas zebrafish lacking the Shh-expressing basal 
plate established a nearly normal ZLI (27). One reasonable explanation is the 
weakening of repression against Shh expression from the dorsal portion (28). 
For example, studies in chick embryos have found that early expression of 
Wnt8b in the ZLI antagonises the expression of Gli3, an inhibitor of Shh 
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signalling, therefore creating a permissive area for Shh expression within the 
ZLI later on (28). Additionally, in Zebrafish, canonical Wnt signalling initiated 
by Wnt3 and Wnt3a inhibits apoptosis and promotes proliferation of cells in the 
ZLI primordium (29). Furthermore, retinoic acid (RA), a signalling molecule 
expresses in the diencephalic roof plate, can block Shh expression in 
diencephalic explants. Therefore, inhibition of RA can create a permissive 
region for dorsal development of the ZLI (30,31).  However, exactly how this is 
achieved needs more thorough investigations. 
 





During development, the ZLI produces and releases several morphogenetic 
signals into the neighbouring tissue that play critical roles in specifying the 
intricate details of the diencephalic development (8). While Wnts, fibroblast 
growth factors (FGFs), RA and bone morphogenic proteins (BMPs) instruct the 
development of dorsal structures in the diencephalic epithelium, Shh is the 
primary signal that acts ventrally (8,32).  
 
The ZLI’s expression of Shh is one of the key sources of signals that pattern 
the diencephalon as abolishing Shh expression in chick and zebrafish results 
in the loss of cell identity and morphogenetic transcription factors in the 
prethalamus and thalamus (2,24). On the other hand, ectopic expression of 
Shh by way of activation of the Shh receptor (smoothened, SmoM2) promotes 
the expression of several thalamic markers such as Gbx2, Neurog2, Olig2 and 
Olig3 in the mouse pretectum (33). These results not only proved the 
qualification of the ZLI as a local organiser but also highlighted the central 
position of Shh in directing diencephalon development. Kiecker et al. further 
demonstrated that Shh is both necessary and sufficient for initiating expression 
of Dlx2 and Gbx2, which are markers for prethalamus and thalamus 
respectively (24). So how does a common morphogen initiate the acquisition 
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of entirely different identities among neighbouring cells? This is due, at least 
in part, to the different competencies of adjacent cells that have been 
established prior to the expression of Shh (2). For example, different Wnt 
signalling gradients that express dorsally set up a coarse prepattern of 
competence in respective areas by inducing transcription factors such as 
FezF1, FezF2 anteriorly and Irx posteriorly (34). Ectopic expression of Irx in 
prethalamus against a Shh-expressing background results in ectopic 
expression of thalamic markers such as Sox14 and Gbx2 (24), while the Fez 
genes in combination with Shh expression seems to have similar effects in 
initiating ectopic expression of prethalamic markers (25).  
 
A small rostral thalamic progenitor region immediately caudal to the ZLI, which 
is exposed to relatively high levels of Shh, is referred to as pTH-R (Figure 1.3B) 
(35). pTh-R expresses marker genes such as Ascl1 (also known as Mash1) 
and Nkx2.2 (22). Unlike the majority of the thalamic progenitors, pTh-R 
generates mostly GABAergic neurons (4). Shh is crucial for specifying the pTh-
R, as specific deletion of Shh in the ZLI resulted in the loss of pTh-R and 
expansion of the pTh-C (22). On the other hand, expansion of pTh-R was 
observed in Pax6 mutant mouse embryos where Shh expression was elevated 
(22,33,36). Caudal to the pTH-R, a larger thalamic progenitor region is referred 
to as pTH-C, which expresses marker genes such as Ngn2 and Olig3 and 




Various genes involved in the Wnt signalling pathways are expressed in the 
developing diencephalon in a temporally and spatially restricted manner 
(28,37,38). In this context, the Wnt/β-catenin signalling has been most 
extensively studied. 
 
Before the onset of neurogenesis, the Wnt/β-catenin signalling plays pivotal 
roles during formation of the ZLI and subsequently facilitates the expression 
of Shh within the ZLI (28,29,32,39). Braun et al. have shown that high levels 
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of Wnt3 and Wnt3a in the posterior neural tube specify the caudal forebrain 
fate by inducing the expression of Irx3. However, in the anterior neural tube, 
canonical Wnt activities are suppressed by DKK1 released from the underlying 
prechordal plate. Low levels of canonical Wnt activities anteriorly enable the 
expression of Six3, which further specifies the rostral forebrain fate. This 
opposition and mutual repression of Irx3 and Six3 can further contribute to 
locating the position of the future ZLI (39).  
 
During and after neurogenesis, canonical Wnt signalling continues to modulate 
the development of the diencephalon. The nuclear β-galactosidase reporter 
(BAT-gal) mice transcribe the LacZ gene under the control of the β-
catenin/TCF responsive elements, upon active canonical Wnt signalling (40). 
These mouse embryos showed distinct and highly contrasting levels of 
canonical Wnt activities within the diencephalon, with thalamus, ZLI, and a 
small prethalamic region directly rostral to the ZLI being highly active, whereas 
a small gap between the ZLI and the thalamus, and the rest of prethalamus 
lack canonical Wnt signalling (36). These results are in concordance with 
others’ findings that the expressions of mediator and reporter genes for 
canonical Wnt signalling, such as Axin2, Lef1 and Tcf7l2 are highly localised 
within the thalamus (36,38,40). Regarding Wnt ligands themselves, Wnt3, 
Wnt3a, Wnt8b and Wnt5a are all expressed strongly in the ZLI and at weaker 
levels in the thalamus, whereas Wnt7b is expressed in ventral regions of the 
thalamus as well as the prethalamus (36–38,41,42).  
 
These highly localised expressions of Wnt and Wnt-related genes in the ZLI 
and thalamus at stages beyond patterning indicates other functions of this 
signalling pathway in the developing diencephalon. Indeed, studies have 
revealed that ectopic expressions of Wnt3 and Wnt3a were sufficient to induce 
the expression of thalamic marker Gbx2 in chick forebrain explants, via 
activation of the caudal forebrain marker Irx3 (39). On the other hand, 
inactivation of canonical Wnt signalling in pTh-C by selective deletion of β-
catenin in this region has shown upregulation of marker genes for pTh-R and 
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prethalamus in the mantle zone of the pTh-C (36). Additionally, in mice lacking 
the LRP5/6 co-receptor, ectopic expressions of prethalamic markers such as 
Dlx2 were found in the mantle zone of the thalamus (32), whereas in mice 
lacking Tcf7l2, severe reduction of thalamic post-mitotic markers such as Rora 
and Hs6st2 was observed, along with expansion of habenular markers such 
as Robo3, Irx1 and Irx2 into the caudal thalamus (43). These findings highlight 
the significance of Wnt/β-catenin pathway in specifying caudal thalamic 




Fibroblast growth factor 8 (FGF8) is expressed in the dorsal part of the 
diencephalon, in a region towards ZLI but slightly anterior to the Shh domain 
(44). pTh-R, the area that flanks ZLI posteriorly with the characteristic marker 
of Nkx2.2 and Sox 14 seems to be controlled by Fgf8 expression (16). Studies 
utilised in utero electroporation to manipulate Fgf8 expression in the 
developing diencephalon of mouse revealed that Fgf8 activates expression of 
the pTh-R marker Ascl1 while it represses that of the pTh-C marker Ngn2 in a 
Shh and Wnt-independent way (16,32). The above information indicates that 
in addition to the prominent effect of Shh-expression on thalamic patterning, 
the expression of Fgf8 might act as another restraining factor that fine-tunes 
the intricate structures of at least the thalamus. Such a mechanism might be 
well adopted in other parts of the diencephalon to secure its correct patterning 
during development. 
 
1.1.5 Specification of neuronal identities and early circuit formation of 
the diencephalic nuclei 
 
1.1.5.1 Region-specific expressions of transcription factors 
specify diencephalic nuclei 
 
As a result of these interplays between morphogens and transcription factors, 
the diencephalon is subdivided into distinct areas that express specific 
transcription factors (4,8,14,32). These transcription factors further convey 
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information of cell fate specification and direct the differentiation and migration 
of diencephalic cells into nuclei with distinct functions, connections and 
architectonic features (cell density and morphology) (4,8). Therefore, 
recognising the genes and TFs expressed in specific diencephalic 
subpopulations will help us understand the underlying mechanisms of how 
these nuclei are formed and how they function.  
 
The diencephalon is a piece of highly heterogeneous tissue (4,8,14,45). Gene 
expression profiles of P1, P2 and P3 showed distinct expression boundaries 
correlated with morphological boundaries (8,13,14). The thalamus and 
prethalamus display rather different expression profiles of genes and 
transcription factors, although they reside on either side of the ZLI and hence 
are under the influence of the same morphogens (8,14,32). In both the 
thalamus and prethalamus, progenitor cells in the ventricular zone mostly 
exhibit different expression profiles of genes than post-mitotic cells that have 
started migrating away from the VZ (8,14,22,35,46,47). For example, In the 
thalamus, the transcription factor Olig3 is expressed in the pTh-C, pTh-R and 
the ZLI, with its ventral boundary abutting the dorsal boundary of prethalamus 
directly (4,22,35). On the other hand, Olig2 is expressed in the ventricular zone 
of the prethalamus, with its dorsal boundary abutting the ventral boundary of 
Olig3 directly (22,48). Olig2 is also expressed in the pTh-C, in a rostral-ventral 
high gradient (35). Interestingly, Dbx1 is expressed in the caudal-dorsal part 
of pTh-C, which complimented the gradient of Olig2 (35). Dbx1 is also 
expressed in the rostral half of P1 pretectum (35). Transcription factor 
Neurogenin1 (Ngn1) is also expressed in the pTh-C, whereas Neurogenin2 
(Ngn2) is expressed in pTh-C and further maintained in the pTh-C derived 
thalamic neurons (35,36,49). Ngn1 and Ngn2 are both target genes of 
canonical Wnt signalling (36). Previous studies have shown that their 
expressions are crucial to antagonise ectopic expression of pTh-R and 
prethalamic markers in the pTh-C and its mantle zone area (36). Other pTh-C 
markers include Fgf15 (rostrodorsal), Irx5 (rostrodorsal), Ebf3, Barhl2 and 
Shox2 (4,47,50) (Figure 1.3B-C).  
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pTh-C gives rise to glutamatergic projecting neurons, whereas the pTh-R give 
rise to GABAergic interneurons that, although they do not project to the cortex, 
will integrate with the glutamatergic projecting neurons and become part of the 
thalamic nuclei (4,22,35). The pTh-R expresses a selection of transcription 
factors unique to itself, such as Ascl1, Nkx2.2, Helt2, Gata2, Gata3, Tal1, Tal2 
and Sox14 (4,22,35,51) (Figure 1.3B-C). It is known that the interaction 
between Helt and Ascl1 is required to maintain pTh-R fate (51).  
 
Although Shh is always used as a marker for the ZLI, the expressions of other 
transcription factors can also outline the ZLI and its surrounding regions. For 
example, Ngn2 is expressed in the caudal part whereas Dbx1 is expressed in 
the rostral part of the ZLI (Figure 1.3B-C) (22). Neurons derived from the ZLI 
contribute to both the thalamic nuclei, such as the dorsal lateral geniculate 
thalamic nuclei (dLGN) and prethalamic nuclei, such as the ventral lateral 
geniculate thalamic nuclei (vLGN) (35,52,53). 
 
As development proceeds, the expression profiles of thalamic progenitor cells 
change accordingly (4,8,47,50). For example, pTh-C derived post-mitotic cells 
turn on their Gbx2 expression, which is one of the first genes identified as a 
thalamic marker (35,54). Global disruption of Gbx2 leads to ectopic expression 
of marker genes of P1-derived neurons, defective maturation of thalamic 
neurons, malformation and mispositioning of the distinct thalamic nuclei 
(4,55,56). Other TFs expressed specifically by pTh-C derived neurons, which 
are under the transcriptional regulation of Gbx2, are Rorα, Id4, Chst1, Glr1, 
Cd47, Slc18a2 (also known as Vmat2), Gas7, Hs6st2, Epha3 and Prokr2 
(4,47,55). In addition to Gbx2, Lhx2 and Lhx9 are both expressed in the post-
mitotic derivatives of pTh-C, whereas Foxp2, Nhlh2 and Kitl are expressed in 
the lateral pTh-C-derived mantle zone (47,49,50). The very few transcription 
factors, whose expressions are maintained from thalamic progenitor cells to 
post-mitotic cells are Sox2, Shox2 and Ngn2 (35,47,50). Sox2 is expressed in 
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the pTh-C and by E16.5, its expression becomes restricted to post-mitotic 
neurons in a rostral-lateral high manner (4,35) (Figure 1.3B, D). 
 
Unlike the thalamus, detailed analysis of gene expression profiles in 
prethalamic subpopulations, and how each of these subpopulations further 
develops into individual nuclei is much less studied. Several transcription 
factors known to mark specific prethalamic regions include Pax6, Gsx2, Dlx1, 
Dlx2, Isl1, Six3, Arx, Olig2 and Ascl1 (8,22,45,48,57). As mentioned above, in 
the thalamus, the expression of Pax6 displays a gradient in the ventricular 
zone as its intensity increases with distance from the ZLI (22). However, in the 
prethalamic ventricular zone, Pax6 is expressed in a homogeneous level 
(22,58). Additionally, Pax6’s expression is maintained in some of the 
prethalamic post-mitotic cells (22,58,59). Interestingly, the level of Pax6 
expression in the prethalamic post-mitotic cells is much higher than that in the 
prethalamic progenitors (58)(60). Dlx1 and Dlx2 are both expressed in the 
ventricular zone of the prethalamus, with Dlx1 expression maintained by post-
mitotic cells in the dorsal prethalamus, close to the ZLI (16,48,51) (Figure 1.3B-
C).  
 
Prethalamus also produces GABAergic interneurons, which unlike thalamic 
projecting neurons that innervate the cortex, project to and only innervate the 
neurons in the thalamic nuclei (8). Gsx2, a marker for progenitors with 
GABAergic fate, is expressed in all the ventricular zone of the prethalamus 
(22,59,61). The expression pattern of glutamic acid decarboxylase 67 
(GAD67), which functions to mediate GABA synthesis, complimented that of 
Gsx2’s and is found in the post-mitotic cells of the prethalamus (16,62). In 
addition to Gsx2, expressions of Olig2 and Ascl1 are also found only in the 
ventricular zone of the prethalamus, as mentioned above (22,48). Isl1 is 
expressed in the medial-lateral post-mitotic region of the prethalamus, with its 
dorsal border slightly overlapping with the ventral border of Pax6’s expression 
(60). Six3 and Arx are expressed in both the VZ and post-mitotic region of the 
ventral prethalamus (16,50,63) (Figure 1.3B, D). Notably, in addition to 
 16 
GABAergic neurons, a small region that is close to the VZ in the dorsal 
prethalamus produce a subpopulation positive for tyrosine hydrolyse (TH), 
which will further develop into A13 sub-nucleus that harbours dopaminergic 





Figure 1.3 Schematic representation that summarizes early domain specification and 
different nuclei in the developing diencephalon. (A) Scheme of sagittal section through 
the early developing brain with prosomere 1-3 and key morphogens indicated. (B) Schematic 
representation of coronal view of the neural tube sectioned at the level indicated by the dash 
line in (A). Different regions of the diencephalon were indicated with areas marked with 
different colours. (C) Progenitor domains and transcription factors expressed in ventricular 
zone (VZ) of the diencephalon. (D) A selection of transcription factors expressed in thalamic 
and prethalamic neurons around E14.5, region of expression indicated. PT pretectum, PTh 
prethalamus. ZLI zona limitans intrathalamica. Figure (A), (C), (D) adapted from (4). 
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1.1.5.2 The thalamic nuclei 
 
Under the instructions of combinational expressions of specific transcription 
factors, most thalamic cells start to differentiate and further organise into 
various thalamic nuclear complexes at about E15.5 (4). Together, they form 
one of the most important sensory information relay stations to the cortex (1,2). 
 
The thalamic nuclei derived from the P2 alar plate are named and classified 
according to their topographic positions within the thalamus and by their 
function (4,8). The posterior nuclei (Po), derived from the Sox2 positive 
thalamic progenitors, are involved in pain transmission, visual orientation, eye 
movement and accommodation, as well as auditory and visual information 
relay (4,8,35,65). The ventral posterior nucleus, which can be further divided 
into posterolateral (VPL) and posteromedial (VPM) sections, also derives from 
the thalamic Sox2 lineage and is related to sensorial systems (4,8). The medial 
dorsal thalamic nuclei (MD) and the centromedian nuclei (CM) both derive from 
thalamic Dbx1 lineage progenitors and express Gbx2 stably (4,6,35). MD 
functions to modulate emotional arousal and the expression of emotional 
based behaviour, memory and feelings of pleasure (8). CM, together with 
intramedular, regulate excitability levels within the cerebral cortex, thus play 
significant roles in arousal and alertness in tune with circadian rhythm (8). The 
ventral lateral (VL) and ventral anterior (VA) nuclei modulate motor function 
whereas the anterior nuclei (AN) resides at the rostral pole of the thalamus, 
functions to modulate alertness, learning and memory (4,8). The medial 
geniculate thalamic nuclei (MGN) relays impulses from auditory structures to 
auditory centres of the cerebral cortex (8). The ventral MGN (MGv) is derived 
from thalamic progenitors positive for both Sox2 and Gbx2 expression (4,35). 
Other thalamic markers explicitly enriched in the MGv include Foxp2 and 
Shox2 (53). The lateral geniculate thalamic nuclei (LGN) process visual 
information and send it on to the visual cortex (Figure 1.4) (8).  
 
The other P2 alar derivative, the epithalamus, further differentiates into 
habenular nuclei, stria medullaris tract and pineal body. The habenular nuclei 
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participate in motor and cognitive actions while the pineal gland (epiphysis) 
controls the internal circadian clock by way of melatonin secretion (8).  
 
1.1.5.3 The prethalamic nuclei 
 
Likewise, postmitotic neurons of the prethalamic derivative of P3 also form 
nuclei of characteristic functions (8). However, in contrast to the thalamus’s 
relay of information to the cortex, nuclei of prethalamic origin possess no 
projection to the cortex whereas they mostly establish efferent connections 
with the thalamic nuclei, the striatum, the red nucleus and the substantia nigra 
(SN) (8).  
 
In rodents, the main prethalamic derivatives of the P3 alar plate include the 
reticular thalamic nucleus (RTN), the zona incerta (ZI), the intergeniculate 
leaflet (IGL), the subgeniculate nucleus (SGN) and the ventral lateral 
geniculate nucleus (vLG) (Figure 3E) (8). Noted that the vLG has a mixed 
origin of cells from the prethalamus, pTh-R, ZLI, and thalamus, with thalamic 
neurons contribute to the dorsoventral region of vLG (4,53,66). The Ret, vLG 
and ZI together connect with other thalamic nuclei, modulating all incoming 
and outgoing information of the thalamus (8). Almost all the neurons in the 
RTN and most neurons in the vLG and ZI are GABAergic, apart from the A13 
sub-nucleus in the ZI that accommodates dopaminergic neurons (45,64,66,67). 
Gene expression analysis of P0 mouse coronal sections showed that Dlx2, 
Isl1 and Six3 are expressed in both ZI and RTN at this age, whereas TH is 
only expressed in the A13 sub-nucleus and GAD67 is only expressed in the 
TRN and ventral ZI (57). Postnatally, Pax6 expression is maintained mainly by 






Figure 1.4 Schematic representation of the diencephalic nuclei.  
 
(A) Summary of the different nuclei and structures in the mammalian diencephalon. Major 
axon tracts were also presented. The P1 alar plate further develops into, from rostral to 
caudal, the precommissural pretectum (PTp), the yuxta commissural pretectum (PTy), and 
the commissural pretectum (PTc). The alar derivatives of P1 function to process afferent 
visual information as well as regulates visual reflexes formation, while the basal 
derivatives of the P1, which include the anterior pole of ventral tegmental area (VTA), 
substance nigra (SN) that involves in movement control, and the interstitial nucleus of 
Cajal (IC) that functionally involves in head orientation reflexes. The thalamic nuclei 
derived from the P2 alar plate can be further grouped into the lateral thalamic complex, 
which is responsible for somatosensory relay and motor control; the medial thalamic 
complex that extends projection to the prefrontal cortex, the striatum and the part of the 
cerebral cortex that innervate the same part of the striatum; the anterior thalamic complex, 
which participates in information relay from the mammillary nuclei to the limbic cortex; the 
posterior thalamic complex, which is involved in pain transmission, visual orientation, eye 
movement and accommodation, and auditory and visual information relay. The 
prethalamic derivatives of the P3 alar plate include: the reticular thalamic nucleus (Ret), 
the ventral lateral geniculate nucleus (vLGN), the subgeniculate nucleus (SG), the zona 
incerta (ZI), the intergeniculate leaflet (IGL) and the caudal pole of vLGN. The Ret, vLGN, 
SG and ZI together connect with other thalamic nuclei, modulating all incoming and 
outgoing information of the thalamus. P1 teg, P2 teg and P3 teg represents the tegmental 
parts of prosomeres 1-3.  
 
(B) (B-C) Atlas of the diencephalic nuclei in the postnatal day 56 mouse brain from the coronal 
view (B) and sagittal view (C). Noted that not all the diencephalic nuclei mentioned in the 
text could be found at this level of sectioning.  
 
Abbreviations for nuclei in the (B) but not mentioned in the text: nuclei derived from the 
epithalamus: medial habenula (MH), lateral habenula (LH); thalamic nuclei: 
intermediodorsal nucleus of the thalamus (IMD), medial dorsal thalamic nuclei central part 
(MDc), medial part (MDm) and lateral part (MDl), paraventricular nucleus of the thalamus 
(PVT), central lateral nucleus of the thalamus (CL), lateral dorsal nucleus of the thalamus 
(LD), paracentral nucleus (PCN), ventral anterior-lateral complex of the thalamus (VAL), 
ventral medial nucleus of the thalamus (VM), rhomboid nucleus (RH), nucleus of reuniens 
(RE), submedial nucleus of the thalamus (SMT), perireunensis nucleus (PR); prethalamic 
nuclei: reticular nucleus of the thalamus (RT); axon tract: mammillothalamic tract (mtt).  
 
Abbreviations for nuclei in the (C) but not mentioned in the text: thalamic nuclei: 
anterodorsal nucleus (AD), anteroventral nucleus of thalamus (AV), anteromedial nucleus 
(AM), lateral posterior nucleus of the thalamus (LP), parafascicular nucleus (PF), 
subparafascicular nucleus, parvicellular part (SPFp), ventral posteromedial nucleus of the 
thalamus, parvicellular part (VPMpc); ml represents one of the fibre tracts.  
 




1.2 Neuronal morphogenesis underlying functional 
neural circuit formation 
 
1.2.1 Neuronal morphogenesis 
 
After cell fate specification, newborn neurons undergo active migration to 
reach their final destination, acquire their specific morphology and eventually 
form synapses with appropriate partners (1). This process is known as 
neuronal morphogenesis. Due to technical difficulties in visualising neuronal 
morphogenesis in vivo, the majority of our current knowledge was obtained 
from in vitro systems. Initially characterised in cultured neurons, neuronal 
morphogenesis can be roughly divided into five stages (69,70). Shortly after 
being plated in culture, the morphologically undifferentiated neurons start to 
extend circumferential actin-rich lamellipodia and filopodia (Stage 1, Figure 1.5) 
(69,70). During the transition from Stage1 to Stage2, neuritogenesis happens 
as the actin-rich lamellipodia, and filopodia further protrude and become 
engorged by microtubules and thus turn into minor neurites. Upon the 
completion of neuritogenesis, neurons typically display multiple minor neurites 
that undergo continuous protrusion and retraction, and all of them have the 
potential to become axons (Stage2, Figure 1.5) (70,71). If no external cues are 
present at this stage, intrinsic mechanisms break neuronal symmetry by 
activation/inhibition of localised cytoskeletal effectors, which further influence 
microtubule stability and actin dynamics in the growth cone at the tip of each 
neurite. As a result, the neurite with a larger and more dynamic growth cone 
will elongate more rapidly and become the axon (70,72). This process is known 
as axon specification, whose occurrence marks the neurons’ transition from 
Stage2 to Stage3 and bestows upon the developing neurons’ polarity (Stage3, 
Figure 1.5) (70,73). The axonal region further suppresses elongation of other 
neurites, which thus remain short and only develop into dendrites at later 
stages (70). At Stage4, the axon continues to elongate and differentiate, 
whereas other neurites acquire their dendritic identities and start to grow and 
arborise. Further on, at Stage5, neurons start to make synapses, develop 
dendritic spines and form neuronal circuits (Stage4-5, Figure 1.5) (70). 
 23 
 
Recent advances in tissue culture and imaging techniques have shown that 
some of the typical morphologies described in cultures are analogous ex vivo. 
For example, several studies have reported that newborn cortical neurons 
displayed multiple processes when they migrate to the subventricular zone 
(SVZ) of the cortex (74–76). These processes were in a constant state of 
extension and retraction, which highly resembled the multiple neurites in 
cultured neurons at Stage2 (74,75). Upon exit of the SVZ, morphological 
transitions that resembled neuronal polarity establishment were also recorded 
as these cortical neurons displayed morphological changes from multipolar to 
unipolar (74,76). However, to date, a truly definitive in vivo description of 







Figure 1.5 Neuronal morphogenesis can be divided into a series of stages which were 
initially characterized in cultured neurons, but also seem to occur in vivo. Figure 
adapted from (70). 
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1.2.2 Reorganization of the cytoskeleton during neuronal 
morphogenesis by effector genes 
 
In vivo, an array of extracellular cues direct neuronal morphogenesis by 
coordinating the establishment of neuronal polarity and axon specification in 
addition to the intrinsic mechanisms and guide the axons towards proper target 
destinations for innervation (77). The external cues do so by binding with 
specific membrane receptors in the growth cones, which then activate various 
signalling pathways (77,78). Such reactions are then relayed to different 
cytoskeletal effectors that eventually carry out extensive remodelling of the 
actin and microtubule cytoskeleton (77). 
 
Take nerve growth factor (NGF), an inductive signal for neuronal polarisation 
and axon elongation, as an example. Although being incompletely defined, it 
is proposed that the binding of NGF with tyrosine receptor kinases (Trks) on 
the growth cone cell membrane activates PI3K, the latter then phosphorylates 
phosphatidylinositol-4,5-bisphosphate (PIP2) to produce phosphatidylinositol-
3,4,5-trisphosphate (PIP3) in the cell membrane (Figure 1.6B). Local activation 
of PI3K and accumulation of PIP3 then activate their downstream targets, such 
as protein kinase B (PKB, also known as AKT) and Rho-GTPases. One of 
AKT’s functions is to phosphorylate and inactivate glycogen synthase kinase 
3β (GSK3β). GSK3β inactivates the activity of several microtubule-associated 
proteins (MAPs) on a post-translational level by phosphorylating these MAPs. 
Upon being phosphorylated, GSK3β substrates such as Tau, adenomatous 
polyposis coli (APC) and Collapsin-response mediator protein-2 (CRMP-2) 
lose their abilities to stabilise microtubule or assembling tubulin dimers onto 
the growing microtubules. Thus, localised inactivation of GSK3β by the PI3K-
AKT pathway results in microtubule polymerisation and cytoskeletal 
remodelling that precedes neuronal polarity establishment (79). Besides, 
localised activation of PI3K can also activate the PI3K–partition defective 
protein (Par) complex. The core of the Par polarity complex is composed of 
Par3, Par6 and atypical protein kinase C (aPKC). The Par complex also 
functions to specify axons from neurites by regulating activities of the MAPs, 
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whereas aPKC itself can also phosphorylate GSK3β, thereby antagonise 
GSK3β’s action (78) (Figure 1.6B).  
 
While signalling pathways converging on GSK3β mainly influence microtubule 
dynamics, regulations of the actin cytoskeleton upon neuronal polarity 
establishment are mostly carried out by three Rho-GTPases (Rho, Rac and 
CDC42). Binding of inductive signals with membrane receptors leads to the 
activation of different kinds of guanine nucleotide exchange factors (GEFs) or 
GTPase activating proteins (GAPs). The former activates whereas the latter 
inactivates specific Rho GTPases. Activations of Rac and CDC42 by GEFs 
such as the DOCK family proteins antagonise the activity of the RhoA-ROCK 
pathway and further lead to activation of specific actin-binding proteins (ABPs) 
that increase actin cytoskeleton dynamics and facilitate actin bundling (77). 
Additionally, signalling pathways relaying onto PI3K and the Par polarity 
complex can also influence actin cytoskeleton remodelling thus coordinating 
cytoskeletal changes among the actin and microtubule systems (Figure 1.6B) 
(78).  
 
The special cytoskeletal arrangements within the growth cone enable it to 
respond to these external cues with corresponding behaviours. The growth 
cone thus serves as a sensory and motile organelle that directs neurite/axon 
pathfinding and target recognition for precise wiring of the neural circuitry (80). 
In response to inductive guidance cues, the actin cytoskeleton in the periphery 
of the growth cone bundles together to support protrusion of nascent 
lamellipodia and filopodia, whose stability is further enhanced by engorgement 
with microtubules. As a result, the once motile proximal section of the growth 
cone consolidates and becomes a new section of the extending axon, whereas 
the distal part of the growth cone ventures further. The actin and microtubule 
cytoskeleton in the growth cone are continuously engaged in this three-step 
cycle of protrusion, engorgement and consolidation in response to gradients 
of external cues, thus achieving growth cone advancement hence axon 





Figure 1.6 Schematic representation of key molecular pathways in regulation of 
neuronal polarity establishment. (A) Stages of development of cultured neurons showing 
the breaking of symmetry that begins in stage 2 neurons with the enlargement of the growth 
cone of the presumptive axon, followed by the accelerated growth of the axon (red) during 
stage 3. The red circle and arrow both point to the enlargement of a sub-membranous 
domain in the growth cone of the future axon as shown in (B). (B) The coordination of 
various molecular pathways underlies axon specification during establishment of neuronal 
polarity. The process requires the contribution of actin cytoskeleton remodelling factors 
(blue), such as cofilin, and factors that regulate the dynamics of microtubules (red), such as 
MAPs. Some factors stand at the crossroads of the microtubule and actin cytoskeleton 
regulations, such as PI3K (yellow). Figure adapted from (78). 
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1.2.3 Axon initial segment maintains neuronal polarity and determines 
the excitability of neurons 
 
Neurons are highly polarised in terms of their morphology, directions of 
information transmission and subcellular structures as ion channels, 
organelles and protein complexes, which are restricted to distinct membrane 
domains or cellular compartments (81,82). Neuronal polarities as such are 
established during neuronal morphogenesis, under the combinational 
influence of intrinsic and extrinsic mechanisms, and will be maintained 
throughout the lifetime of the neurons (81,83). All the above forms of neuronal 
polarity are regulated and exemplified by the axon initial segment (AIS), which 
is a subcellular structure located at the proximal end of the axon that serves 
as both a physiological and a physical bridge between the somatodendritic and 
axon domains (Figure 1.7A-A’) (81). A range of cytoskeletal proteins, cell 
adhesion molecules and voltage gated ion channels are meticulously arranged 
within the AIS (81,82). For example, fasciculated microtubules and actin rings 
are the cytoskeletal backbones of the AIS. Cell adhesion molecules, voltage-
gated Na+ and K+ channels at the cell membrane of the AIS region are 
tethered to this cytoskeletal backbone via the other two cytoskeletal proteins 
βIV Spectrin and Ankyrin G (AnkG, also known as Ank3) (81,82) (Figure 1.7C). 
It has been shown that Na+ channel density in the AIS is about 40-50 times 
that in the soma or proximal dendrites (81,84,85). As a result, this high degree 
of subcellularly polarised enrichment of Na+ channels facilitates a high Na+ 
influx upon stimulation (84,86). Therefore, the AIS is usually where the action 
potential initiates, and its specific structure and molecular constituents 
determine the excitability and electrophysiology profile of the neurons 
(81,86,87).  
 
The AIS was first described more than 50 years ago (88). However, until today, 
many crucial steps during AIS assembly remain elusive (82). For example, we 
are still trying to understand how the location and length of the AIS are 
determined, and how the ion channels are recruited to the AIS during 
development (81,82). Nevertheless, it is known that the AIS assembly is an 
 28 
intrinsic property of the neurons as no extracellular or glial-dependent cues are 
required (81,89). The cytoskeletal scaffold protein AnkG plays a determining 
role during AIS assembly due to its modular structure (81,82,90). AnkG has a 
membrane binding domain, a spectrin-binding domain, a serine-rich domain, 
a tail domain and a carboxyterminal domain (Figure 1.7B) (82,91). With its 
membrane binding domain, AnkG can bind to the cytoplasmic portion of the 
transmembrane Na+ channels, K+ channels and cell adhesion molecules 
(CAMs) such as NrCAM and Neurofascin 186 (NF 186). With its spectrin 
binding domain, AnkG is able to tether itself to the underlying cytoskeletal 
scaffold protein βIV spectrin and aII spectrin. One end of the spectrin protein 
is anchored on the actin ring backbone of the AIS, whereas the other end is 
tethered to the overlying plasma membrane (82). As a result, by binding to the 
voltage-gated ion channels, cell adhesion molecules and spectrin proteins, 
AnkG is able to enrich the distribution of voltage-gated ion channels within the 
AIS region while also securing such a specialised structure to the overlaying 
plasm membrane, the underlying cytoskeleton and also the surrounding 
environment (Figure 1.7C). Besides, AnkG is also essential for the long-term 
stability of the AIS in mature neurons (81,82). Suppression of AnkG expression 
in hippocampal neurons using short hairpin RNA (shRNA) results in 
disassembly of the AIS with diminished expressions of Na+ channels, βIV 
spectrin and the AIS adhesion molecules NrCAM and NF 186 (92).  
 
In neuronal cultures, AnkG clusters along the proximal axon early during 
development (about 3-4 days in vitro (DIV)), which further directs AIS 
assembly by recruiting the other AIS components such as ion channels, CAMs 
and βIV spectrin (82,93). However, little is known about the mechanisms that 
guide the concentrated distribution of AnkG to the putative AIS region (81). It 
has been shown that soon after the establishment of neuronal polarity and 
axon elongation, the periodic actin rings can be seen prior to the assembly of 
AIS (94). These actin rings likely coordinate the micro-architecture within the 
AIS, and serve as the initial scaffold, on which the future AIS will be assembled 
(94,95). However, actin rings as such are not sufficient to restrict the AIS 
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complex to the proximal axon, as they are present throughout the entire axon 
(95). The actin rings at the proximal axon are organised by βIV spectrin 
whereas the actin rings at the distal axon are organised by βII spectrin. While 
βIV spectrin tethers AnkG, βII spectrin tethers Ankyrin B (AnkB) (94,95). It is 
known that AnkG and AnkB compete against each other and this competition 
between them functions to enhance AnkG targeting to the proximal axon and 
regulate the length of AIS (93). However, it is not essential for localised 
distribution of AnkG at the putative AIS site in the first place (96).  
 
Findings from two recent studies have shed more light on this issue. Stephen 
L. Berger et al. have found that diphosphorylated myosin light chain (pMLC) is 
enriched in the putative AIS region before the localised expression of AnkG in 
the primary cultures of rat hippocampal and cortical neurons (97). Myosin light 
chains are part of the hexameric structure of the contractile Myosin II, which is 
a classical actin-directed motor protein complex (98). Increased 
phosphorylation of MLC resulted in ectopic AnkG expression in the distal axon 
(97). In the other study, M. Tapia et al. showed that phosphorylated β-catenin 
is also enriched at the putative AIS region in the cultured hippocampal and 
cortical neurons, before the localised expression of AnkG. Additionally, 
enriched expression of GSK3αβ was also found in the AIS. Inhibition of GSK3 
function by lithium chloride and pharmacological inhibitors, as well as reducing 
the expression level of β-catenin by shRNA resulted in reduced AnkG and 
voltage-gated Na+ channels at the AIS (99). It remains to be determined how 
these different molecules and phosphorylation systems coordinate to facilitate 
AIS assembly. However, a very intriguing message conveyed by these studies 
is that although AIS assembly is a cell-autonomous event, various signalling 
pathways can affect the details of the AIS structure via controlling the activities 
of kinases and phosphatase, as a method to regulate the development of 







In neurons that fire repeatedly, the summation of synaptic inputs into bursts of 
action potentials is carried out by the AIS, given the high densities of voltage-
gated Na+ and K+ channels at the AIS (81). As a result, the various 
characteristics of each AIS, such as its location, length, populations and 
locations of the voltage-gated ion channels, as well as their expression levels 
within the AIS, are all closely linked to the electrophysiology profile of that 
Figure 1.7 The molecular structure of the AIS and Ankyrin G. (A) A typical neuron 
receives input on the cell body and dendrites (left). The hillock leads to the axon, which 
contains the AIS (orange). The distal axon contacts downstream neurons (right). (A’) 
Hippocampal neurons after 22 d in culture labelled for the AIS components NF-186 (green) 
and β4-spectrin (red). The somato-dendritic compartment is labelled using an anti-MAP2 
antibody (blue). Scale bar, 50 μm. (B) Modular structure of ankyrin G, which exists as isoforms 
of 480 and 270. Important residues (red) and EB-binding SxIP motifs (blue) are indicated. 
Binding sites of partners are indicated below the protein (gray bars). Figure (A), (A’) and (B) 
adapted from reference (82). (C) The molecular organization of the AIS. The AIS is comprised 
of ion channels (Nav1.x, KCNQ2–KCNQ3 and Kv1.x), cell adhesion molecules (neuronal cell 
adhesion molecule (NrCAM), neurofascin 186 (NF186), a disintegrin and metalloproteinase 
domain-containing protein 22 (ADAM22), transient axonal glycoprotein 1 (TAG1, also known 
as contactin 2) and CASPR2), extracellular matrix molecules (brevican and versican), 
cytoskeletal scaffolds (AnkG, βIV spectrin and postsynaptic density protein 93 (PSD93)) and 
other signalling proteins. GK, guanylate kinase; PDZ, PSD95/discs large/zonula occludens; 
SH3, SRC homology 3. Figure adapted from reference (81). 
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neuron (81,87,100). For example, previous studies have shown that the AIS 
size and its distance from the soma are considerably variable across the 
substantia nigra pars compacta (SNc) dopaminergic neuronal population (101). 
Extracellular recording of these neurons in the SNc and corresponding staining 
of AnkG showed that their rate of tonic firing is positively correlated with AIS 
length, but negatively correlated with the distance between AIS and 
soma(101) . Besides, increased expression of the Na+ channel NaV1.6, AnkG 
and increased lengths of the AISs were observed in pyramidal neurons in the 
hippocampal CA1 area of the Angelman Syndrome mouse model, which was 
correlated with more hyperpolarised resting membrane potential, more 
hyperpolarised threshold potential, larger amplitudes and maximum rates of 
action potentials (102). Last but not least, when AnkG expression was 
diminished in the AIS due to a reduced level of β-catenin by shRNA, Tapia et 
al. further showed that these neurons were less excitable, with lower 




1.2.4 Excitability and electrophysiology profiles of the thalamic and 
prethalamus-derived neurons 
 
Diencephalic-derived neurons show distinct electrophysiology properties in 
comparison to cortical neurons, as diencephalic neurons are known to display 
two distinct response modes of action potential firing- tonic and burst firing 
(67,103,104). Cortical neurons that are involved in the thalamocortical relay 
circuits only fire in the tonic mode (104). To elaborate, I will take neurons from 
the lateral geniculate nucleus (LGN) as representatives for the thalamic 
neurons and neurons from the thalamic reticular nucleus (TRN) as 
representatives for the prethalamus-derived neurons. The LGN, as mentioned 
before, is the thalamic relay of retinal information to the cortex and provides a 
reasonable model for all thalamic nuclei (4,103). The TRN might be one of the 
most studied nuclei of prethalamic origin. Hence there is more comprehensive 
electrophysiological analysis on the TRN in the existing literature than any 
other prethalamus-derived nuclei.  
 
When a neuron fires in the tonic mode, the cell responds with a stream of 
unitary action potentials as long as the stimulus is suprathreshold for firing 
(Figure 1.8A) (103). On the other hand, when a neurons fires in the burst mode, 
which is usually in response to more hyperpolarised stimuli, the cell fires with 
short-lasting (up to 100ms) high-frequency bursts of action potentials riding on 
the crest of an overshoot (Figure 1.8A’) (67,103). An inward Ca2+ current that 
is known as IT, which is mediated by the T-type low-threshold Ca2+ channels, 
is responsible for the burst firing mode (103,105,106). Unlike the voltage gated 
Na+ channels and K+ channels, which are tethered by AnkG at the AIS, the T-
type low-threshold Ca2+ channels are located in the membranes of the soma 
and dendrites (103,107–109). The threshold voltage that activates the T-type 
low-threshold Ca2+ channels are more hyperpolarised than the threshold 
voltages that activate the Na+ channels (110,111). Therefore, when a neuron 
is hyperpolarised, a depolarising stimulus is more likely to activate the T-type 
low-threshold Ca2+ channels instead of the voltage-gated Na+ channels (111). 
Consequently, IT is activated and the inflow of Ca2+ causes depolarisation of 
 33 
the cells. The latter further activates a burst of conventional action potentials 
mediated by Na+ and K+ channels (103,110,111). As a result, which mode of 
firing the neurons undergo is determined by both the types and abundance of 
membrane bound voltage-dependent ionic channels and the state of resting 
membrane potentials (103,110,111). When a neuron is relatively depolarised, 
the T-type low-threshold Ca2+ channels are inactivated (110,111). The neuron 
thus responds to depolarising stimuli with voltage-gated Na+ channels and fire 
in the tonic mode. However, when the neuron is relatively hyperpolarised, T-
type low-threshold Ca2+ channels are de-inactivated, and therefore the 





Figure 1.8 Tonic and burst firing of neurons in the LGN and TRN. (A) and (A’) Responses 
of one LGN neuron to the same depolarising current pulse delivered intracellularly are shown, 
but from two different initial holding potentials. (A) IT is inactivated, and the cell responds with 
a stream of unitary action potentials as long as the stimulus is suprathreshold for firing. This 
is the tonic mode of firing. (A’) When the cell is relatively hyperpolarized, IT is de-inactivated, 
and the current pulse mediated by the low-threshold Ca2+ channels further activates the 
voltage gated Na+ channels, leading to four action potentials. This is the burst mode of firing. 
Adapted from (103). (B) and (C) Two functionally different types of TRN cells. (B) This type is 
a bursting cell since it usually emits a high-frequency burst of action potentials at both the 
offset of hyperpolarizing current pulses and the onset of depolarizing pulses (from a strongly 
hyperpolarized level). (C) That unit is a tonic cell since it does not fire a burst discharge of 
action potentials at both the offset of hyperpolarizing current pulses and the onset of 
depolarizing pulses (from a strongly hyperpolarized level). Adapted from (67). 
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All thalamic relay cells exhibit both the tonic and burst firing modes (103). They 
can switch between these two modes depending on the specific afferent stimuli 
from the peripheral sensory organs, prethalamus-derived nuclei and cortex 
(67,103,104). However, this is not the case in the prethalaic nuclei such as the 
TRN (67). In the TRN, neurons can be divided into two functionally different 
types- the ones that can fire in both the tonic and burst modes and the ones 
that can only fire in the tonic mode (Figure 1.8B-C) (67,112). Also, thalamic 
neurons and prethalamus-derived neurons that can fire in both the tonic and 
burst modes display several other differences in terms of their firing 
characteristics. Firstly, the transient Ca2+ conductance mediated by the T-type 
low-threshold Ca2+ channels inactivates much more slowly in the TRN cells 
than the thalamocortical (TC) neurons (113). Secondly, the low-threshold 
current of the TRN cells has different voltage dependence features to those 
recorded in the TC cells (67). Thirdly, in urethane-anaesthetised or lightly 
narcotised rats, TRN cells transiently fire at both the onset and offset of whisker 
deflection and display robust tonic firing during sustained whisker deflection. 
However, to compare, the TC neurons of the corresponding somatosensory 
thalamic nucleus display a weaker tonic pattern and usually exhibit tonic 
suppression (67,114,115). Finally, in vitro intracellular recording found 
evidence of electrical coupling between two adjacent TRN neurons- current 
pulses that evoke tonic firing in cell1 can induce attenuated voltage oscillation 
(set of spikelets) in cell2 and vice versa (116). Whether such electrical coupling 
also exists between TC neurons remains to be confirmed.  
 
So why are the diencephalic neurons programmed to fire in two modes? How 
does each mode contribute to the functionality of the neural circuitries? In 
general, tonic firing is known to afford better linearity, whereas burst firing 
supports better signal detection (103,105,111). For thalamic neurons, such as 
the ones in the LGN, both tonic and burst firing serve as effective relay modes 
in the awake state in rodents, cats, monkeys and humans (103,117–120). 
Therefore, tonic firing might be utilised to support a more faithful reconstruction 
of the visual world as it can minimise nonlinear distortion in the relay, while 
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burst firing can serve as some sort of ‘wake-up call’ when something has 
changed in the environment as it can maximise initial stimulus detection 
(67,103). As for prethalamus-derived neurons, such as the ones in the 
postnatal TRN, either tonic or burst firing would trigger inhibitory postsynaptic 
potentials (IPSPs) and further results in hyperpolarisation in a TC neuron due 
to the inhibitory nature of the GABA neurotransmitter produced by neurons in 
the TRN (67,104,121). Therefore, the TRN appears poised to induce a switch 
from tonic to burst firing of the TC neurons due to its ability to hyperpolarise 
TC neurons (104,122). However, the exact effects and functions of tonic and 
burst firing of TRN neurons on the responsiveness of the TC neurons remain 
elusive.  
 
One thing to keep in mind is that the very roles of tonic and burst firing in both 
thalamic and prethalamus-derived neurons need to be considered within the 
big picture of what type of neural circuitries they are involved in. For example, 
open-loop arrangements between the thalamus and TRN have been found, in 
which the TRN receives input from regions of the thalamus that do not receive 
returning axons from the TRN (104,123,124). Adam M. Willis et al. have 
simulated a simple neural circuit, in which the TC cells innervate both the TRN 
and layer4 (L4) cortex, and either the TRN innervate reciprocally with TC cells 
to create a closed-loop arrangement or the TRN do not project to the TC cells 
to create an open-loop arrangement. In the closed-loop arrangement, tonic 
input to the TC cells can induce rhythmic tonic spiking in the TC cells and the 
TRN cells, as well as an onset response in the L4 neurons. However, in the 
open-loop arrangement, when tonic stimulations were applied to the TC cells, 
the latter can only fire intermittent spikes, which further drive tonic firing in the 
L4 cells, with occasional failures of stimulation not being able to be 
recapitulated in the L4 cells. Nevertheless, when another tonic input was 
added to the TRN cells along with the tonic stimulation as above on the TC 
cells in the open-loop arrangement, TC cells occasionally bursts in addition to 
the individual spikes of tonic firing, which further led to a higher total number 
of spikes in the L4 cells (104). Therefore, how these neural circuitries are 
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constructed impacts profoundly on how the neurons within would respond to 
the same stimuli. Although neurons in the TRN only send axons to and 
innervate neurons in different thalamic nuclei, it receives monosynaptic 
glutamatergic inputs mainly from both the cerebral cortex and the thalamus, 
as well as GABAergic, cholinergic and monoaminergic inputs from other parts 
of the brain, such as basal forebrain and the amygdala (67). All these afferent 
inputs affect which firing mode the TRN neurons undergo, and further 






1.3 The Pax6 gene 
 
1.3.1 Structure and transcription regulation of the Pax6 gene 
 
The Pax6 gene encodes a highly conserved transcription factor from the paired 
box (Pax) family (125–127). Both the human PAX6 and mouse Pax6 gene 
contain 16 exons that span over 30 kb of the genomic DNA, and the human 
and mouse PAX6 proteins being produced share the identical amino acid 
sequence (128–130). PAX6 contains a paired domain (PD) and a paired-like 
homeodomain (HD) (125). Although both the PD and HD can bind to specific 
DNA target sites, only the PD is crucial for most of the well-known functions of 
Pax6, including regulation of proliferation, neurogenesis, telencephalic 
regionalisation, the formation of the pallial-subpallial boundary (PSPB), and so 
on (131–135). Four transcriptional initiation sites have been identified in the 
mouse Pax6 gene (Figure 1.9A) (128,136–139). With P0 and P1 giving rise to 
the primary transcripts of Pax6 (MW 46kDa) and an alternatively spliced 
variant Pax6(5a) (MW 48kDa), the two internal initiation sites, Palpha and P4, 
produce transcripts that encode for truncated PAX6 proteins that lack the PD 
(128,136,140). The Pax6(5a) variant includes 14 additional amino acid 
residues encoded by the exon 5a, which also results in disruption of DNA 
binding properties of the PD (128,140–142) (Figure 1.9B). Quantitative studies 
have revealed that in embryonic mouse tissues, the expression ratio of Pax6 
and Pax6(5a) was around 8:1 (141).  
 
A number of regulatory elements that regulate tissue-specific expression of 
Pax6 are within the vicinity of the Pax6 coding region (128,137,140,143). For 
example, the long non-coding RNA (lncRNA) Paupar is located within about 
25kb 5’- from the P0 promoter (140,144). Paupar is expressed in the brain and 
can regulate the expression of Pax6 and other genes located on other 
chromosomes (140,144). Subsequent studies based on analysis of 
evolutionarily conserved non-coding regions identify an ectodermal enhancer 
(EE) upstream from the P0 promoter, which contains an array of Meis1/2, Oct1 
(Pou2f1), Pax6, Pknox1 (Prep1), Six3 and Sox1/2 binding sites (140). Indeed, 
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molecular and genetic evidence showed that Pax6 could autoregulate its 
expression, whereas Pax6 and Six3 have been shown to mutually regulate the 
transcription of each other during mouse lens development (140,145,146).  
 
1.3.2 Function of the PAX6 proteins 
 
PAX6 proteins recognise specific DNA sequences through a variety of 
mechanisms enabled by their HD, PD and alternative splicing (140). The PD 
contains two independent subdomains- the N-terminal (PAI) and C-terminal 
(RED) subdomains (Figure 1.9B) (128,131,140,147). Both of these 
subdomains can bind to DNA (142,147). As a result, binding of PD exhibits a 
bipartite feature, so do the DNA sequences that the PD binds (131,142,147).  
The current model proposed that PAX6 binds to DNA by both the HD and PD 
(135,148). However, the DNA-binding properties of the HD receive less 
attention, possibly due to the findings that subtle defects were observed in the 
mouse developing forebrain when a point mutation was introduced to abolish 
the HD of Pax6 specifically (135). As a result, it was proposed that Pax6 HD 
might primarily function as a protein-protein interaction domain (135,140). In 
Pax6(5a), the HD is the only DNA binding domain available as the inclusion of 
the extra 14 amino acid residues from exon 5a interfere with the DNA-binding 
function of the PD (148). Under this premise, Zhang et al. found that in adult 
ocular tissues (cornea, lens and retina), the ratio of Pax6 and Pax6(5a) had 
decreased from 8:1 as observed in the embryonic tissues to 1:1 and deletion 
of exon 5a in these tissues disrupted iris formation (141,149). These findings 
indicated tissue-specific functions of exon 5a and also the HD of PAX6(5a). 
On the other hand, more recent studies have identified DNA sequences that 
can be recognised by both HD and PAI subdomain, as well as HD-recognition 
sequence that locate immediately to the 5’ end of the PD binding sequence, 
therefore forming the Pax6 HD-PD recognition site (148,150). These findings 
have complicated the mechanisms of function of the PAX6 proteins. 
 
Nonetheless, a recent genome-wide Pax6-ChIP sequencing study identified a 
total of 3514 and 3723 Pax6-containing peaks in mouse forebrain and lens 
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respectively, with about 70% of them found in both tissues (150). When linking 
these Pax6 peaks to their adjacent genes, Sun et al. found 1808 putative Pax6-
target genes in the forebrain, and 2099 putative Pax6 target genes in the lens. 
When comparing these two lists of Pax6-target genes with previously found 
deferentially expressed genes in Pax6-null cortices and lens placodes, they 
further confirmed 90 and 191 genes directly regulated by Pax6 in the forebrain 
and lens respectively. The largest functional classes these genes are involved 
in include DNA-binding transcription factors, cell surface receptors including 
cell adhesion molecules and their ligands, intracellular signalling molecules 
and cytoskeletal proteins (150). 
 
1.3.3 Expression patterns of Pax6 in the developing mouse forebrain 
 
Pax6 exhibits a restricted spatiotemporal expression pattern in the CNS, eye 
and nose (151). It is first detected when the major components of the 
developing CNS start to emerge after neural tube closure (around E8.0), and 
its expression pattern changes considerably as major structures such as 
cerebral cortex specialise and expand (128). In the mouse neural tube at E13.5, 
Pax6 is expressed in the ventricular zone of the cerebral cortex, in a lateral-
high, medial-low and rostral-high, caudal-low manner (128,152). However, in 
the diencephalon, Pax6 is expressed in the ventricular zone of the thalamus, 
in a gradient that increases with distance from the ZLI, and in both the 
ventricular zone and a subset of post-mitotic cells in the mantle zone of the 
prethalamus (Figure 1.9C) (22). This expression pattern in the prethalamus is 
unique as in the developing CNS, Pax6 is mostly expressed by neural 
progenitor cells, which then shut down Pax6’s expression upon exit of the cell 
cycle and embark on their journey of migration and differentiation (68). Various 
studies have proved the pivotal functions of Pax6 in diverse developmental 
processes of the CNS. However, most of these identified functions come from 
the Pax6-positive progenitor cells within the CNS and retina (128,133,140,153). 
The functions of Pax6 in the post-mitotic cells remain largely unknown. The 
prethalamus thus provides us with a unique and excellent system for us to 







Figure 1.9 Structure of the Pax6 locus, the PAX6 proteins and the expression patterns 
of Pax6 in the mouse embryos. (A) Pax6 locus (exons marked by dark blue rectangles), 
promoters P0, P1, Palpha and P4, regulatory elements are marked by magenta ovals. Figure 
adapted from (128). (B) Diagrammatic representation of Pax6 proteins (PAX6, PAX6(5a), 
PAX6(S) and PAX6 (DPD)) due to alternative splicing and transcription initiation at different 
promotors. The bipartite paired domain of each PAX6 protein is represented by the rectangle 
on the left, with PAI subdomain being represented by the dark blue rectangle on the left (N-
terminal) and the RED subdomain being represented by the red rectangle on the right, which 
is closer to the C-terminal. The homeodomain is represented by the yellow rectangle. The 
P/S/T domain where post-translational modifications usually take place is represented by the 
dark green rectangle. Figure adapted from (140). (C) Expression pattern of Pax6 in a coronal 
section of an E12.5 mouse embryonic brain. Pax6 is expressed in the ventricular zone of the 
cortex, in a gradient in the ventricular zone of the thalamus (Th), and in both the ventricular 
and mantle zone of the prethalamus (PTh). Pax6 expression is absent at the zona limitans 
intrathalamica (ZLI). Figure adapted from (22). 
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1.3.4 Pax6 acting as a master regulator of neural development 
 
Since Pax6 sits at the top of the hierarchy of gene regulatory network, PAX6 
proteins are classified as part of a rare group of ‘master’ regulators 
(128,133,140). These master regulators are capable of controlling cell fate 
specification and differentiation through regulating the expressions of 
‘secondary’ transcription factors that further convey cell fate specification, and 
terminal differentiation products that underlie the functionalities of the mature 
cells (140). Therefore, disruption of the Pax6 gene can cause cascading 
defects in various processes during the development of the nervous system 
(128,133,140,154). For example, the Pax6 gene itself was first discovered and 
cloned by multiple groups that were trying to identify the genetic causes of 
congenital eye defects (125,133,155). Mutation or loss of one allele of Pax6 in 
human patients can lead to a spectrum of eye abnormalities such as Aniridia 
(i.e. lack of iris) and Peters’ anomaly (thinning and clouding of the cornea) 
(156,157). In addition to eye defects, these patients also had symptoms 
associated with a range of neurological and psychiatric conditions including 
nystagmus, impaired auditory processing and verbal working memory, autism, 
and mental retardation (128,133). These conditions are linked to structural 
brain defects including a reduced size of the corpus callosum and anterior 
commissure, abnormalities of the cerebral cortex and cerebellum and absence 
of the pineal gland (128,140,154). Mouse models with Pax6 mutation share 
similar phenotypic defects, as haploinsufficiency of Pax6 in mice also leads to 
reduced sizes of eyes whereas loss of both alleles of Pax6 results in a 
complete absence of eyes (155,158). However, in Pax6 haploinsufficient mice, 
other parts of the developing central nervous system, such as the cerebral 
cortex and diencephalon, appeared to be normal, indicating divergence of 
Pax6’s functions in evolution (134). Additionally, loss of both alleles of Pax6 in 
these mouse models is lethal as Pax6-null embryos die before birth with the 
absence of olfactory bulb, prethalamus, reduced size of cerebral cortex and 
cerebellum (22,128,152,153,155).  
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In the developing CNS, Pax6 plays crucial roles during various processes, 
including patterning of the neural tube, cell proliferation, migration of neurons, 
and formation of neural circuits (134). Mouse embryos with both copies of 
Pax6 alleles mutated display severe defects of dorsal-ventral patterning of the 
telencephalon (154). Decreased expressions of dorsal telencephalic markers 
such as Emx1, Ngn1, Ngn2, Tbr1 and Tbr2, along with ectopic expressions of 
ventral markers in the cortex, such as Gsh2, Mash1 (Ascl1), Dlx1, Vax1 and 
Six3 were observed in these embryos (151,154,159,160). Also, the boundary 
between the dorsal and ventral telencephalon, the pallial-subpallial boundary 
(PSPB), was severely impacted due to the loss of Pax6, as the expression 
levels of several PSPB markers are reduced or completely lost (151,154). 
What is more, due to Pax6’s function to activate expression of specific 
adhesion molecules, such as R-cadherin, the loss of Pax6 further resulted in 
the loss of a mechanical palisade at the PSPB formed by radial glial cells (161). 
This palisade acts as a physical barrier to prevent mixing of the dorsal and 
ventral telencephalic progenitors. As a result, increased dorsal migration of 
ventral telencephalic cells was also observed upon loss of Pax6 (161). Apart 
from misspecification of dorsal-ventral identities, loss of innate structures and 
migration defects, these Pax6 mutant mice also have thinner cortices due to 
Pax6’s function to increase cortical progenitor proliferation in a dosage-
dependent manner (58,128,152). Loss of Pax6 in these mice caused 
increased cell cycle exit of cortical progenitors at early stages, which 
exhausted the progenitor cell pool prematurely and shifted the balance 
between proliferation and differentiation of the system towards the latter (152).  
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1.3.5 Pax6 removal causes severe defects in the developing 
diencephalon 
 
1.3.5.1 Patterning defects and disruption of TCA formation 
 
As mentioned above, Pax6 is expressed in a unique pattern in the 
diencephalon (22). At E12.5, Pax6 is expressed in a gradient in the ventricular 
zone of the thalamus, with its expression level increaseing with distance from 
the ZLI (22). This is likely due to the mutual repression of Pax6 and Shh 
released from the ZLI. In the prethalamus, Pax6 is expressed at a 
homogeneous level in the ventricular zone, and also in a subset of post-mitotic 
cells in the mantle zone (22). Previous studies have shown disruption of 
patterning and thalamocortical axons (TCAs) formation as the two major 
defects of the diencephalon after Pax6’s removal. For example, Caballero et 
al., 2014 showed that Pax6 repress Shh expression in a cell-autonomous 
manner around the ZLI. Loss of Pax6 resulted in the expansion of markers of 
ZLI and pTh-R, such as Nkx2.2, Ascl1 and Gsx1, at the cost of reduction of 
pTh-C markers such as Sox2, Gbx2 and Ngn2 (22). In Pax6-null embryos, 
ectopic expression of some prethalamic genes (e.g., Lim1/Lhx1) are found in 
the prospective thalamic area, whereas other prethalamic markers, such as 
Sfrp2 that is expressed exclusively in the ventricular zone of the prethalamus, 
is completely lost (42,162). The physical structure of the prethalamus is hardly 
recognisable in the mouse line of constitutive Pax6 mutant, which lack Pax6 
expression since conception (22,154). Additionally, previous studies have also 
shown that Pax6 is required in setting up a prepattern that contributes to the 
induction of pTh-R and pTh-C cell fate in the thalamic primordium in response 
to graded Shh concentrations (163). What is more, the loss of Pax6 would 
cause an anterior shift of mesencephalic markers, such as Dbx, into the 
prospective pretectum and the loss of several pretectum markers such as 
Gsh1, Lim1/Lhx1 and Wnt7b (164). 
 
The thalamocortical axons are axonal projections sent by thalamic neurons to 
innervate the cerebral cortex (3,4). The TCA formation starts at about E12.5 in 
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mouse. TCAs extend rostral-ventrally through the adjacent prethalamus, then 
turned laterally to avoid the hypothalamus and enter the ventral telencephalon 
at about E13.5. After that, they turn dorsally into the cortex and innervate the 
correct cortical regions by about E18.5 (59,165,166). It is known that the 
deletion of Pax6 can cause defects in various key steps during this process, 
which all lead to the disrupted formation of the TCA (59,162,166,167). For 
example, in Pax6-null mouse embryos, the TCAs descend ventrally into the 
hypothalamus instead of turning laterally to enter the ventral telencephalon. 
The TCA bundle was more disorganised and showed a fan-out phenotype as 
the growth cones of the TCAs head towards different directions. Co-culture 
experiments using the thalamus explants of these embryos and wild-type 
ventral telencephalon showed the thalamic axons either fail to reach the medial 
part of the ventral telencephalon or turn dorsally towards the cortex (162,166). 
Additionally, loss of Pax6 resulted in disruption of thalamic patterning and 
miss-expressions of regional markers, axon guidance cues and receptors, 
which severely obstructed the process of TCA path-finding towards the 
cerebral cortex (59,162,166,167). Last but not least, Pax6-null rat embryos 
also showed abnormalities of Pax6-expressing cell clusters in the ventral 
prethalamus and amygdala, which lie along the path of TCAs and would 
usually guide them (167). Prior to the thalamic neurons sending out their axons 
rostral-ventrally to enter the prethalamus, the prethalamic neurons send out 
their axons caudal-dorsally into the thalamus (48,59,60). These axons act as 
scaffolds for the TCAs, which follows the prethalamic axons and descend into 
the prethalamus. Previous study in the lab has also shown that when Pax6 is 
conditionally knocked-out in the prethalamus, these ascending prethalamic 
axons have greatly reduced their numbers (unpublished data).  
 
1.3.5.2 RNAseq data in the lab 
 
So far, most of the studies on the functions of Pax6 during the development of 
the CNS comes from the progenitor cells, mostly in the cortex 
(128,140,153,154). Despite the unique expression patterns Pax6 displays in 
the prethalamus, the functions of Pax6 in the developing prethalamus, 
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especially in the post-mitotic cells of the prethalamus, remain largely unknown. 
However, due to its high position in the hierarchy of gene regulation networks, 
it is difficult to speculate and hypothesise the exact functions of Pax6 in the 
developing prethalamus. Data from the RNA sequencing study in the lab, 
which analysed the transcriptional changes of genes in the anterior cortex, the 
thalamus and the prethalamus upon acute deletion of Pax6, provided us with 
an unbiased starting point to answer these questions (58). In the experimental 
set up of this RNA sequencing study, the mouse model carries the tamoxifen-
inducible Cre recombinase, which follows the ubiquitously expressed CAG 
promoter (CAGCreER). Therefore, the activity of the Cre recombinase will 
become active in every cell in these mouse embryos upon tamoxifen 
administration. This mouse model also carries the green fluorescent protein 
(GFP) reporter allele, and one (control) or two (mutant) copies of the floxed 
Pax6 (Pax6loxP) alleles, in which the loxP sites are flanking the 5, 5a and 6 
exons of the Pax6 gene. As a result, upon activation of the Cre recombinase 
by tamoxifen, GFP expression will be activated, and the 5, 5a and 6 exons of 
Pax6 will be excised, giving rise to a truncated functionless PAX6 protein. The 
control embryos have the other Pax6 allele intact, therefore can still produce 
functional PAX6 proteins.  
 
Analysis of differences between the transcriptomes of control and mutant 
prethalamus showed that there were over 3500 genes, whose expressions 
were significantly (adjusted p < 0.05) altered due to the loss of Pax6. 
Interestingly, this number is also the highest in comparison to the number of 
genes that showed significant differential expressions in the anterior cortex 
(over 2000 genes) or in the thalamus (over 1800 genes) after Pax6 deletion. 
Over half of these dysregulated genes were upregulated in the thalamus and 
prethalamus in response to the loss of Pax6 (Figure 1.10A). Gene ontology 
(GO) term enrichment analysis on all the genes that showed significant 
differential expressions in the prethalamus revealed 10 most highly enriched, 
non-redundant GO terms with obvious relevance to developmental processes. 
While the 10 most down-regulated GO terms could be roughly divided into two 
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categories- cell cycle (6/10) and translation (4/10), the 10 most up-regulated 
GO-terms were shared among differentiation (4/10), neuronal morphogenesis 
(3/10) and cell signalling (3/10) (Figure 1.10B). When all the significantly 
differentially expressed genes were hierarchically clustered according to the 
direction and magnitude of their log2 fold changes (LFCs) across all three 
tissues, we saw that most genes showed LFCs in the same direction in 
prethalamus and thalamus, but in an opposite direction in anterior cortex. 
Additionally, the prethalamus was the tissue with more extreme dysregulation 
of genes in both the downregulated clusters (cluster 1, 2 and 4) and the 
upregulated clusters (cluster 5, 6, 8 and 10). Interestingly, the GO terms 
related to neuronal morphogenesis (cluster 5, 7 and 8) also showed the most 
intense increase of LFCs. This indicated that there were not only quite a large 
number of neuronal morphogenesis related genes that are upregulated in the 
prethalamus when Pax6 is lost, they are also the most highly upregulated ones. 
Additionally, cluster 8 also showed enrichment for “Wnt signalling pathway,” 
indicating that this pathway might be explicitly upregulated in the diencephalon 






Figure 1.10 The Effects of Pax6 Deletion on the Transcriptomes of Prethalamic, 
Thalamic, and Anterior Cortical Cells. (A) An overview of the numbers of significantly 
differentially expressed (DE) genes resulting from Pax6 deletion in each region. (B) The 10 
most highly enriched, non-redundant gene ontology (GO) terms with obvious relevance to 
developmental processes for up- and downregulated genes in the prethalamus. (C) 
Hierarchical clustering of all genes that showed significant differential expression in at least 
one tissue according to the direction and magnitude of their log2 fold change (LFC) across 
all three tissues. The dendrogram is cut to generate 14 clusters and enriched GO functional 
terms are listed against these clusters. Figure adapted from reference (55).  
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1.4 Aims of this thesis 
 
The primary aim of this thesis is to utilise the information provided by the RNA 
sequencing experiment as a starting point and find out the novel functions of 
Pax6 during development of the prethalamus, especially in the prethalamic 
post-mitotic cells. As mentioned above, GO terms related to neuronal 
morphogenesis showed the most drastic upregulation in terms of the number 
of genes and levels of expressions. Therefore, in Chapter 3, by developing an 
in vitro culture system that allows me to observe neuronal morphogenesis of 
the prethalamic neurons, I aim to: 
1. Characterise the process of neuronal morphogenesis of the prethalamic 
neurons in vitro 
2. Investigate whether and how neuronal morphogenesis of the 
prethalamic neurons changes in the absence of Pax6 
 
Based on the results from Chapter 3 and the RNAseq data, in Chapter 4, I 
further moved on to investigate the abilities of the prethalamic neurons to 
establish and maintain their neuronal polarity, aiming to test: 
1. Whether the establishment of neuronal polarity is defective in the 
absence of Pax6 
2. Whether the structure and components of the AIS, which is the key 
structure to maintain neuronal polarity, is altered in the absence of Pax6 
3. Whether the excitability of the Pax6-null prethalamic neurons is 
changed due to altered AIS structure 
 
According to the RNAseq data, the Wnt signalling pathway is also highly 
upregulated in the prethalamus when Pax6 is lost. Therefore, in Chapter 5, I 
aim to: 
1. Determine the expression patterns of selected Wnt and Wnt-related 
genes in the prethalamus and how they change in response to the loss 
of Pax6 
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2. Further investigate the potential mechanisms by which Pax6 might be 
inhibiting Wnt signalling pathways in the prethalamus  
 
Although the thalamus and prethalamus both reside on either side of the ZLI, 
hence receive the same dosages of morphogens released by this secondary 
organiser, the thalamus and prethalamus exhibit very different developmental 
profiles and produce neurons with very different morphologies and functions. 
The sharp difference of Pax6 expressions in the thalamus and prethalamus 
makes it an excellent candidate to test whether Pax6 can cause this regionally 
different development of the thalamus and prethalamus. Therefore, in Chapter 
6, by utilising the existing RNAseq data, I aim to: 
1. Test whether the Pax6-null prethalamus develops a thalamus-like 
expression profile of voltage-gated ion channels and AIS component 
genes 
2. Find out the potential mechanism- whether this is due to loss of 
transcriptional control of Pax6 or upregulation of Wnt signalling pathway 























2.1.1 Generation of the FP6CD1 line and mouse colony maintenance  
 
All animal husbandry was conducted in accordance with the UK Animal 
(Scientific Procedures) Act 1986 regulations. 
 
To generate conditional Pax6 knockout mice, I utilized the Pax6flox allele (167) 
in combination with the RCE: LoxP EGFP reporter allele (168) and the CAG-
CreER allele (168). Homozygous Pax6flox/flox mice were crossed to CAG-
CreER+/- mice to generate double heterozygous. CAG-CreER+/-, Pax6flox/+ 
males were selected in timed mating with Pax6flox/flox females to generate CAG-
CreER-/-, Pax6+/+ or CAG-CreER+/-, Pax6flox/+ embryos as the control group 
(Ctrl) and CAG-CreER+/-, Pax6flox/flox embryos as the Pax6-mutant 
experimental group (Hom or Pax6-null).  
 
The Pax6flox allele have the 5, 5a and 6 exons of the Pax6 gene being floxed 
by the loxP sites. Therefore, with the conditional Pax6 knockout mice, upon 
the administration of tamoxifen, the 5, 5a and 6 exons will be excised, resulting 
in a truncated, functionless PAX6 protein.  
 
For staging of embryos, the first day the vaginal plug was detected was 
designated as embryonic day 0.5 (E0.5). 
 
To induce knockout of Pax6 in the CAG-CreER+/-, Pax6flox/flox embryos, 10mg 
of tamoxifen was given to each female by oral gavage at E9.5. The oral gavage 
experiments were carried out by technicians from the animal unit of the Hugh 
Robson Building. All the mouse lines were managed by Dr. Martine Manuel. 
 
The effectiveness of the tamoxifen induced Pax6 deletion was verified using 
the mouse monoclonal Pax6 antibody, which recognises the N-terminal of the 
PAX6 protein that is absent in the truncated PAX6 protein after the deletion of 
the 5, 5a and 6 exons (167). Figure 2.1 shows the effectiveness of Pax6 
 52 
deletion, when I apply tamoxifen at E9.5 and harvest the embryos at E13.5. 
The examination of the effectiveness of Pax6 deletion was perform this way 
using one of the adjacent sections for every embryo that was sectioned with 
cryostat and processed for in situ hybridisation or immunohistochemistry. For 
embryos used for dissociated cell culture, genotyping for the floxed allele as 




Figure 2.1 The expression of Pax6 is absent in the forebrain after 4 days of tamoxifen 
gavage. (A) In the control embryos (Ctrl, CAG-CreER-/-, Pax6+/+ or CAG-CreER+/-, Pax6flox/+), 
Pax6 is expressed in the ventricular zone of the cortex and thalamus, and in the ventricular 
zone and the post-mitotic cells of the prethalamus. (B) At E13.5, which is 4 days after 
tamoxifen gavage (at E9.5), no Pax6 protein was detectable in the forebrain of the mutant 
genotype (Hom, CAG-CreER+/-, Pax6flox/flox). Ctx, cortex; Th, thalamus; ZLI, zona limitans 




2.1.2 Dissection and tissue fixation 
 
All embryos were collected at E13.5. To minimize animal suffering, pregnant 
females were first treated with terminal anaesthesia followed by cervical 
dislocation according to the Code of Practice for Humane Killing of Animals 
under Schedule 1 to the Animals (Scientific Procedures) Act 1986 issued by 
the Home Office. 
 
Embryos were placed in ice-cold PBS (pH7.4) after their dissection from the 
uterine horns. Embryos with GFP signal were selected under the GFP scope 
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followed by decapitation. For embryos used for dissociated cell culture, please 
refer to Chapter 4 for specific methodologies. 
 





2.2.1 Extraction of DNA 
 
Extraction of DNA was performed according to the Hotshot method. Briefly, 
75μl of Hotshot buffer was added to each 1.5ml Eppendorf tube containing the 
tail bud sample, which was followed by a 30-minute incubation at 95°C on a 
PCR machine. The Eppendorf tubes were left in the PCR machine to cool 
down to 4°C. Then 75μl of neutralization buffer was added to each tube for 
equilibrium. The extracted DNA was placed on ice for follow-up genotyping, 
otherwise it would be stored in -20°C freezer until genotyping. 
 
2.2.2 Genotyping by Polymerase Chain Reaction 
 
Reaction mix for each sample consists of 15.3μl ddH2O, 2.5μl of 2.5mM dNTP 
mix, 5μl of the 5X PCR reaction buffer, 0.5μl Primer mix (Simpson et al. 2009, 
forward primer: 5’-AAA TGG GGG TGA AGT GTG AG-3’; reverse primer: 5’-
TGC ATG TTG CCT GAA AGA AG-3’), 0.2μl Taq DNA polymerase (Qiagen) 
and 1.5μl of the extracted DNA to make up a total volume of 25μl. The 
themocycler (MJ Research PTC-225 Peltier Thermal Cycler) condition is 
shown in Table 2.1. PCR products were analysed with 2% agarose gel (Sigma) 
containing 3μl SYBRsafe (Invitrogen), ran at 115V for 70 minutes with a 100bp 
DNA ladder (New England Biolabs). PCR products were visualized with the IN 
GENIUS SYNGENE BIO Imaging machine and the Genesnap Imaging 
Acquisition Software.  
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The floxed allele fragment amplified with these primers was 195bp, whereas 
wild type allele was 156bp. Therefore, heterozygous condition (used as 
controls) was identified by two bands and the homozygous floxed allele 




Step 1 96°C for 2 minutes 
Step 2 95°C for 30 seconds 
Step 3 59°C for 30 seconds 
Go back to Step2 for 30 cycles 
Step 4 72°C for 30 seconds 
Step 5 4°C forever 
 
 
2.2.3 Tissue embedding and sectioning 
 
Selected tissues with desired genotypes were rinsed with 1x PBS for 3 times 
and cryoprotected in 30% sucrose (in 1x PBS) overnight at 4°C with rocking. 
Tissues were then equilibrated in 30% sucrose: OCT compound (50:50) at 4°C 
with rocking for 6 hours and embedded in the same solution in truncated 
moulds. The orientations of the tissues were adjusted to make sure that the 
snouts of the embryonic head were facing upwards for cutting coronal sections. 
The tissues were frozen on dry ice and stored at -80°C until cryostat sectioning 
at thicknesses of 10µm. Each slide of the tissue was transferred onto 





Table 2.1. Thermocycling condition used for genotyping of the floxed Pax6 allele 
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2.3 In situ hybridization (ISH) 
 
2.3.1 Probes used 
 
DIG-labelled probes used were: Pax6 (from Michael Molinek). Wnt3a (kindly 
donated by Dr. Gareth Brady), Axin2 (kindly donated by Dr. Ondrej Machon, 
Oslo University Hospital), Lef1 (kindly donated by Dr. J. Galcerán, University 
of Alicante, Spain), Sfrp2 (kindly donated by Dr. Jeremy Nathans, JHU, USA), 
Dkk3 (synthetized from cDNA using primers specified in reference (168)), 
Ngn2 and Wht5a (kindly donated by Dr Thomas Theil, University of Edinburgh, 
UK). Except for DKK3, which was synthesized from primers for the use of this 
study, all the other probes as mentioned above were kept in the lab as 
plasmids. 
 
2.3.2 Probe preparation 
 
2.3.2.1 Amplification of target DNA sequence 
 
To generate plasmids containing the DNA segments to make the probes, PCR 
reaction mix of a total volume of 50μl was prepared, which contained 32.6 μl 
ddH2O, 5μl of 2.5mM dNTPs, 10μl of 5X PCR reaction buffer, 1μl of 25mM 
primer mix, 0.4μl Taq DNA polymerase (Qiagen) and 1μl of cDNA (prepared 
by Dr. Idoia Quintana-Urzainqi). The same programme was run (Table 2.1) to 
amplify the target sequence. PCR products were analysed with 1% agarose 
gel (Sigma) containing 1μl SYBRsafe (Invitrogen), ran at 60V for 20 minutes 
with both the 100bp and 1kb DNA ladder (New England Biolabs). PCR 
products were visualized with the IN GENIUS SYNGENE BIO Imaging 
machine and the Genesnap Imaging Acquisition Software. 
 
2.3.2.2 Gel extraction 
 
The amplified DNA sequences with correct lengths were then excised from the 
gel under UV illumination. Gel extractions were performed using the 
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GENECLEAN® KIT (MP Biomedicals) according to the manufacturer’s 
protocol. Concentrations of the DNA segments were measured with the 




Ligation of the DNA segments to the pGMT-easy (Promega) vectors was 
performed afterwards. The optimal amount of DNA segments and vectors for 
ligation was calculation using the following equation:  
 
!	𝑘𝑏	𝑜𝑓	𝑖𝑛𝑠𝑒𝑟𝑡𝑘𝑏	𝑜𝑓	𝑣𝑒𝑐𝑡𝑜𝑟 	´	𝑛𝑔	𝑜𝑓	𝑣𝑒𝑐𝑡𝑜𝑟0´	3
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛	𝑜𝑓	𝑖𝑛𝑠𝑒𝑟𝑡 = 𝑣𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	𝑖𝑛𝑠𝑒𝑟𝑡	𝑖𝑛	𝑡ℎ𝑒	𝑙𝑖𝑔𝑎𝑡𝑖𝑜𝑛	𝑠𝑦𝑠𝑡𝑒𝑚 
 
The ligation reaction mix contained 5μl of 2x rapid ligation buffer, 1μl T4 ligase, 
1μl of pGMT-easy vector (all from Promega), the calculated volume of the 
specific inserts and lastly appropriate amount of ddH2O to top up to a final 
volume of 10μl. This reaction mix was then placed in the 4°C fridge for ligation 
to happen overnight. 
 
2.3.2.4 Transformation, plasmid amplification and extraction 
 
After ligation, transformation was performed using competence cells (JM109, 
Promega) and the heat shot method. The cells were then plated onto agar 
plates coated with 100μl ChromoMaxTM IPTG/X-GAL solution (Fisher Scientific) 
and cultured overnight in a 37°C oven. The next day, white single colonies 
were selected, amplified in overnight incubation at 37°C in agar medium 
supplemented with Ampicillin. Plasmid extraction using the Midiprep Kit 
(Qiagen) was performed according to manufacturer’s protocol after the 
bacterial growth had reached certain confluency. The plasmid yielded was 
then sent for sequencing (Eurofins Genomics) to determine the orientation and 
the exact sequences of the inserts. The sequences of the inserts were 
matched against the whole mouse genome (Standard Nucleotide BLAST, 
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Mouse genomics plus transcripts (Mouse G+T), blastn, NCBI) to double check 
the specificity of the probes made from such DNA sequences. The 
concentration of the extracted plasmid was determined using the Thermo 
Scientific Nanodrop 1000. 
 
2.3.2.5 Plasmid linearization 
 
To linearize the extracted plasmid, a reaction mix of a total volume of 200μl 
was prepared, containing 10x CutSmart® Buffer and 5μl of either SacII or NdeI 
restriction enzyme (NEB Biolabs) depending on the orientation of the insert, 
10μg of plasmid DNA, and lastly ddH2O to top up to 200μl. Digestion of plasmid 
by restriction enzyme was carried out at 37°C for 3 hours on a thermocycler or 
at 4°C overnight in the fridge. The digestion product, i.e. the linearized DNA, 
was cleaned using the Qiagen Gel Extraction Kit according to manufacturer’s 
protocol. 5μl of the digestion product was analysed with 1% agarose gel 
(Sigma) containing 1μl SYBRsafe (Invitrogen) ran at 60V for 30 minutes with 
both the 100bp and 1kb DNA ladder (New England Biolabs), and visualized 
with the IN GENIUS SYNGENE BIO Imaging machine and the Genesnap 
Imaging Acquisition Software, to check whether all the plasmid DNA had been 
linearized. The concentration of the linearized plasmid was determined with 
the Thermo Scientific Nanodrop 1000 after being eluted. 
 
2.3.2.6 Transcription and DIG-labelling of the probes 
 
Digoxigenin (DIG)-labelling of the probes was carried out by DIG RNA-labelling 
kit (Sigma-Aldrich) during in vitro transcription. Briefly, transcription mix was 
set up containing 3μg of linearized plasmid, 2μl of 10x solution, 2μl Sp6 or T7 
RNA polymerase (Sigma-Aldrich, depending on the orientation of the insert), 
and ddH2O to make up a final volume of 20μl. Transcription was carried out in 
the thermocycler at 37°C for 2 hours.  
 
To eliminate the DNA template in the transcription mix, 2μl of DNAse was 
added and the transcription mix was placed back into the thermocycler to react 
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for 15 minutes at 37°C. Afterwards, 0.8μl EDTA (0.5M, pH 8.0), 7μl LiCl (5M), 
75μl chilled 100% Ethanol were added to the mixture. The latter was placed in 
-20°C overnight. 
 
The resulting mixture was then centrifuged at 4°C, 13000rpm for 15 minutes. 
The supernatant was carefully discarded, and the pellet was washed with 75μl 
Ethanol. The mixture was further centrifuged at 4°C, 13000rpm for 15 minutes, 
after which the supernatant was discarded, and the pellet was left to dry at 
room temperature (RT) for 1 hour. 20μl ddH2O was used to dissolve the pellet 
and the concentration for the probe was read by Nanodrop 1000 (Thermo 




In situ hybridizations were performed following a standard three-day protocol. 
On the first day, slides were taken out of the -20°C freezer and warmed to RT 
for at least 30 minutes. Probes were first diluted with hybridization buffer by 
1:500 to make the stock solutions. Probe stock solutions were further diluted 
to desired working concentration, also using the hybridization buffer. The 
diluted probes were incubated in water bath above 85°C for at least 10 minutes 
to denature the diluted probes.  Probe solutions were mixed thoroughly before 
applying to each slide (200μl/slide). A coverslip was placed onto each slide. 
Slides were then placed in a sealable plastic box containing 2 sheets of 3mm 
Whatman paper saturated with 50%Formamide/1X salt for overnight 
incubation at 72°C. 
 
2.3.4 Post hybridization washes, blocking and antibody staining 
 
Slides were retrieved from the humid box and incubated at 65°C in Coplin jars 
filled with fresh wash buffer for 3 times (30 minutes, 20 minutes and 20 minutes 
each time). Slides were then transferred to new Coplin jars containing 1X 
MABT buffer and washed with rocking for 30 minutes and another 2 hours. 
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A humidified box was prepared by lining the bottom of a Tupperware container 
with 3MM Whatman filter paper saturated with water. Slides were taken out 
from the 1X MABT buffer and dried around edges. Sections were outlined with 
hydrophobic pen (Vector Labs) and incubated with blocking solution at RT for 
at least 1 hour in the humidified box. After blocking, blocking solution was 
removed and anti-DIG antibody (1:2500 in blocking solution) was applied to 
each slide and incubated in the humidified box at 4°C overnight. 
 
2.3.5 Post antibody washes and colour reaction 
 
Slides were transferred to Coplin jars and washed with 1X MABT and 
subsequently pre-staining buffer at RT with rocking.  
 
Slides were retrieved from pre-staining buffer and dried around edges. 
Staining buffer were added to each slide and incubated in the dark in a 37°C 
incubator for 3 hours or at 4°C over the weekend to develop the colour. Colour 
reaction was then stopped by washing the slides in Coplin jars with 1X PBS 
for several times.  
 
For counter staining, slides were submerged in Nuclear Fast Red (Vector Labs) 
for 1 minute per slide. Then slides were quickly rinsed and washed with 1x 
PBS. 
 
2.3.6 Mounting  
 
Slides were first transferred to a slide rack and submerged in 50%, 70%, 90%, 
95% and 100% ethanol successively (1 minute/concentration) at RT. Slides 
were further incubated in 100% ethanol, and two times in 100% xylene for 2 
minutes. Slides were taken out of the xylene and dried around edges and were 
further left to dry. A few drops of DPX were applied to each slide and a 
coverslip was carefully placed on top of each slide. The mounted slides were 
left in the fume hood overnight to dry. 
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2.4 Fluorescence in situ hybridization 
 
2.4.1 Hybridization, washes and antibody staining 
 
Fluorescence in situ hybridization was performed as previously described. The 
hybridization step was the same as described above. Afterwards, slides were 
retrieved from the plastic box and incubated at 65°C in Coplin jars filled with 
fresh wash buffer for 3 times. Slides were then transferred to new Coplin jars 
containing TNT buffer and incubate at RT for 30 minutes with rocking for 2 
times. Then slides were dried around edges and sections were outlined with 
hydrophobic pen and were blocked with TNB blocking buffer for more than one 
hour at RT. Anti-DIG POD antibody was diluted in blocking solution (1:1000) 
and applied to slides. Slides were incubated with antibodies in TNB buffer 




Slides were washed in TNT buffer. Cyanine 3 tyramide (Perkin Elmer) was 
taken out of the 4°C fridge 30 minutes before use and was diluted to a working 
concentration of 1:200 in amplification diluent. The diluent of Cyanine 3 
tyramide was added to each slide (100μl/slide) and further incubate with the 
slides for 10 minutes at RT in the dark (slides were kept in the dark in steps 
onwards). Slides were then washed in TNT buffer and further counterstained 
with DAPI. Slides were then washed in 1X PBS and mounted with Vectashield 
Hard Set (Vector Labs). The slides were sealed with nail polish around the 




Immunofluorescence was performed as previously described (28). Briefly, 
sections were warmed to RT and incubated in 37°C incubator for 30 minutes 
for better section attachment. Afterwards, sections were submerged in running 
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water for 5 minutes to rehydrate and subsequently washed in 1x PBS and 
further equilibrated and boiled in 10mM sodium citrate by microwaving for 4 
times, 5 minutes each to increase tissue permeability and achieve antigen 
retrieval. Sections were incubated with blocking solution (PBS-0.1%Triton + 
20% goat serum) for 1hr at room temperature, and then incubated with primary 
antibodies in antibody solution (PBS-0.1%Triton + 10% goat serum) at 4°C 
overnight. Sections were then washed with PBS-0.1%Triton and goat anti-
mouse IgG biotinylated was used as secondary antibody and was incubated 
with the section for 1 hour at RT. Colour reactions were developed by 
submerging slides in DAB solution (150ml PBS, 1.5ml DAB 3%, 1.5ml 30% 
H2O2) for 5 minutes at RT in the fume hood. Sections were washed and then 




Immunofluorescence was performed as previously described. Steps before 
secondary antibody incubation were done in the same way as described in the 
immunohistochemistry section above. Afterwards, slides were incubated with 
fluorophore-conjugated secondary antibodies in blocking solution for 1hr at RT. 
Primary and secondary antibodies and their concentration used in this study 
are listed in Table 2.2 and 2.3. Slides were washed with PBS-0.1%Triton for 5 
minutes, and counterstained with DAPI for 5 minutes. Slides were further 
washed with PBS for 3 times, 5 minutes each and mounted with AF1 mounting 
medium sealed with nail polish and stored at 4°C until imaging. 
 
2.7 In situ hybridisation in combination with 
immunohistochemistry 
 
In situ hybridization was performed first as described above. After colour 
reaction, the slides were washed in 1x PBS to get rid of all the residue of the 
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staining buffer. Then slides were transferred and washed in PBS-0.1%Triton 
and proceed for immunohistochemistry as described above. 
 
To perform fluorescence in situ hybridization in combination with 
immunofluorescence, the slides were processed with FISH as described 
above. After colour reaction with Cyanine 3 tyramide, slides were washed with 
TNT buffer and further transferred to and washed with PBS-0.1%Triton and 














Pax6 (1:10)  
A gift from Prof. V van 
Heyningen, AD2.38 
Simpson et al., 2009  
N/A 
Mouse monoclonal anti-
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Pax6 regulates neuronal 







3.1.1 Defects in neuronal morphogenesis and axon formation in Pax6-
null neurons 
 
In addition to the prethalamus, Pax6 is also expressed post-mitotically in the 
retinal ganglionic cells (RGCs), granule cells in the cerebellum and 
dopaminergic neurons of the olfactory bulb (169). The functions of Pax6 in 
these post-mitotic cells remain to be fully uncovered. Interestingly, several 
groups have reported defects in neuronal morphogenesis and axon formation 
in some of these Pax6-expressing post-mitotic cells when Pax6 is deleted. 
 
For example, in the cerebellum, granule cells extend bipolar axons when 
migrating from the external germinal layer (EGL) to the internal granule layer 
(IGL). These bipolar axons are termed parallel fibres because the axon 
bundles they form are parallel to the pial surface. Yamasaki et al. (170) showed 
that in the rat Pax6-null (rSey2/rSey2) cerebellum, the parallel fibres are 
distorted and clustered together. When assessing cell morphology and 
migration of granule cells in in vitro tissue culture of the EGL, they found that 
the Pax6-null granule cells do not possess long neurites and they fail to follow 
specific trajectories during migration. The effects of Pax6’s loss seemed to be 
cell-autonomous, as defects in morphology and migration of the Pax6-null 
granule cells were not rescued when they were co-cultured with the postnatal 
day 2 (P2) P2 wild-type (WT) EGL cells. However, when Pax6 expression was 
restored by transferring Pax6 cDNA into the cultured Pax6-null EGL, these 
Pax6-null EGL cells exhibited long neurites that resembled the morphology of 
the WT granule cells. These results indicate that Pax6 functions as an intrinsic 
factor and is required for the formation of bipolar axons and probably 
subsequent migration of granule cells in the developing rat cerebellum (170). 
In addition to rat granule cells, granule cells in mouse cerebellum seem to 
display similar defects in neuronal morphogenesis when Pax6 is lost. Swanson 
et al. (171) showed that in dissociated cell cultures of the E18.5 mouse 
cerebellum, the number of differentiated cells (Tuj1-positive) with at least one 
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neurite greater than twice the cell body diameter was significantly lower in the 
Sey/Sey cell culture. This result indicated that the post-mitotic cells’ abilities to 
produce and/or maintain long neurites (or axons) were compromised when 
Pax6 is lost (171). Furthermore, Sebastian-Serrano et al. (169) showed that 
the axonal length of retinal ganglion cells could be augmented by the addition 
of the secreted protein SFRP1. However, knock-down of Pax6 in these 
cultured RGCs by shRNA blocks the SFRP1-stimulated growth of retinal axon. 
These results indicated that both extrinsic and intrinsic factors affect axon 
formation in the RGCs, and Pax6 might regulate axon formation by controlling 
the transcription of intrinsic factors downstream of the Sfrp1 signalling pathway 
(169). These observations raised the intriguing possibility that Pax6 might 
regulate neuronal morphogenesis, or more specifically, axon formation, in 
neurons that still maintain its expression postmitotically.  
 
3.1.2 Aim of this chapter 
 
As a subset of the prethalamic-derived neurons maintains the expression of 
Pax6 during and after neurogenesis, the developing prethalamus provides us 
with an ideal system to investigate the functions of Pax6 in post-mitotic cells. 
Interestingly, in our RNAseq data, GO terms such as axonogenesis, neuron 
projection development, cell projection organisation and axon guidance were 
among the most highly enriched and significantly upregulated in the 
prethalamus when Pax6 is lost.  
 
Based on the analysis of the RNAseq data and previous studies in granule 
cells and retinal ganglion cells, I hypothesised that Pax6 promote neuronal 
morphogenesis and axon elongation in the Pax6-positive prethalamic neurons. 
 
In this chapter, by developing an in vitro culture system that allows me to 
observe neuronal morphogenesis of the prethalamic neurons, I aim to: 
 
1. Characterise the process of neuronal morphogenesis of the prethalamic 
neurons in vitro 
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2. Investigate whether and how neuronal morphogenesis of the prethalamic 




3.2 Materials and Methods 
 
3.2.1 Animal model 
 
The animal model used in this study is the FP6CD1 mouse. Protocol for 
tamoxifen gavage and embryo collection remains the same as previously 
described where 10mg of tamoxifen was given to the pregnant female on E9.5 
and embryos were collected on E13.5. 
 
3.2.2 Dissection of the prethalamus 
 
To dissect the prethalamus, embryos from E13.5 are collected and decapitated. 
The neural tube is separated from the epidermal and mesodermal tissue 
(Figure 3.1A) and cut in half along the dorsal and ventral midline (Figure 3.1B). 
From E9.5, morphologic segmentation of the diencephalon starts and the 
diencephalic prosomeres become apparent from E10-11 as ventricular ridges 
and lateral wall bulges appear (18). These morphological landmarks are used 
to distinguish prethalamus from the surrounding tissue (the thalamus and the 
eminentia thalami (EmT)) during dissection (Figure 3.1B arrows). 
 
3.2.3 Dissociated cell culture 
 
After being cut out, the two prethalamic pieces from the two halves of the 
neural tube of the same embryo were put together and chopped into smaller 
pieces for dissociated cell culture using the Papain Dissociation System 
(Worthington Biochemical Corp.) according to the manufacturer’s protocol 
(Figure 3.1C-D). The prethalamus from each embryo was dissociated and 
cultured individually. The number of cells obtained after dissociation was 
measured using a haemocytometer. Additionally, trypan blue staining was 
used to determine the ratio of viable to damaged cells. To adjust the plating 
density of the cell culture, cells obtained after dissociation were resuspended 
using a certain amount of culture medium (Advanced DMEM/Neurobasal 
medium 1:1, supplemented with N2 (100x) and B27 (50x) neural supplement, 
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Thermo Fisher Scientific). 130μl of the culture medium containing the 
resuspended cells was then added onto the 9mm circular coverslips (Fischer 
Scientific) coated with Poly-L-lysine and Laminin (Thermo Fisher Scientific). 
Due to the surface tension of the culture medium, the culture medium 
containing the dissociated cells would stay within and fill up the realm of the 
coverslips. The cell cultures were then incubated at 37°C with 5% CO2 for 1 
hour to allow the cells to attach to the coverslips. In this way, all the cells 
obtained after the dissociation was retained within the coverslip, and the exact 
cell density of plating could be calculated using the total amount of cells divided 
by the surface areas of the coverslips being used. After 1hr, 240μl of the 
culture medium was then added into each well of the 48-well plate (Greiner 
Bio-One) that contains the coverslip. The dissociated prethalamic cells were 
cultured for 1-6 days (Figure 3.1E). Light microscopy was used to monitor the 









--- cell density: 20cells/mm2
Coverslip was taken 
out and cells were 
fixed on 1 day in vitro 
(1 DIV)
2DIV 3DIV 4DIV 5DIV 6DIV
CAG-CRE-/-, Pax6+/+ , 
5DIV, Immunofluorescence for Tuj1
• Control: CAG-CRE-/-, Pax6+/+






Figure 3.1. Steps of dissociated cell culture of the prethalamus. After the embryo was 
decapitated, the neural tube was isolated (A) and separated into two halves (B). Then, 
according to the morphological ridges and furrows (B, arrow heads), the prethalamus from 
both halves of the neural tube was cut out (C) and processed for dissociated using the 
Papain Dissociation System (Worthington Biochemical Corp.) according to the 
manufacturer’s protocol, as one sample (From C to D). The numbers of cells yielded was 
determined by haemocytometer, and further diluted to make a final plating concentration 
of 20 cells/mm2 (From D to E). Dissociated prethalamic cells from the same embryo were 
then plated onto coverslips and cultured for 1-6 days (E). On each individual day, the 
coverslip was taken out, and processed for fixation and further fluorescent 
immunohistochemistry with the Tuj1 antibody (F). Scale bar in F: 10µm. 
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3.2.4 Fluorescent immunohistochemistry for whole morphology of 
neurons 
 
To stain for the whole morphology of neurons, the coverslips containing the 
prethalamic neurons were removed from the culture medium, rinsed with 
1xPBS and fixed in 4% PFA for 20 minutes. These coverslips were then rinsed 
again in 1xPBS, and the cells were permeabilised in 0.1% Triton X-100 in 
1xPBS (0.1% PBST) for 10 minutes. After that, 0.1% PBST was removed, and 
cells were washed with 0.1% PBST for three times and further blocked with 
blocking solution (20% goat or donkey serum in 0.1% PBST) for 2 hours. Then 
the blocking serum containing primary antibodies was added to the cells for 
overnight incubation. On the second day, cells were replaced with clean 0.1% 
PBST for washes and further incubated with blocking serum containing the 
corresponding secondary antibodies for 1 hour. Cells were then washed with 
1xPBS, and further incubated with DAPI for counterstaining of the nucleus. 
 
The expression patterns of GFP, Neurobiotin and Tuj1 in the dissociated 
prethalamic neurons were analysed and compared in order to decide which 
one is the most suitable marker to label the entire morphology of the neurons. 
As mentioned above, the animal model I use carry a cytoplasmic GFP reporter, 
which becomes active upon tamoxifen induction. Neurobiotin is an amino 
derivative of biotin, which can be taken up by the cytoplasm of the cultured 
neurons when added to the culture medium and visualised by fluorophore-
conjugated streptavidin. Tuj1 labels the neuron-specific Class III β-tubulin of 
the cytoskeleton. Therefore, in theory, all three of them can be used as 
markers for the morphology of the neurons. In the end, I chose Tuj1 as the 
marker because its expression within the neurons highly correlated with that 
of GFP and Neurobiotin’s (Figure 3.2A, B, C’). Unlike the Neurobiotin staining, 
whose efficiency depended on how much of the Neurobition was taken in and 
thus could vary among neurons (Figure 3.2A arrows), the neuronal 
morphology staining I got from Tuj1 was rather homogenous. Additionally, as 
it labels neuron-specific Class III β-tubulin, which is specifically expressed in 
newly generated immature post-mitotic neurons and differentiated neurons 
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(19), Tuj1 staining can also help us distinguish undifferentiated cells in the 








Figure 3.2 Comparison of neuronal morphologies labelled by Neurobiotin and Tuj1.  
(A-B) Dissociated prethalamic neurons were fixed and immuno-reacted with Streptavidin-488 
to detect Neurobiotin and antibody for Tuj1. The effectiveness of Neurobiotin staining for 
whole-neuron morphology depends on how well the neurons can absorb the Neurobiotin, 
which is heterogenous among the cultured prethalamic neurons (A, arrows). 
(C) Enlargement of the boxed area in B.  
(C’) Neurobiotin staining was seen in the filopodia and small processes surrounding the 
growth cone (arrow heads).  
(C’’) Tuj1 staining was seen all the way to the end of the neurite and bigger protrusions (C’, 
C’’, arrows), but not in small filopodia and processes (C’’, arrow heads).  




Fluorescence images of the dissociated cells were taken using a Leica 
DM5500B automated upright microscope connected to a DFC360FX camera. 
The route of acquiring images started from the upper-left corner towards the 
lower-right of the 9mm circular coverslip. Every image being taken was from 
an adjacent visual field of the previous image, in an attempt to cover as many 
cells on the coverslip as possible and without imaging the same cells twice. 
 
3.2.6 Neurite tracing and cell counting 
 
Images obtained were processed with Fiji-ImageJ. Three parameters were 
chosen to represent the dynamics of neuronal morphogenesis at each day of 
the cell culture - the number of neurites, the length of the longest neurite and 
the total length of neurites. All these three parameters were counted for each 
Tuj1-positive cell. A neurite was defined as a stable protrusion from the soma 
(Figure 3.3A-B). Protrusions from the soma which were thin and had vague 
Tuj1 staining were considered as either filopodia or artefacts. Filopodia mainly 
consist of F-actin, therefore were not considered as neurites. Length 
measurements were done by using the freehand line tool in Fiji. To measure 
the length of one neurite, the tracing would start at the edge of the soma, where 
neurite protrusion started and continued all the way to the furthest possible 
edge of the growth cone (Figure 3.3B, white line tracing). The longest neurite 
for each neuron was defined as the one with the highest reading for this 
measurement. All the other protrusions stemmed from that neurite were 
considered as branches. The length of each branch was measured from where 
it stemmed from the neurite to its furthest edge possible (Figure 3.3C, green 
line tracing). The total length of neurites for each neuron was calculated as the 





Figure 3.3 Example of how the measurements were carried out for each neuron. The 
images were processed with Fiji and the freehand line tool was used to measure the lengths. 
For our example neuron in (A), five protrusions from the soma display strong Tuj1 staining. 
Therefore, we defined the number of neurites for this neuron to be 5. (B) To measure the 
length of each neurite, we would start the tracing with the freehand line tool at the edge of 
the soma and continue all along to the furthest point where the Tuj1 staining was detectable. 
(C) To measure the length of each branch, where that branch stemmed from the neurite 
would be considered as the start point, and the tracing would continue all the way to the 
furthest point where Tuj1 staining was detectable. (D) Total length of neurites was calculated 





Three independent experiments were performed using embryos from three 
litters (n=3). The dissociated prethalamic neurons from embryos from these 
three litters were cultured for 1-6 days. For each day of the cell culture, at least 
100 neurons from the control genotype and 100 neurons from the Pax6-null 
genotype were measured. The data I collected consisted of two fixed effects- 
days and genotype, one random effect- litters and three output variables- the 
length of longest neurite, the total length of neurites and number of neurites. 
We then processed these data sets for mixed-effect models for statistic test. 
 
To elaborate, as the data set of the length of longest neurite and the total length 
of neurites consisted of continuous numerical data, they were first tested for 
best distribution fit using Quantile-Quantile plots, and the best fit was gamma 
distribution. The data set of the number of neurites consisted of discrete 
numerical data, therefore was fitted to the Poisson distribution.  
 
As shown in Figure 3.4, both sets of data for the length of the longest neurite 
and total length of neurite fitted well with the gamma distribution. However, the 
data set of the number of neurites did not fit well with the Poisson distribution. 
Nevertheless, we still proceeded for mixed-model with all three data sets. From 
there, type III ANOVA was applied to test which factors, and which interactions 
affect the data. With such information, the data sets were further processed 
for Tukey comparisons. To elaborate, one-way ANOVA tests were first 
performed to see if there was any evidence that the means of populations differ. 
If the ANOVA led to the conclusion that there was evidence of differences 
between the group means, we then considered the pair-wise factors and 
further investigate which of the means are different. Statistics for mixed-model 





Figure 3.4 Quantile-Quantile plots showing the best fitted distribution for the data 
sets of length of the longest neurite, the total length of neurites and the number of 
neurites. Fitting the data sets Data points for length of longest neurite (A) and total length 
of neurites (B) fitted gamma distribution. Data points for number of neurites did not fit the 




3.3.1 Genes involved in regulating cytoskeletal reorganisation in favour 
of neuritogenesis and axon elongation are up-regulated in the 
prethalamus when Pax6 is lost. 
 
To understand how neuronal morphogenesis might have changed in the 
prethalamus when Pax6 is lost, I first looked into the genes in the neuronal 
morphogenesis related GO-terms, which were highly enriched and 
significantly upregulated in the RNA-seq data. Candidate genes were cross-
referenced from reviews and research articles addressing cytoskeletal 
regulation during neuronal morphogenesis (neuritogenesis, axon specification 
and elongation). The results showed upregulation of effector genes involved 
in both actin and microtubule cytoskeleton modification that underlie increased 
actin nucleation, actin bundling, microtubule assembly and bidirectional 
intracellular transportation, which have been shown to augment axon/neurite 
elongation. Besides, genes involved in relaying extracellular signals to both 
the actin and microtubule cytoskeleton are also upregulated. These include 
several GEFs that relay membrane-signalling activities to members of the Rho 
GTPases, and several Rho GTPases themselves. Genes that function to 
manipulate membrane curvature in order to accommodate cytoskeletal 
changes during neurite outgrowth are also upregulated. Table 3.1 shows a 
selection of these genes, their functions during neuronal morphogenesis in 
other systems, their mean-base expression level in the prethalamus, and their 
LFCs of expression levels in the absence of Pax6.  
 
The above data indicate that cytoskeletal organisation is influenced when Pax6 
is deleted in the prethalamus. Surprisingly, they also seem to imply that, 
opposite to defective axon formation and decreased axon/neurite length 
observed in granule cells and retinal ganglion cells, axon formation may be 
augmented in the prethalamic post-mitotic cells upon Pax6’s loss.  
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To find out exactly how neuronal morphogenesis might have been impacted, I 
then turned to the in vitro culture system, to observe the process of neuronal 
morphogenesis in the dissociated prethalamic neurons in the presence and 




Table 3.1 Log2-fold change (LFC) of representative genes involved in the process of 
neuritogenesis, axon specification and elongation.  
 
In terms of actin cytoskeleton regulation, for example, the Rho family GTPase1- Rnd1, which 
has been shown to regulate axon extension by enhancing microtubule destabilising activities, 
is upregulated by a LFC of 0.779. Overexpression of Rnd1 induces the formation of multiple 
axons (172). Members of the Dock180-related proteins, which function as GEFs for Rac and/or 
CDC42, were upregulated. The included (ranked according to their LFC changes) Dock4 (LFC 
1.03), Dock8 (LFC 0.95), Dock2 (LFC 0.86), Dock10 (LFC 0.76), Dock3 (LFC 0.68) and Dock9 
(LFC 0.66). Studies on Dock4 have indicated that it functions to transduce several upstream 
signals such as Wnt, RhoG towards the activation of Rac1. In hippocampal neurons, 
upregulation of Dock4 expression resulted in dendritic elongation (173,174). Dock2’s binding 
with the scaffold protein ELMO1, which was also upregulated in the RNAseq data (LFC 0.87), 
is critical for Dock2-mediated Rac1 and Rac2 activation that result in cytoskeletal 
reorganisation during neutrophil chemotaxis (175). Dock3 enhances axonal outgrowth through 
activating Rac1 and stimulating membrane recruitment of the WASP family verprolin-
homologous (WAVE) protein complex. The WAVE proteins function to relay activated Rac1 
and CDC42 signalling to Arp2/3 that eventually result in actin nucleation (176). Interestingly, 
WAS protein family member 1, also known as WAVE-1, is also upregulated by a LFC of 0.759. 
Several actin cytoskeletal effector proteins regulating actin elongation and bundling were also 
upregulated. For example, the murine and avian Ena ortholog Mena (mammalian Enabled), 
which is a member of the Ena/VASP family, functions to out-compete capping proteins and 
subsequently recruits Fascin to generate nascent filopodia (177). The expression of Mena was 
upregulated by a LFC of 0.677. In C. elegans, it has been shown that in addition to Arp2/3’s 
function in growth cone filopoia initiation, Enabled and the actin binding LIM protein (Ablim) 
function in similar fashions but in parallel pathways to Arp2/3 (178). Notably, expressions of 
Ablim3 (LFC 1.195), Ablim2 (LFC 0.913) and Ablim1 (LFC 0.594) were all upregulated.  
 
In terms of microtubule effector genes, several microtubule binding proteins (MBPs), which 
bind directly to the microtubules and modify their organisation, were upregulated in the 
prethalamus in the absence of Pax6. For example, members of the type II family of MAPs, 
Tau and Map2 showed upregulated expression of LFCs of 1.16 and 0.326 respectively. Map2 
is particularly important for the initial phases of neurite outgrowth, as suppressing its 
expression abolishes neurite outgrowth and extension in cerebellar neurons. Suppressing Tau 
expression, on the other hand, only prevent axonal elongation, indicating Tau’s specific role 
in axonal growth. Other studies showed that elevating Tau’s expression can increase the 
number and length of axons (69). The expression of the microtubule dimer binding protein 
Crmp-2 is upregulated by a LFC of 0.495. CRMP-2 associates with kinesin and functions to 
deliver free tubulin dimers to the plus ends of the microtubules. It also transports effectors for 
actin organisation such as WAVE proteins to the distal tip of the protruding filopodia. CRMP-
2 thus can facilitate microtubule and F-actin assembly and promote growth cone advancement 
(69,179). In addition, +TIPs such as APC (LFC 0.78), APC2 (LFC 0.86) and CLIP1 (LFC 0.815) 
are also upregulated.  
 
Genes that functions to manipulate membrane curvature in order to accommodate cytoskeletal 
dynamics during neurite outgrowth were also upregulated. These included Syndapin/Pascin1 
(LFC 0.81) and srGAP3 (LFC 0.92) (180)(181).  
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3.3.2 Progression of neuronal morphogenesis of individual prethalamic 
neurons can be observed in the dissociated cell culture system 
 
Morphogenesis of dissociated prethalamic cells started soon after the cells 
were plated onto the coverslips and attached to the coverslip surfaces. When 
cells were fixed after 24 hours after plating (1DIV), neuritogenesis had already 
happened, and the majority of the dissociated prethalamic cells had transited 
from stage 1 to stage 2 or even later stages (Figure 3.5A-A’). At 1DIV, Pax6-
positive and Pax6-null prethalamic neurons, which were positive for Tuj1 
staining, and mostly display 2-3 short neurites with similar lengths (Figure 
3.5A-A’). From 2DIV onwards, most Pax6-positive and Pax6-null prethalamic 
neurons displayed one longest neurite, which was presumably the developing 
axon, and several shorter neurites (Figure 3.5B-F’). The progression of 
neuronal morphogenesis of the prethalamic neurons generally followed the in 
vitro model that previous studies proposed. However, branching of neurites in 
the prethalamic neurons took place prior to the establishment of neuronal 
polarity and later, alongside neurite elongation (Figure 3.5A-C’). Interestingly, 
the longest neurites the prethalamic neurons displayed also developed a lot of 
branching and small protrusions, especially at later stages (Figure 3.5D-F’). By 
visual inspection, the general morphologies of the Pax6-null prethalamic 
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3.3.3 Neuronal morphogenesis is highly heterogeneous among the 
primary neurons of the prethalamus at the same age of cell culture. 
 
To find out if the dynamics of neuronal morphogenesis was affected when 
Pax6 was deleted from the prethalamus, I measured the length of longest 
neurite, the total length of neurites and the number of neurites in each 
individual Pax6-positive and Pax6-null prethalamic neurons. Scatter plots were 
used to demonstrate whether there were any correlations between the length 
of the longest neurite and total length of neurites among the prethalamic 
neurons being measured. Interestingly, on the averaged population level, it 
seemed that both Pax6-positive and Pax6-null prethalamic neurons distributed 
nearly half of their cytoskeletal contents to make up the stem of the longest 
neurite, as the ratio of the length of longest neurite over the total length of 
neurites always ranged from 0.4 to 0.5 across the 6 timepoints examined 
(Figure 3.6A-F). Another interesting result showed by these scattered plots 
was that the morphologies of prethalamic neurons, when represented by 
correlation of these two parameters, exhibited high levels of heterogeneity, 
especially at later stages when the neuronal morphologies are more mature 
(Figure 3.6D-F). Additionally, Pax6-null prethalamic neurons seemed to 
display shorter longest neurites and lower total length of neurites at earlier 
stages (Figure 3.6A-C). However, at later stages, the Pax6-null population 
seemed to be more spread out than the control cells, and the averaged the 
longest neurite, and total neurite length seemed to have surpassed the control 
cell population (Figure 3.6D-F). 
 
In terms of the number of neurites, the majority of the prethalamic neurons 
constantly display 2-3 neurites throughout the time points examined (Figure 
3.7A-F’). However, the Pax6-null prethalamic neurons seemed to have a larger 
proportion of cells displaying lower numbers of neurites than the Pax6-positive 
prethalamic neurons (Figure 3.7A’-F’). The number of neurites displayed by 
both the Pax6-positive and Pax-null neurons increased as neuronal 
morphogenesis proceeded (Figure 3.7A’-F’), indicating that unlike what the 
conventional model of neuronal morphogenesis in vitro proposes, 
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neuritogenesis of prethalamic neurons can also happen at later stages, such 
as beyond the stages of establishment of neuronal polarity and axon 
elongation. 
 
The above observations indicated that although the general morphologies the 
Pax6-null prethalamic neurons displayed were similar to that of the Pax6-
positive prethalamic neurons, the dynamics of neuronal morphogenesis might 
differ. Therefore, we further performed statistical tests on the data I collected 
on the length of the longest neurite, the total length of neurites and the number 
of neurites from the control and Pax6-null prethalamic cells. As mentioned 
above, the prethalamic cells collected from these six days of cell culture came 
from the prethalamus of a single embryo. Moreover, on each day of the cell 
culture, images of at least 100 cells were processed for measurement of the 
three morphological parameters. Therefore, to accommodate the fact that the 
cells on each day of the cell cultures were not independent, and to avoid 
creating pseudo-replications in our statistical tests, we performed mixed-effect 
models on the data collected, to verify if loss of Pax6 can significantly alter any 
of these three parameters, and thus affect the dynamics of neuronal 








Figure 3.6 Scatter plots showing correlation between length of longest neurite and total 
length of neurites in each of the neurons measured (Page 85-86). (A-F) Neurons cultured 
for 1-6 DIV. At least 100 prethalamic neurons from each litter of both the control and Pax6-null 
genotype were measured on each of the six days of the cell culture. Measurements of 
prethalamic neurons from three litters were pulled together to make up each scatter plot. 
Linear trendlines with a set intercept of zero were calculated with Excel to fit for the two 
measurements in both genotypes of prethalamic neurons on each day of the cell culture. The 
closer the R2 values were to 1, the better the trendlines were fitting and representing the 
population. The mean values of length of longest neurite and total length of neurites for each 





Figure 3.7. Number of neurites displayed by prethalamic neurons of the control and 
Pax6-null genotypes on each of the six days of the cell culture. The neurons being 
measured were the same as the ones that were used for measurements of length of longest 
neurite and total length of neurites. Therefore, at least 100 prethalamic neurons were 
measured for both genotypes and measurements of numbers of neurites in neurons from three 
litters were pulled together to make each one of the scatter plots (A-F) and stacked column 
graphs (A’-F’). (A-F) Scatter plots with smooth lines and markers showed the number of 
neurons displaying a set number of neurites on each day of the cell culture. (A’-F’) Stacked 
column graphs showed the percentage of neurons displaying a set number of neurites on each 
day of the cell culture. 
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3.3.4 Loss of Pax6 affects neuronal morphogenesis dynamics in the 
prethalamic neurons. 
 
For the data sets of the length of longest neurite and the total length of neurites, 
fixing a mixed model with litter as random effect made the model unable to 
converge, meaning that the parameters of the model (days, genotypes and 
output variables) cannot be estimated correctly. Therefore, we left out the litter 
effect from the model. Analysis of deviance by Type III ANOVA showed 
significant effects of days and genotype (P< 2.2 x 10^-16), as well as their 
interaction. From this, the pairwise comparison can be made between 
genotypes within the same days for data collected for the length of the longest 
neurite and total length of neurites. 
 
Data points of the three data sets were processed for box plots, to show the 
distributions of the data of each genotype on each individual day. The upper 
and lower edge of each box indicated the 75th percentile and 25th percentile, 
while the horizontal line inside the box indicated the median and the cross 
inside the box indicated the mean value of each data set. The whiskers were 
drawn according to the Tukey method. Briefly, the difference between the 25th 
and the 75th percentile was calculated and termed interquartile range (IQR). 
The upper whisker was drawn by adding 1.5 times of IQR on top of the 75th 
percentile, and the lower whisker was drawn by deducing 1.5 times of IQR 
from the 25th percentile. Any value greater than the value of the upper whisker 
or lower than the value of the lower whisker was plotted as individual points in 
the box plots. If no values in a data set were higher than the value of the 75th 
percentile plus 1.5 times of IQR, or no value was lower than the 25th percentile 
minus 1.5 times of IQR, the upper or lower whisker was drawn as the highest 
or lowest value in that data set.  
 
As shown in Figure 3.8 and 3.9, Pax6-null prethalamic neurons constantly 
displayed shorter length of longest neurite and the total length of neurites from 
1-3 DIV, indicating that neuronal morphogenesis might have been delayed in 
the prethalamic neurons at early ages of cell culture (1-3 DIV) when Pax6 is 
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lost (Figure 3.8A-C, Figure 3.9A-C). However, the rate of neurite elongation 
increased dramatically from 3-5 DIV (Figure 3.8D-F, Figure 3.9D-F), and this 
lack of neurite growth was soon caught up by the Pax6-null prethalamic cells 
as at 4DIV, as no difference was seen in the length of longest neurite and the 
total length of neurites between the control and the Pax6-positive prethalamic 
neurons (Figure 3.8D, Figure 3.9D). Additionally, at 5 and 6 DIV, the Pax6-null 
prethalamic neurons display longer length of the longest neurite, and on 5DIV, 
they also displayed a longer total length of neurites (Figure 3.8E-F, Figure 
3.9E-F).  
 
In terms of numbers of neurites, although on all six days of the cell culture, 
Pax6-null prethalamic cells always displayed a larger proportion of cells 
possessing lower numbers of neurites, these differences were not significant 
except for 1 DIV (Figure 3.10).  
 
These results showed that when Pax6 is lost from the prethalamus, the 
process of neuronal morphogenesis was affected in the prethalamic neurons 
as in the early stages, neuronal morphogenesis was delayed but soon caught 





Figure 3.8 Pax6-null prethalamic neurons displayed different dynamics of extending 
their longest neurites during neuronal morphogenesis. (A-C) From 1-3 DIV, Pax6-null 
prethalamic neurons had shorter length of longest neurites. (D) At 4 DIV, Pax6-null 
prethalamic neurons showed similar length of longest neurites as the control prethalamic 
neurons, indicating an increased rate of neurite elongation from 3-4 DIV. (E-F) At 5 and 6 
DIV, Pax6-null prethalamic neurons showed longer length of longest neurites. Data were 
analysed with mixed-model, measurement of length of longest neurite from at least 100 
neurons of both genotypes were collected from each litter on each of the six days of cell 
culture. Three litters in total (n=3). ***: P<0.001. 
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Figure 3.9 Similar to length of longest neurite, Pax6-null prethalamic neurons also 
showed different dynamics when extending all of their neurites. Total length of 
neurites in the Pax6-null prethalamic neurons were shorter at 1-3 DIV (A-C), whose 
extending rate also seemed to have increased during 3-4 DIV and displayed similar length 
to the control prethalamic neurons on 4 DIV (D). (E) On 5DIV, Pax6-null prethalamic 
neurons displayed significantly longest length of total neurites. Although the average 
lengths of total neurites were still higher in the Pax6-null prethalamus, the difference was 
not significant on 6 DIV (F). Data were analysed with mixed-model, measurement of length 
of longest neurite from at least 100 neurons of both genotypes were collected from each 
litter on each of the six days of cell culture. Three litters in total (n=3). ***: P<0.001. 
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Figure 3.10 Pax6-null prethalamic neurons displayed slightly lower number of 
neurites during neuronal morphogenesis. Across the six days measured, only on the 
first day of the cell culture (1DIV) (A) that the number of neurites differed significantly 
between the control and the Pax6-null neurons. In the rest of the days tested (B-F), Pax6-
null neurons constantly displayed lower averaged number of neurites on a populational 
scale, but such difference was not significant. Data were analysed with mixed-model, 
measurement of number of neurites from at least 100 neurons of both genotypes were 
collected from each litter on each of the six days of cell culture. Three litters in total (n=3). 
**: 0.001<P<0.01.  
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Figure 3.11 Summary of neuronal morphogenesis of prethalamic neurons in 
culture through time. (A-B) Neuronal morphogenesis was delayed in the Pax6-null 
prethalamic neurons as they displayed shorter length of longest neurite and total neurites 
from 1-3DIV, and these differences were significant for both parameters from 1-3DIV. 
From 3-5DIV, the rate of axon elongation in the Pax6-null prethalamic cells increased 
dramatically, and they displayed longer longest neurite and total neurite length in later 
stages (5-6DIV). These differences were significant for both parameters on 5DIV. (C) The 
average number of neurites per neurons was constantly less in the Pax6-null prethalamic 
cells, and such difference were only significant on 1DIV. Mixed-effect model, at least 100 
neurons of both genotypes were collected from each litter on each of the six days of cell 




In this chapter, I utilised the dissociated cell culture system to study neuronal 
morphogenesis of prethalamic neurons in vitro. Three parameters- length of 
the longest neurite, the total length of neurites and the number of neurites were 
chosen to represent the dynamics of neuronal morphogenesis as primary 
prethalamic neurons mature. By comparing these three parameters in control 
and Pax6-null prethalamic neurons, I found that Pax6-null prethalamic neurons 
displayed different dynamics when extending their neurites during neuronal 
morphogenesis. At earlier stages (1-3 DIV), neuronal morphogenesis was 
delayed in the prethalamic neurons as they showed a shorter length of the 
longest neurite and total neurites. However, the rate of neurite extension 
increased dramatically from 3-5 DIV and the Pax6-null prethalamic neurons 
displayed longer length of the longest neurite and total neurites at later stages 
(5-6 DIV).  
 
The prethalamus is one of the very few places in the neural tube where Pax6 
is expressed post-mitotically (22). Previous researches investigating the 
relationship between Pax6 and neuronal morphologies in granule cells of the 
cerebellum and retinal ganglionic cells have pointed out a possible general 
trend of Pax6 facilitating these neurons in extending their neurites or axons 
(169–171). However, in the prethalamic neurons, Pax6 seemed to play a role 
in limiting axon elongation, at least during the later stages of the cell culture 
when the morphologies of the prethalamic neurons were more mature. This 
has once again pointed out an intriguing but quite frequently observed situation, 
in which the same transcription factor plays opposite roles in different tissues 
during development of the nervous system (58).  
 
Unlike the thalamic neurons, which receive afferent sensory input (except 
olfactory) and relay them onwards by projecting to and innervating specific 
regions of the cortex, prethalamic neurons only project to and innervate the 
neighbouring thalamus and form close or open circuitries with thalamic 
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neurons to fine tune the latter’s excitability (12,104). Prior to the formation of 
the thalamocortical axons (TCA), prethalamic axons that innervate the 
thalamus would act as scaffolds for the descending of the TCA into the 
prethalamus before the TCA exit the ventral diencephalon and turn for the 
cortex. Misroute of the TCA has been a known phenotype of the Pax6 mutant 
mice, and previous studies have shown that in these Pax6 mutant mice, 
prethalamus failed to send out as many pioneer axons to the thalamus 
(unpublished data) (59). Indeed, dysregulated expressions of guidance 
molecules within the diencephalon might be one significant contributor 
(60,165,166). However, by confirming that Pax6 can regulate morphogenesis 
of the prethalamic neurons in a cell-autonomous manner, my findings provided 
another potential explanation and a new insight into how TCA formation could 
be disrupted in the Pax6 mutants. If what I showed in vitro reflects what 
happens in vivo, then disrupted dynamics of morphogenesis of the prethalamic 
neurons might cause the prethalamic axons to arrive at the thalamus at an 
incorrect timepoint or even not arriving at the thalamus at all, therefore failing 
to support the formation and descending of the TCA.  
 
Different attempts of visualising neuronal morphogenesis of the prethalamic 
neurons in vivo had been made during this PhD. For example, as the animal 
model I used carries a GFP reporter for the activities of the tamoxifen-
dependent Cre recombinase, lowering the dose of the tamoxifen enables me 
to create a mosaic deletion of Pax6 and activation of GFP expression. If this 
dosage is low enough, I will be able to see a random set of Pax6-null cells with 
cytoplasmic GFP expression lighting up their entire morphology. Additionally, 
when the dose of tamoxifen is so low, these Pax6-null cells would still be in a 
Pax6-positive environment, meaning that the environmental information for 
neuronal morphogenesis in vivo would still be more or less correct. Therefore, 
this set up creates an ideal in vivo counter-situation to the in vitro culture 
system, that would allow me to study the cell-autonomous effect of Pax6 on 
neuronal morphogenesis if any of the prethalamic neurons were randomly hit 
by the tamoxifen. Unfortunately, despite the repeated effort of trying different 
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dosages of tamoxifen and different length of time for the low-dose tamoxifen 
to activate the Cre-recombinase, I was not able to set up this mosaic system 
to study neuronal morphogenesis in vivo. The reason was that the dose of 
tamoxifen needed to activate the GFP reporter was way lower than the dose 
needed to excise the floxed Pax6 exons effectively. As a result, when the dose 
of tamoxifen was low enough for me to visualise the clear morphology of single 
neurons, that neuron still had at least one of its Pax6 allele intact despite it was 
also positive for GFP expression. 
 
To compensate this, another effort I made to visualise neuronal 
morphogenesis in vivo was to perform intracellular filling of cells using 
microinjection electrodes in fixed diencephalic sections of the same mouse 
model. The technique worked for what I needed, which was to outline the entire 
morphologies of a few prethalamic neurons selectively. However, due to the 
difficulty of performing this technique, it was time-wise unrealistic to use this 
technique in an attempt to collect enough numbers of prethalamic neurons for 
statistical analysis. For future experiments to visualise and trace the 
morphologies of prethalamic neurons at different developmental stages, I 
might be able to utilise in utero electroporation. To elaborate, a low 
concentration of plasmids containing a cytoplasmic marker different than GFP 
can be injected into the third ventricles of the control and Pax6-null embryos 
of the same mouse model, followed by electroporation. That way I might be 
able to selectively label the morphologies of a subset of prethalamic neurons 
for further analysis. 
 
How does Pax6, as a transcription factor, regulate neuronal morphogenesis in 
a cell-autonomous manner remains elusive. One possibility might be that Pax6 
directly controls the expression of the cytoskeletal regulatory genes in the 
Pax6-positive prethalamic neurons. This remains to be confirmed. Another 
possibility might be that through activation or inactivation of other signalling 
pathways. In our RNAseq data, the Wnt signalling pathway was also highly 
enriched and upregulated in the prethalamus when Pax6 is lost. Both 
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canonical and noncanonical Wnt signalling were known to be able to regulate 
cytoskeletal reorganisation during neuronal morphogenesis. Therefore, could 
the change of neuronal morphogenesis dynamics in the Pax6-null prethalamic 
neurons be a result of altered Wnt activities? Which Wnt signalling pathway 
exactly and also in which prethalamic cells? On the other hand, it is known that 
canonical Wnt signalling plays a role in specifying cell fate of the pTh-C derived 
neurons. Could the change of neuronal morphogenesis simply be a result of 
changes in cell fate of the prethalamic neurons due to this upregulation of 
canonical Wnt signalling in the prethalamus? These are all interesting 
questions that need to be further pursued in the future. 
 
The upregulated expressions of cytoskeletal regulatory genes found in the 
RNAseq data after Pax6 deletion might be the reason for the overshoot of the 
length of the longest neurite and total neurites. However, it remains 
exceptionally intriguing why at early stages of the cell culture, neuronal 
morphogenesis was slower in the Pax6-null prethalamic neurons.  
 
Due to my experimental design, when I applied tamoxifen gavage at E9.5, 
almost all the cells in the neural tube at this age were progenitors. Therefore, 
I started deleting Pax6 in the prethalamic progenitor cells, and these 
progenitors carried the impacts of absence of Pax6 during and after they 
become post-mitotic cells. As a result, one possibility to explain the delayed 
neuronal morphogenesis in the early stages of the cell culture might be that I 
saw a total effect of Pax6’s deletion throughout the development of the 
prethalamic cells, from when they were still progenitors to when they have 
become neurons. Could this be the underlying reason why the Pax6-null 
prethalamic neurons develop their morphologies slower at the early stages of 
the cell culture? 
 
In order to distinguish the effect of loss of Pax6 in progenitor cells and post-
mitotic cells, I attempted to delete Pax6 only in the prethalamic post-mitotic 
cells. However, as we did not have a mouse model which initiate the 
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expression of the Cre-recombinase only in the post-mitotic cells, this 
experiment was done in the dissociated prethalamic cell cultures. To elaborate, 
embryos of CAG-Cre+/-, Pax6+/loxP and CAG-Cre+/-, Pax6loxP/loxP were collected 
at E13.5, and their prethalamus were dissected out and processed for 
dissociated cell culture as described above. Unlike my experimental design for 
observing neuronal morphogenesis, these embryos had not experienced 
tamoxifen. After the dissociated cells have attached to the coverslips and 
rested for 2 hours, 4OH-tamoxifen was added into the cell culture to active the 
Cre-recombinase in these prethalamic primary cell cultures. As most of the 
cells in the prethalamus at E13.5 have already exited the cell cycle, by applying 
active tamoxifen directly into the cell culture, I made sure to delete Pax6 almost 
only in the prethalamic post-mitotic cells. Unfortunately, the prethalamic 
primary cells in culture were susceptible to 4OH-tamoxifen. Also, when I lower 
the dose of 4OH-tamoxifen to a level that cell viability could be achieved, it 
was too low for the Cre-recombinase to excise the floxed Pax6 exons 
effectively. GFP expression, however, could still be activated under this dose 
of 4OH-tamoxifen, a scenario similar to the in vivo mosaic experiment 
described above.  
 
In addition to low tamoxifen dosage that was not high enough to excise the 
floxed Pax6 exons, another complication I encountered when I attempted to 
delete the Pax6 in only post-mitotic cells was that it seemed that a high Pax6 
deletion efficiency was much harder to achieve in the post-mitotic cells than 
progenitor cells. Previous work done in the lab has shown that when applying 
tamoxifen gavage at E9.5 to these FP6CD1 mice, Pax6 deletion can reach 
approximately 80% or above even just after two days (58). However, when I 
tried to delete Pax6 only in the post-mitotic cells by applying tamoxifen at E13.5 
to the pregnant females, Pax6 expression could still be found in prethalamic 
derivative neurons at P0. Interestingly, when I cross the FP6CD1 mouse with 
the constitutive Pax6 mutant mouse to generate embryos carrying one allele 
of constitutively mutated Pax6 and one allele of floxed Pax6, the efficiency of 
Pax6 deletion did not increase much in comparison to the embryos carrying 
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two alleles of floxed Pax6. It remains to be determined whether this 
persistence of Pax6 expression in the post-mitotic cells was due to the inability 
of Cre-recombinase to excise the Pax6 gene from the chromosome, or 
extremely low level of turnover of the PAX6 protein. Nevertheless, with the 
mouse model available, I could not proceed any further on investigating the 
deletion of Pax6 only in the post-mitotic cells and how that might impact on 
neuronal morphogenesis of the prethalamic neurons. 
 
Another possibility to explain the delay of neuronal morphogenesis in the 
Pax6-null prethalamic neurons might be the disruption of the establishment of 
neuronal polarity. As what people previously proposed, one of the speed-
limiting steps during neuronal morphogenesis was the establishment of 
neuronal polarity. In cultured hippocampal neurons, for example, the 
establishment of neuronal polarity can take up to 24-48 hours (33). To find out 
whether this is the reason for the delayed neuronal morphogenesis I observed 
in the Pax6-null prethalamic neurons, I next moved on to study the 







In this chapter, by analysing the most highly enriched and upregulated GO 
terms in the prethalamus in the absence of Pax6, I further set out to investigate 
whether neuronal morphogenesis of the prethalamic neurons was disrupted 
when Pax6 is deleted. By comparing the length of longest neurites, total length 
of neurites and number of neurites the control and Pax6-null prethalamic 
neurons displayed from 1-6 days of the cell culture, I found that the dynamics 
of neuronal morphogenesis in the Pax6-null prethalamic neurons altered as 
they displayed slower rate of extension for lonest neurite and also total neurites 
at early stages of the cell culture (1-3 DIV). This delay in neuronal 
morphogenesis was then soon caught up from 3-5 DIV and the Pax6-null 
prethalamic neurons displayed an overshot for the length of longest neurite 
and total neurites at later stages when the morphologies of the neurons were 









The roles of Pax6 in regulating the 
establishment and maintenance of 
neuronal polarity during the 







The primary function of neuronal cells, which is to receive, process and 
propagate electrical signals in a unidirectional manner, is tightly linked to their 
unique and complex morphological features (83,182). A mature neuron usually 
displays a single extended axon and an elaborated web of dendrite arbours 
that have different membrane composition and cytoskeletal structures (73). 
Such distinctions, called neuronal polarity, are established during neuronal 
morphogenesis and maintained throughout the lifetime of the neuron 
(70,83,182).  
 
4.1.1 The PAR3/6 complex plays vital roles during the establishment of 
neuronal polarity 
 
During the establishment of neuronal polarity, the developing neurons 
integrate the spatial and intrinsic cues and ultimately convert them to 
cytoskeletal rearrangements that give rise to the axons and dendrites (83). The 
PAR3/6 complex is a core component of polarity determination in many tissues 
and cells (183). Recent studies have shown that it also plays a vital role during 
the establishment of neuronal polarity (182,184,185). It is composed of the 
scaffold proteins PAR3 and PAR6, and various protein kinases that are 
tethered to them (183). For example, the small GTPase cdc42 and the guanine 
exchange factor (GEF) Tiam1/STEF are both components of the PAR3/6 
complex (183). Upon activation of the PI3K-PIP3 pathway by growth factors or 
adhesion molecules, CDC42 and Tiam1/STEF can be activated and further 
modulate the actin cytoskeleton in favour of neurite protrusion and axon 
elongation (182). Another type of kinase involved in the PAR3/6 complex is the 
atypical forms of protein kinase C (aPKC: PKC λ and z) (183). Activation of 
aPKC by CDC42 or Dishevelled (DVL) due to increased activity of Wnt 
signalling pathways can both phosphorylate Lethal Giant Larvae 1 (Lgl1), thus 
promoting membrane insertion at the nascent axon; and inactivate MARK-2, 
causing microtubule stabilisation and growth (Figure 4.1) (182). As a result, 
the PAR3/6 complex can mediate rearrangements of cytoskeleton and plasma 
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membrane structures in response to localised activation of membrane 
receptors, hence achieving polarised modification of cellular morphology. This 
is why the function of the PAR3/6 complex is highly dependent on its 
subcellular localisation in the polarised cells (83,182).  
 
Indeed, the kinesin motor protein KIF3A has been shown to interact directly 
with PAR3 and direct the transportation and accumulation of PAR3 and aPKC 
to the tip of growing axons in cultured rat hippocampal neurons (185). The 
expression of a dominant-negative form of PAR3 and fragmented KIF3A 
inhibited the accumulation of PAR3 and aPKC at the axonal tip and induced 
sprouting of multiple neurites with similar lengths, indicating that the 





4.1.2 The AIS is a crucial indicator of maintenance of neuronal polarity 
in the mature neuron 
 
As mentioned before (Chapter 1), one of the critical indicators of maintenance 
of neuronal polarity is the axon initial segment (AIS) (81,82). The AIS is 
strategically located at the most proximal part of the axon, and functions as 
both a physiological and a physical bridge between the somatodendritic and 
axonal domains (81). With its specialised ultrastructural features, such as 
fasciculated microtubules and periodically arranged actin rings, and its unique 
molecular constituents, such as the highly concentrated cytoskeletal 
molecules of AnkG, βIV-spectrin and various voltage-gated Na+ and K+ 
Figure 4.1 Schematic depiction of key signalling events regulating neuronal polarity. 
Following Ras activation after growth factor/adhesion signals, PI3K activation and PIP3 
accumulation trigger a series of signaling events: 1) Akt activation and GSK3 inhibition 
resulting in microtubule stabilization; 2) activation of Rac regulating actin and microtubule 
dyamics; 3) Rheb-Rap1b-Cdc42 activation leading to activation of aPKC in the PAR 
complex, promoting actin cytoskeletal remodeling and polarized membrane delivery. Local 
activation of RalA and the exocyst complex also favour proper localisation of PAR complex 
at the tip of the nascent axon. cAMP-dependent activation of PKA leads to activation of 
LKB1, which in turn phosphorylates SAD kinases and MARK/PAR1, regulating microtubule 
dynamics via modulating the affinity of MAPs for microtubules. The Wnt pathway may 
regulate polarity via Dvl by activating aPKC and/or inihibiting GSK3. Figure adapt from (182). 
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channels, the AIS functions as the nexus of neuronal polarity in the mature 
neuron (81).  
 
4.1.3 Aim of this chapter 
 
In Chapter 3, I found that, although axon and neurite elongation was 
augmented in the Pax6-null prethalamic neurons at later stages of the cell 
culture, which might be due to the increased expressions of various 
cytoskeletal effector genes, neuronal morphogenesis was initially delayed in 
the prethalamic neurons when Pax6 is lost. Interestingly, RNAseq data in the 
lab showed significantly increased expression of components of the PAR3/6 
complex and the AIS, which indicated that the establishment and maintenance 
of neuronal polarity might be disrupted in the prethalamic neurons upon Pax6 
removal. Therefore, in this chapter, I moved on to investigate the abilities of 
the prethalamic neurons to establish and maintain their neuronal polarity, 
aiming to test: 
 
1. Whether the establishment of neuronal polarity is defective in the 
absence of Pax6, and if that can contribute to the delayed neuronal 
morphogenesis of the Pax6-null prethalamic neurons 
 
2. Whether the structure and components of the AIS, the key structure to 
maintain neuronal polarity, is altered in the absence of Pax6 
 
3. Whether the excitability of the Pax6-null prethalamic neurons is 
changed due to altered AIS structure and components 
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4.2 Materials and methods 
 
4.2.1 Fluorescent Immunohistochemistry on dissociated cell cultures 
of the prethalamic neurons  
 
The animal model used in this study was still the FP6CD1 mouse. Protocol for 
tamoxifen gavage and embryo collection remains the same as previously 
described. 10mg of tamoxifen was given to the pregnant female on E9.5 and 
embryos are collected on E13.5. Dissection of the prethalamus and 
dissociated cell cultures of the prethalamic neurons were performed in the 
same way as previously described in Chapter 3. 
 
Prethalamic neurons used for investigating the establishment of neuronal 
polarity were collected on 3 DIV of the cell culture, whereas neurons used for 
investigating the AIS were collected on 5, 7 and 9 DIV of the cell culture. At 
each one of these time points, the coverslips containing these cells were 
removed from the cell culture, rinsed with 1x PBS and the cells were further 
fixed with 2% PFA/4% sucrose for 10 minutes at room temperature. Both the 
1x PBS and the 2% PFA/4% sucrose were warmed to 37°C before applying to 
the cells.  
 
After fixation, cells were processed for fluorescent immunohistochemistry in 
the same ways as described in chapter 4. Primary antibodies and secondary 




Fluorescence images of the dissociated cells used to test PAR3 distribution 
were taken using the Zeiss LSM800 confocal microscope with Airy Scan. 
 
Fluorescence images of the dissociated cells used to test the AIS structures 
and measurements of intensity profiles were taken using the Andor Revolution 
XDi Spinning disk confocal microscope. 
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4.2.3 Measurement of PAR3 distribution 
 
Dissociated prethalamic neurons cultured for 3DIV were fixed and stained with 
antibodies for PAR3, GFP for whole-cell morphology and DAPI for 
counterstaining of the nucleus (Figure 4.2A), in order to measure the amount 
of PAR3 and compare its distribution within the cytoplasm of the control and 
Pax6-null prethalamic neurons. With such staining, I first masked out the 
cytoplasmic volume of each neuron using signals from the GFP channel with 
IMARIS software (Bitplane, version 9.1.2). To elaborate, I first utilised the 
surface function of IMARIS to create a new GFP channel (Figure 4.2B). To do 
so, I manually adjusted the signal intensity threshold based on the specific 
situation of each neuron so that IMARIS was able to detect the space where 
the GFP signal is above that set threshold. This threshold was determined by 
fitting and adjusting different threshold values so that the GFP-positive space 
IMARIS detected optimally matched the actual cytoplasmic volume and 
included almost all the neurites and cytoplasmic protrusions. Places where 
their GFP signals were above this threshold but resided outside of the 
cytoplasm were manually deleted. In this way, I was able to create a new GFP 
channel, which only included and highly resembled the entire cytoplasm of the 
neurons (Figure 4.2B). Then I created a new PAR3 channel using this new 
GFP channel as the template of the cytoplasmic volume of that neuron to 
exclude any Par3 staining outside of the cytoplasm (Figure 4.2C). With this 
new PAR3 channel, I was then able to find out the value of the highest intensity 
of PAR3 expression within the cytoplasm. I then set different thresholds for 
IMARIS to detect the cytoplasmic volumes in which the PAR3 intensities were 
above 75%, 50%, 25%, 20% and 10% of its own highest intensity value (Figure 
4.2D1-D5). This allowed me to quantify the cytoplasmic volume that had higher 
expression levels of PAR3 at each of these thresholds, and also visualise the 
distribution of different intensities of PAR3 within the cytoplasm. By comparing 
the values of these volumes between the control and Pax6-null prethalamic 
neurons, I was then able to determine if the expression level and distribution 






Figure 4.2 Setting the different intensity thresholds to detect PAR3 distribution within 
the cytoplasm of the prethalamic neurons. (A) Prethalamic neurons cultured for 3DIV were 
stained with antibodies detecting PAR3, GFP and DAPI for counterstaining of the nucleus. (B) 
A new GFP channel was created for each neuron by fitting the detection threshold so that the 
GFP-positive space IMARIS detected optimally matched the actual cytoplasmic volume and 
included almost all the neurites and cytoplasmic protrusions. (C) A new PAR3 channel was 
created by excluding any PAR3 staining outside the new GFP channel. By doing this, we 
obtained a new PAR3 channel, which only included the cytoplasmic PAR3. (D1-D5) PAR3-
positive cytoplasmic volume detected when the threshold was set at 75%, 50% 25% 20% and 




4.2.4 Measurement of the intensity profile of the axon initial segment 
marked by either AnkG or sodium channels 
 
The axon initial segment of a prethalamic neuron was marked by a segment 
of concentrated expression of either AnkG or voltage-gated Na+ channels at 
the proximal part of a neurite. The neurite bearing such AnkG or sodium 
channel staining would then be recognised as the axon, regardless of whether 
the position of the AIS is somatic or dendritic (Figure 4.3A).  
 
The intensity profiles of the axon initial segments were measured by tracing 
down the axons of the prethalamic neurons using the freehand line tool in Fiji-
ImageJ. The tracing would start at the edge of the soma (Figure 4.3B, 
arrowhead) and follow the track of the axon for at least 80μm (Figure 4.3B, 
yellow line). If the AIS is dendritic, i.e. the position of the AIS is on a branch of 
the axon, tracing of the AIS intensity profile would then follow that specific 
branch instead of the stem of the axon as we did for measuring the length of 
longest neurite in Chapter 3. All the AISs being measured this way were within 
the 80μm length limit. Fiji was then able to measure the intensity of 
expressions of either AnkG or sodium channels at each pixel along the line 
drawn by the freehand line tool when tracing down the axon. The intensity 
profile of the AIS of each prethalamic neuron was thus created by 
corresponding the intensity of AnkG or sodium channels with the distance from 
the soma (Figure 4.3C). 
 
Three independent experiments using embryos from three litters were 
performed (n=3). Within each litter, the prethalamus from one embryo of the 
control genotype and the prethalamus from one embryo of the Pax6-null 
genotype were processed with dissociated cell culture. Neurons were cultured 
for 5 days, 7 days and 9 days in vitro. 30 neurons from each embryo of control 
or Pax6-null genotype, at each time point, were measured. The intensity 
profiles were created by plotting the intensity of each pixel (Y-axis) along the 
line traced by the freehand line tool, against the distance of that pixel from the 
soma (X-axis). 80μm was set as the limit for the distance from soma as all the 
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neurons measured have their AISs located within this distance. The 
representing line for the intensity profile at each time point for each genotype 
was the averaged intensity profiles of all neurons from three litters (90 




Figure 4.3 How intensity profiles of AIS, marked by either AnkG or voltage-
gated Na+ channels staining, are generated. (A) A Pax6-null prethalamic neuron 
cultured for 9DIV and stained for AnkG, GFP, PAX6 and DAPI was used as an 
example. The axon is indicated by the presence of the AIS, which was shown by a 
clear concentrated distribution of AnkG in this case (the magenta segment, yellow 
arrowheads). (B) Zoomed in view of (A). Intensity profiles were measured by tracing 
down the axon using the free-hand line tool in Fiji-ImgeJ. The start point of every 
tracing was at the edge of the soma where the axon (or the stem of a dendrite, if the 
AIS is on a dendritic branch) initiated (yellow arrowhead). The tracing will follow the 
axon for at least 80μm. (C) The intensity profile generated by Fiji-ImageJ. After tracing 
down the axon, Fiji-ImageJ can read out the intensity of each pixel on the axon that 
overlapped with yellow line that was drawn and generate a scatter plot with 2D-line 
with distance from soma (μm) as the X-axis and intensity of the pixels at the Y-axis. 
Fiji-ImageJ call also generate an excel file of such readings, which were used for 
further analysis. Scale bar for all images: 10 μm. 
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4.2.5 Electrophysiology recording 
 
4.2.5.1 Preparation of cells for electrophysiology recording 
 
Dissociated prethalamic neurons cultured for 7 DIV were prepared in the same 
way as described in Chapter 3. After being retrieved from the incubator, the 
coverslips containing the cultured prethalamic neurons were placed directed 
into the external solutions for further electrophysiological recording. 
 
4.2.5.2 External and internal solutions 
 












The pH of the solution was set to 7.3 by addition of 1M NaOH. The solution 













The pH of the solution was set to 7.2 by addition of 1M KOH, and the osmolarity 
was adjusted to around 300 mOsm.L-1 by addition of sucrose. The solution 
was kept at room temperature during electrophysiology recording. 
 
4.2.5.3 Stimulation programmes 
 
Three protocols were applied to the cultured prethalamic neurons sequentially.  
 
In the first protocol, I switched the amplifier to no current input (I=0) for 30 
seconds to record the resting membrane potential of these neurons.  
 
In the second protocol, I applied current steps to the prethalamic neurons for 
28 cycles, where each cycle lasts for 1400ms. Within these 1400ms, the first 
100ms the cells were clamped at -70mV with no current input. In the first cycle, 
within the next 1000ms, a current input of -30pA was applied. Then the current 
input was again returned to 0, and the neurons were clamped and stabilised 
at -70mV for the next 300ms. For the following cycles, the current inputs in the 
1000ms were increased 10pA per cycle, while the conditions in the first 100ms 
and the last 300ms stayed the same (Figure 4.4A).  
 
In the third protocol, the neurons were clamped at -70mV for 100ms with no 
current input. Then, a hyperpolarising current pulse of -70pA was applied to 
the neurons for 500ms. After that, such current was withdrawn, and the 
neurons were clamped at -70mV for another 200ms. Each repeat was 
composed of these three consecutive steps, and 20 repeats were applied to 






Figure 4.4 Schematic representation of stimulation protocols. (A) Details of the cycles 




4.2.6.1 PAR3 intensity and distribution 
 
Three independent experiments were performed using embryos from three 
litters (n=3). The dissociated prethalamic neurons from embryos of these three 
litters were cultured for 3 days. For each litter, 10 neurons randomly selected 
from the control genotype and 10 neurons from the Pax6-null genotype were 
measured. For each neuron, I measured the total cytoplasmic volume and the 
cytoplasmic volumes that the PAR3 expressions within were above 75%, 50%, 
25%, 20% and 10% of the maximum PAR3 intensity. Therefore, there were 10 
data sets to be analysed- cytoplasmic volumes that PAR3 expressions were 
above 75%, 50%, 25%, 20% and 10% of its maximum intensity (PAR3 volume 
at different percentage threshold); and the ratio of such cytoplasmic volume 
against the total cytoplasmic volume (PAR3 volume at different percentage 
threshold /total cytoplasm volume). 
 
These data sets consisted of two fixed effects- genotype and percentage. Litter 
and cell are nested random effects, whereas PAR3 volume at different 
percentage threshold and PAR3 volume at different percentage threshold 
/total cytoplasm volume are output variables to be tested based on effects.  
 
As the data sets of PAR3 volume at different percentage threshold and PAR3 
volume at different percentage threshold /total cytoplasm volume consisted of 
continuous numerical data, they were first tested for best distribution fit using 
Quantile-Quantile plots. As shown in Figure 4.5, both data sets didn’t exactly 
fit any of the standard distributions but seemed to fit normal distribution well 
enough.  
 
We then processed these 10 data sets for mixed-effect models for statistical 
analysis. From there, type III ANOVA tests were applied to test which factors, 
and which interactions affect the data. If the type III ANOVA leads to a 
conclusion that there is a significance of variance introduced by factors 
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(effects), we then considered the pair-wise comparisons (Tukey comparison) 
and further investigate which of the means are different. Statistics for mixed-




Figure 4.5 Data points of PAR3 volume at different percentage thresholds. (A) and 
PAR3 volume at different percentage thresholds /total cytoplasm volume (B) fitted quite well 
with normal distribution. 
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4.2.6.2 Electrophysiological data analysis 
 
Analysis of electrophysiology results was carried out with a MATLAB (Version 
R2018b, The MathWorks, Inc.) plug-in programme developed and kindly 
provided by Dr Adam Jackson. With this programme, from protocol 1 and 
protocol 2, I was able to calculate the resting membrane potentials and 
rheobases in the neurons I patched.  
 
One neuron per genotype per litter was subjected for whole-cell patch clamp 
recording. Neurons from three litters of embryos were patched (n=3). Paired 
student t-test was performed to test if resting membrane potentials and 
rheobases in the prethalamic neurons differ significantly between the control 







4.3.1 Expressions of components of the PAR3/6 complex and the axon 
initial segment were significantly upregulated in the prethalamus 
when Pax6 was lost. 
 
To have an idea of whether and how establishment and maintenance of 
neuronal polarity might have changed in the absence of Pax6, I first cross-
referenced with literature that identified the components of the PAR3/6 
complex and AIS and compared that with the list of significantly dysregulated 
genes in our RNAseq data. Interestingly, the results showed that most of the 
component genes of the PAR3/6 complex and AIS showed significantly 
upregulated expressions in the prethalamus when Pax6 is lost.  
 
For example, Par-3 Family Cell Polarity Regulator Beta (Pard3b), the paralog 
B of the mammalian Par3 gene, was upregulated by a log2-fold change (LFC) 
of 1.03 in the prethalamus when Pax6 is lost. PARD3B can interact with 
PARD6B to mediate specification of cell polarity. Other known components of 
PAR3/6 complex, such as aPKC- PKCz, Tiam1, the GTP activating protein 
(GAP) p190RhoGAP and the ubiquitin ligase Smurf1 all showed different 
levels of upregulation. Additionally, genes encoding for proteins that have 
shown to interact with the PAR3/6 complex and direct its localised distribution 
at the nascent axon tip, such as the kinesin motor protein KIF3A and scaffold 
protein APC, were also upregulated in the RNA seq data. The only known 
PAR3/6 complex components whose gene expression level was significantly 
downregulated were STEF (LFC -0.61) and the transforming growth factor 
receptor 1 (TGFbR1) (LFC -0.40) (Table 4.3).  
 
Expression of various component genes of the AIS also showed significant 
upregulation in the RNA seq data. These include genes encoding for the 
cytoskeletal proteins, voltage-gated Na+ channels and K+ channels. AnkG, 
the master regulator gene for AIS assembly, was upregulated by a LFC of 2.01 
in the prethalamus when Pax6 is lost. The expression of bIV-Spectrin, which 
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is the cytoskeletal protein that links AnkG to the actin cytoskeleton and plasma 
membrane, showed an upregulation of 1.73 LFC. Expression levels of other b-
Spectrins were also upregulated. Voltage-gated Na+ channels consist of the 
core a subunits, which conduct Na+ passage in a voltage-dependent manner, 
and b subunits, which associate with a subunits and regulate channel gating 
and linkage with the cytoskeleton or the extracellular matrix. Genes encoding 
for both the a and b subunits showed upregulated expression in the 
prethalamus when Pax6 is lost (Table 4.4). On the other hand, voltage-gated 
K+ channels also consist of the a subunits, which form the actual conductance 
pore, and b subunits that associate with a subunits and modulate the activities 
of K+ channels. The majority of a subunits and all b subunits of K+ channels 
that showed dysregulated expressions were upregulated. As voltage-gated K+ 
channels have not been studied in this thesis, the exact voltage-gated K+ 
channel subunit genes were not included in Table 4.4 for simplicity. 
 
The above information indicated that the protein levels of these PAR3/6 
complex and AIS component genes might have also increased in the Pax6-
null prethalamic neurons. However, in order for the PAR3/6 complex and the 
AIS to initiate the establishment and maintenance of neuronal polarity, the 
proteins of all these component genes need to be assembled into specific 
functional structures that take specific locations within the neurons. Therefore, 
with fluorescent immunohistochemistry, I further stained for the PAR3, AnkG 
and voltage-gated Na+ channels to find out if their distributions and expression 




Table 4.3 Log2-fold changes of 
genes encoding for proteins 

















Table 4.4 Log2-fold changes of 





4.3.2 PAR3 distribution in the cytoplasm of the prethalamic neurons 
was not significantly affected when Pax6 is lost 
 
I used the PAR3 protein as the marker for the PAR3/6 complex, and with 
fluorescent immunohistochemistry, I was able to reveal the distribution of 
PAR3 proteins within the developing prethalamic neurons in vitro. As shown in 
Figure 4.6A-D, PAR3 was present in both the soma and neurites. However, 
the expression level of PAR3, unlike what has been emphasised by previous 
studies, showed the highest expression levels within the soma (Figure 4.6C-
D). This was further confirmed when I tried to measure the cytoplasmic volume 
being occupied by PAR3, whose expression level was above a certain 
percentage of the maximum intensity of the PAR3 channel. As shown in Figure 
4.6E-F, when the threshold was set at 75% of the maximum intensity of the 
PAR3 channel, the cytoplasmic volumes being occupied by PAR3 above this 
threshold were always located within the soma. Outside the soma, some 
neurons also showed PAR3-positive cytoplasmic volumes only in their most 
extended neurites (Figure 4.6E1, 4.6F1, yellow arrowheads). However, the 
locations of these PAR3-positive cytoplasmic volumes were not always at the 
tip of the longest neurite. This highly concentrated presence of PAR3/6 
complex localised only in the longest neurite was in concordance with what 
people have described in other systems (184,185). When the threshold was 
set at 50% of the maximum intensity of the PAR3 channel, the cytoplasmic 
volumes being occupied by PAR3 above this threshold increased within the 
soma, as well as propagated further towards the distal part of the longest 
neurite (Figure 4.6E2, 4.6F2, yellow arrowheads). Interestingly, PAR3-positive 
volume started to appear in the proximal part of other neurites (Figure 4.6E2, 
4.6F2, grey arrowheads) at this threshold.  When the threshold was set at 25% 
of the maximum intensity of the PAR3 channel, the PAR3-positive volumes 
reached the tip of the longest neurites (Figure 4.6E3, 4.6F3, yellow 
arrowheads), while PAR3-positive volumes in the other neurites further 
propagate towards the neurite tips (Figure 4.6E3, 4.6F3, grey arrowheads). 
Additionally, PAR3-positive volumes started to appear in the rest of the 
neurites (Figure 4.6E3, 4.6F3, blue arrowheads). When the threshold was set 
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at 20% of the maximum intensity of the PAR3 channel, PAR3-positive volumes 
occupied more cytoplasmic space and propagated further towards the neurite 
tips (Figure 4.6E4, 4.6F4, grey and blue arrowheads).  When the threshold 
was set at 10% of the maximum intensity of the PAR3 channel, PAR3-positive 
volumes could be seen in almost all the tips of neurites and protrusions (Figure 




Figure 4.6 Distribution of PAR3 proteins within the developing prethalamic neurons in 
vitro. (A, B) Prethalamic neurons from the control (A) and Pax6 mutant (B) embryos were 
cultured for 3DIV and stained for PAR3, GFP and DAPI. (C, D) PAR3 expression within the 
cytoplasm of the neurons. (E1-F1) PAR3 expression within the cytoplasm when the intensity 
threshold was set at 75% of the maximum intensity of the PAR3 channel. The majority of the 
PAR3 volumes were distributed within the soma. However, PAR3 volumes were also found in 
the stem of the longest neurites (yellow arrowheads). (E2-F2) PAR3 expression within the 
cytoplasm when the intensity threshold was set at 50% of the maximum intensity of the PAR3 
channel. More PAR3 volumes were detected in the soma, the stem of the longest neurites 
(yellow arrowheads), as well as in other neurites (grey arrowheads). (E3-F3) PAR3 expression 
within the cytoplasm when the intensity threshold was set at 25% of the maximum intensity of 
the PAR3 channel. PAR3 volumes within the cytoplasm continued to increase. PAR3 volumes 
could be found at the tip of the longest neurites (yellow arrowheads) and other neurites (grey 
and blue arrowheads). (E4-F4) PAR3 expression within the cytoplasm when the intensity 
threshold was set at 20% of the maximum intensity of the PAR3 channel. (E5-F5) PAR3 
expression within the cytoplasm when the intensity threshold was set at 10% of the maximum 
intensity of the PAR3 channel. PAR3 volumes had filled up the cytoplasm and could be found 
at almost all the tip of the neurites and protrusions (orange arrowheads). Scale bars: A-D, 





To find out if the distribution of PAR3 as described above changed significantly 
due to the loss of Pax6, I compared the PAR3-positive cytoplasmic volumes 
at different thresholds between the control and Pax6-null prethalamic neurons 
using the mixed-effect model.  
 
As the data fitted quite well with a normal distribution, we further processed 
the five data sets of PAR3 volume at different percentage threshold with Type 
III ANOVA, in order to find out if interactions between any of the effects (fixed 
effects- genotype and percentage; random effects- litter and cell) were 
significant. Overall, there is a significant effect of percentage, i.e. that the 
differences of PAR3 volumes at different thresholds were significant 
regardless of genotype. The interaction between genotype and PAR3 volume 
at different percentage threshold was not significant, meaning that the effect 
of genotype did not change when the thresholds were set at any of the different 
percentages (Figure 4.7A-D). This can be shown with pairwise comparisons 
which will all show insignificant effect, except for the PAR3 volume at 10% 
percentage threshold. When the threshold was set at this percentage, the 
PAR3-positive volume was significantly higher in control prethalamic neurons 
(Figure 4.7E). 
 
As the functions of the PAR3/6 complex are highly dependent on its localised 
distribution, in addition to the absolute PAR3 volume at different percentage 
threshold, it was also worth finding out whether the ratio of PAR3 volume at 
different percentage threshold against the total cytoplasmic volumes showed 
any significant difference in the absence of Pax6. To elaborate, if the absolute 
PAR3 volumes at a particular threshold of two neurons (neuron A and neuron 
B) are the same, but neuron A has a smaller total cytoplasmic volume, then 
the PAR3 volume in A will occupy a relatively larger cytoplasmic space. This 
might affect the accessibility of resources to the available PAR3/6 complex and 
hence further impact on how the neurons respond to intrinsic and extrinsic 
signals during the establishment of neuronal polarity. For this aim, I calculated 
the ratio of PAR3 volume at different percentage threshold against total 
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cytoplasmic volume. We then processed the resulting data sets with Type I 
ANOVA. As shown in Figure 4.8, the interaction between genotype and PAR3 
volume/ total cytoplasmic volume was not significant at the threshold set at 
any percentage. Nevertheless, the effect of percentage was still significant, i.e. 
PAR3 volume/ total cytoplasmic volume differed significantly across thresholds 
set at different percentages, regardless of genotype. Interestingly, Pax6-null 
prethalamic neurons seemed to have smaller cytoplasmic volumes. The 
delayed neuronal morphogenesis that I discovered in Chapter3, that Pax6-null 
prethalamic neurons at this stage showed a shorter length of longest neurite 
and the total length of neurites, might be the underlying reason. 
 
The above results indicated that, although the RNAseq data showed 
upregulated expressions of component genes of the PAR3/6 complex, the 
distribution of the PAR3/6 complex, marked by PAR3, was not affected in the 
prethalamic neurons when Pax6 is lost. From here, I can only conclude that 
the establishment of neuronal polarity, marked by the distribution of PAR3, 





Figure 4.7 PAR3 volume at different percentage thresholds did not differ significantly 
between the control and Pax6-null prethalamic neurons. (A-D) When the thresholds 
were set at 75%, 50%, 25% and 20% of the maximum intensity of the PAR3 channel, the 
PAR3 volume within the cytoplasm of neurons did not differed between the control and 
Pax6-null genotype. (E) When the thresholds were set at 10% of the maximum intensity of 
the PAR3 channel, the PAR3 volume within the cytoplasm of control prethalamic neurons 
was significantly higher than that in the Pax6-null prethalamic neurons. The error bar 
represented the value of standard error of the mean (SEM). PAR3 volume at different 
percentage thresholds from 10 neurons from the control and Pax6-mutant genotypes were 
measured. Three litters in total (n=3). Each dot (data point) represented the value of PAR3 
volume from each neuron at a specific threshold. The data points of the neurons from the 




Figure 4.8 PAR3 volume at different percentage thresholds/ total cytoplasmic 
volume did not differ significantly between the control and Pax6-null prethalamic 
neurons. When the thresholds were set at 75% (A), 50% (B), 25% (C), 20% (D) and 10% 
(E) of the maximum intensity of the PAR3 channel, the cytoplasmic PAR3 volume/ total 
cytoplasmic volume did not differed between the control and Pax6-null genotype. The error 
bar represented the value of standard error of the mean (SEM). PAR3 volume at different 
percentage thresholds, as well as the total cytoplasmic volumes from 10 neurons from the 
control and Pax6-mutant genotypes were measured. Three litters in total (n=3). Each dot 
(data point) represented the value of PAR3 volume/ total cytoplasmic volume from each 
neuron at a specific threshold. The data points of the neurons from the same litter were 
marked with the same colour. Data were analysed with mixed-model. *: P<0.05. 
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4.3.3 Pax6-null prethalamic neurons showed altered AIS structures with 
increased expressions of AnkG and voltage-gated Na+ channels 
 
I chose the axon initial segment (AIS) as the primary indicator of maintenance 
of neuronal polarity in the prethalamic neurons. AnkG and voltage-gated Na+ 
channels were used to mark the AIS due to their highly concentrated 
localisation within this structure. As the AIS is formed at the later stages of 
neuronal morphogenesis, and it is also a feature of mature neurons, I 
performed fluorescent immunohistochemistry to detect the distribution of AnkG 
and voltage-gated Na+ channels in the prethalamic neurons cultured for 5, 7 
and 9 days. The antibody I used to detect voltage-gated Na+ channels 
recognises all the a subunits of the voltage-gated Na+ channels. Therefore, 
the readout of this staining would be the sum of all the a subunits expressed 
within the neurons. This way, I was able to find out whether the prethalamic 
neurons are able to form AISs, whether the number of AISs per neuron, the 
structure and components of the AIS, and the rate of AIS formation differed in 
any ways in the prethalamic neurons when Pax6 was lost. 
 
Prethalamic neurons in culture were able to develop single AISs, which were 
marked by the signature localised expressions of AnkG and voltage-gated 
sodium channels at the proximal end of a neurite (Figure 4.9A, C, E and Figure 
4.10A, C, E, magenta segments). The exact locations of the AISs varied 
among the prethalamic neurons- some neurons have their AIS located on a 
somatic neurite (axon), while others have their AIS located on a dendritic 
branch (compare the location of the magenta segments in Figure 4.10C, E). 
Previous studies in cultured hippocampal neurons suggested that AnkG acts 
as the master regulator of AIS formation and localised AnkG expression at the 
putative AIS region further facilitates localised distribution of voltage-gated 
Na+ and K+ channels (81,82). Therefore, localised expression of AnkG at the 
putative AIS should happen before localised expressions of voltage-gated Na+ 
channels. I found that this is exactly the case in cultured prethalamic neurons. 
At 5DIV, AnkG expression started to show localised distribution at the proximal 
end of neurites and its intensity profile exhibited a gentle rise, which then 
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plateaued and decreased with distance from the soma (Figure 4.9A, G, blue 
line). However, at 5 DIV, expressions of voltage-gated sodium channels did 
not show any localised distribution and its intensity only decreased with 
distance from the soma (Figure 4.10A, G, blue line). At 7DIV, AIS marked by 
AnkG showed more of a distinct peak in its intensity profile in comparison to 
5DIV, indicating more AnkG localisation and the AISs being more mature at 
this stage (Figure 4.9C, H, blue line). At 7DIV, AIS marked by voltage-gated 
sodium channels showed a gentle peak in its intensity profile, indicating the 
recruitment and assembly of voltage-gated Na+ channels to the AIS region at 
this stage (Figure 4.10C, H, blue line). Interestingly, the locations of the AnkG 
and Na+ channels peaks seemed to be colocalising, as both peaks in the 
intensity profiles showed similar distances from the soma and similar widths 
(Figure 4.11C, D blue lines). At 9DIV, the AnkG intensity profile showed a 
decreased level of AnkG localisation at the AIS, although the position 
remained more or less the same as 5 and 7 DIV (Figure 4.9E, I, blue line). The 
localisation of Na+ channels at the AIS, however, showed a drastic decrease 
as the peak seen in 7 DIV in the Na+ channel intensity profile was dismissed 
at 9 DIV (Figure 4.10E, I, blue line). 
 
When Pax6 is deleted, the prethalamic neurons were still able to develop and 
form AISs, as staining for AnkG and voltage-gated sodium channels showed 
clear concentrated localisation of both at the proximal end of neurites (Figure 
4.9B, D, F and Figure 4.10B, D, F, magenta segments). The Pax6-null 
prethalamic neurons also displayed somatic or dendritic locations of AISs and 
these locations of AISs also varied among individual neurons (compare the 
locations of the magenta segments in Figure 4.9B and 4.9D). At 5 DIV, AnkG 
started to show localised distribution at the putative AIS region in the Pax6-null 
prethalamic neurons (Figure 4.9B, G, orange line). The location of the putative 
AIS overlapped with the putative AIS location in the control prethalamic 
neurons with AnkG staining. However, in the Pax6-null neurons, the length of 
the putative AIS seemed to be slightly longer (Figure 4.9G). Similar to the 
situation in the control neurons, at this stage of cell culture, voltage-gated Na+ 
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channels have not yet displayed localised distribution either. However, the 
expression level of Na+ channels was higher in the putative axons of the Pax6-
null prethalamic neurons (Figure 4.10B, G orange line). At 7 DIV, the intensity 
profiles of AnkG of Pax6-null neurons also showed more of a distinct peak in 
comparison to 5DIV, indicating that AIS in the mutant neurons were also being 
formed during this period of cell culture (Figure 4.9D, H, orange line). The 
highest intensity of AnkG in the AIS of the Pax6-null prethalamic neurons was 
comparable to that of the control neurons. However, the location of the AIS 
seemed to have shifted further away from the soma, whereas the length of the 
AIS seemed to be slightly shorter in the mutant neurons (Figure 4.9H). The 
intensity profile of Na+ channels at this stage also showed a clear peak, 
indicating that recruitment and assembly of voltage-gated Na+ channels were 
also taking place during this period of cell culture in the mutant neurons (Figure 
4.10D, H, orange line). However, the intensity of Na+ channels was once again 
higher in the AIS region and axons of the Pax6-null prethalamic neurons 
(Figure 4.10H). Additionally, the location of AIS marked by AnkG and Na+ 
channels did not colocalise in the Pax6-null prethalamic neurons, indicating 
that the tethering of Na+ channels by AnkG might have been faulty in the 
absence of Pax6 (Figure 4.11C, D). At 9 DIV, the AIS region marked by AnkG 
was still further away from the soma in the mutant neurons. Additionally, the 
mutant neurons also showed a higher intensity of AnkG expression in the AIS 
(Figure 4.9F, I, orange line). Similarly, expression of Na+ channels also 
showed a drastic drop in the Pax6-null prethalamic neurons (Figure 4.10F, I, 
orange line).  
 
These results indicate that loss of Pax6 did not affect the ability of the 
prethalamic neurons to form AISs. However, the locations of the AISs in the 
Pax6-null prethalamic neurons were further away from the soma and their 
lengths seemed slightly shorter in more mature neurons. Additionally, these 
AISs showed higher expressions of AnkG and voltage-gated Na+ channels, in 





Figure 4.9 Development of AIS marked by AnkG expression through time in the 
cultured prethalamic neurons. Morphological representation of AIS marked by AnkG 
staining in the control (A, C, E) and Pax6-null (B, D, F) prethalamic neurons cultured for 5 
DIV (A-B), 7DIV (C-D), 9 DIV (E-F). (G-I) The intensity profile of AIS marked by AnkG in 
prethalamic neurons cultured for 5 DIV (G), 7DIV (H) and 9DIV (I). 30 neurons per embryo 
per genotype were processed for intensity profile measurement. For each litter, one control 
embryo and one Pax6-null embryo was processed for dissociated cell culture to generate 
prethalamic neurons as above. Three litters in total (n=3). The blue and orange lines were 
the averaged intensity for the intensity profile of 90 neurons. The scale bars represented the 
95% confidence interval. Scale bar for A-F: 10µm. 
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Figure 4.10 Development of AIS marked by voltage-gated Na+ channels expressions 
through time in the cultured prethalamic neurons. Morphological representation of AIS 
marked by voltage-gated Na+ channels staining in the control (A, C, E) and Pax6-null (B, D, 
F) prethalamic neurons cultured for 5 DIV (A-B), 7DIV (C-D), 9 DIV (E-F). (G-I) The intensity 
profile of AIS marked by voltage-gated Na+ channels in prethalamic neurons cultured for 5 
DIV (G), 7DIV (H) and 9DIV (I). 30 neurons per embryo per genotype were processed for 
intensity profile measurement. For each litter, one control embryo and one Pax6-null embryo 
was processed for dissociated cell culture to generate prethalamic neurons as above. Three 
litters in total (n=3). The blue and orange lines were the averaged intensity for the intensity 





Figure 4.11 Comparison of AIS intensity profiles marked by AnkG or voltage-gated Na+ 
channels through time in the cultured prethalamic neurons. Intensity profile of 
prethalamic neurons at 5DIV (A-B), 7DIV (C-D), and 9DIV (E-F). 
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4.3.4 Prethalamic neurons are more excitable in the absence of Pax6 
 
In addition to its ability to maintain neuronal polarity, the AIS is also where 
action potentials are being shaped and fired. Changes in the location, structure 
and components of the AIS have been linked to altered electrophysiological 
properties in other neurons in vivo and in vitro. To find out whether these 
changes in the AISs of the Pax6-null prethalamic neurons can affect how these 
neurons fire their action potentials, and further impact their functionality, I 
performed whole-cell patch clamp in cultured prethalamic neurons at 7DIV. 
 
By switching the amplifier to no current input, I was able to record the resting 
membrane potential of the cultured prethalamic neurons. Previous studies 
have recorded the average resting membrane potential in neurons of the 
thalamic reticular nucleus in vivo to be around -57mV (104). As shown in 
Figure 4.12E, the resting membrane potentials in the prethalamic neurons did 
not show a significant difference between the control and Pax6-null genotypes. 
However, the average resting membrane potentials displayed by prethalamic 
neurons from both genotypes were around -30mV, which were much higher 
than what other people described in the TRN neurons in the postnatal brain in 
vivo.  
 
By stimulating the neurons with increased current steps as described in 
protocol 2, I was able to find out if the cultured prethalamic neurons can fire 
action potentials and also what would the rheobases of these neurons be. 
Rheobase is defined as the minimum current amplitude to elicit at least one 
action potential. Therefore, rheobase reflects how excitable the neurons are. 
As shown in Figure 4.12A, B, prethalamic neurons from both genotypes were 
able to fire action potentials. As mentioned in the Introduction chapter, when 
TRN neurons fire in tonic mode, they normally display a train of action 
potentials (67). However, the cultured prethalamic neurons fire only one action 
potential once the rheobases were reached, regardless of genotype nor further 
increment of current amplitudes. Interestingly, Pax6-null prethalamic neurons 
displayed much lower rheobases in comparison to the control neurons (Figure 
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4.12F). Although paired Student t-test showed that such a difference was not 
significant with a P value of 0.0766, these results indicated that the prethalamic 
neurons might be more excitable when Pax6 is lost. Previous studies have 
reported that a longer AIS that is closer to the soma, with increased levels of 
AnkG and voltage-gated Na+ channels are associated with higher levels of 
excitability in various types of neurons (99,101,102). In the cultured Pax6-null 
prethalamic neurons, AIS structures were slightly shorter and further away 
from the soma. However, they displayed higher levels of expressions of AnkG 
and voltage-gated Na+ channels. How and whether such changes of the AISs 
might contribute to changes in the rheobases of Pax6-null prethalamic neurons 
deserve immediate further investigation. 
 
To find out if the prethalamic neurons in culture can fire in the burst mode and 
whether the deletion of Pax6 can affect that, I applied a hyperpolarising current 
pulse to these neurons. If enough T-type low-threshold Ca2+ channels are 
present, I should be able to see rebound firing of action potentials at the offset 
of these hyperpolarising current pulses. Depending on the number and 
frequency of the action potentials being fired, I can then determine whether 
this prethalamic neuron is a tonic cell or a bursting cell. As shown in Figure 
4.12C-D, no firing of action potentials was observed in all the three control 
neurons that were patched. However, one of the Pax6-null neurons was able 
to fire an action potential at the offset of the hyperpolarisation current pulse at 
the 18th repeat. Noted that this neuron did not fire more action potentials in 
the next 19th and 20th repeats. Due to the low numbers of neurons being 
recorded and inexperience with electrophysiology recording, immediate further 








Figure 4.12 Analysis of electrophysiological properties of the prethalamic neurons 
cultured for 7DIV. Both the control (A) and Pax6-null (B) prethalamic neurons were able 
to fire action potentials. Noted that (A) and (B) showed the complete responses of a 
representative control (A) and Pax6-null (B) prethalamic under the stimulus from Protocol 
2. The red line showed the first action potential fired in (A) and (B). (C-D) The complete 
responses of a control (C) and Pax6-null (D) prethalamic neuron to hyperpolarisation 
current pulses (Protocol 3). Noted that the red line in (C) and (D) highlighted the response 
of the neurons at the 18th sweep of the hyperpolarisation current pulses. Also noted that (D) 
might not be a representative as only one out of three for Pax6-null prethalamic neurons 
were able to a fire action potential at the offset of this hyperpolarising stimuli. One neuron 
per genotype per litter was subjected for whole-cell patch clamp recording. Neurons from 
three litters of embryos were patched (n=3). (E-F) Resting membrane potentials and 
rheobases recorded in these prethalamic neurons. Neurons the same litter were marked 




4.4.1 Comments on the PAR3 experiment 
 
In this chapter, I recorded in detail the distribution of PAR3 proteins within the 
cytoplasm of prethalamic neurons by setting up different intensity thresholds. 
Interestingly, the results showed the highest intensity of PAR3 expression was 
in the soma and the proximal part of the most extended neurites. When the 
intensity thresholds were set at lower values, the PAR3-positive volumes 
started to propagate towards the tips of the longest neurites and appeared in 
the proximal part of other neurites. As PAR3 functions to direct polarised 
modification of neuronal morphology in an expression level-dependent manner, 
this consecutive appearance of PAR3-positive volumes in different areas of 
the neurons as the set intensity threshold dropped can also serve as an 
indicator of the hierarchy of the neurites. In studies where pinpointing the 
identities of the neurites were necessary, researchers usually utilise axon and 
dendrite markers. These markers are usually linked to the specialised cellular, 
membranous and cytoskeletal structures axons and dendrites display, which 
become fully developed only after the establishment of neuronal polarity. For 
example, in my cultured primary prethalamic neurons, the frequently used 
axonal marker Tau and the dendritic marker MAP2 showed clear regional 
segregation of expression within the neurons after 5 DIV. However, the 
morphological distinctions among neurites in the cultured prethalamic neurons 
started to appear after 1DIV. Therefore, there is a gap in the neuronal 
morphogenesis timeline, where many of the frequently used morphological 
markers could not be applied. Detailing the PAR3 distribution at different 
intensity thresholds as above might be able to fill this gap, and serve as 
indicators of the putative axon, the primary dendrite, the secondary dendrite 
and so on. 
 
One puzzling phenomenon in my PAR3 analysis was that the PAR3-positive 
cytoplasmic volumes were much higher in one of the litters. This was more 
obvious when the thresholds were set at higher values and could be seen in 
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neurons of both genotypes (Figure 4.7 and Figure 4.8A-B, compare the values 
of the red dots and squares with the black and blue dots and squares). Note 
that neurons from the control and mutant genotypes of the same litter were 
processed and imaged at the same time. And although the experiments that 
led to these results were performed independently for the three litters, all the 
conditions were kept the same among experiments. If such variations among 
litters were not due to human error, then it is intriguing how PAR3 expression 
can change so drastically among litters on the same days of the cell culture. 
One possible explanation for this result would be that although the neurons 
were collected on the same day of the cell culture (all on 3DIV), the actual 
development of the neurons might have varied among experiments, which 
might have led to the different expression levels of PAR3. (And that one day 
has 24 hours, therefore, that particular litter might be a bit older than the others 
because the embryos could have been several hours older.) The primary 
reason for me to choose to test PAR3 expression and distribution at 3DIV was 
that according to my analysis on neuronal morphogenesis of the prethalamic 
neurons, this is the age when most of the neurons had formed a distinct longest 
neurite, but neurite extension of the mutants was still lagging. Judging by the 
results of PAR3 analysis as above, it is worth stepping back and examining 
PAR3 expression and distribution at earlier time points such as 1 and 2 DIV. 
This will allow us to track PAR3 distribution and correlate the establishment of 
neuronal polarity with morphological changes through time. Additionally, it will 
also allow us to compare the expression and distribution of PAR3 across 
different time points and give us a clue of whether such variation among litters 
as above was caused by a difference in maturation of the neurons. Last but 
not least, it is also worth increasing the N number of the above experiments, 
to find out if variations among litters can be seen in more than one litter.  
 
PAR3 is not the only indicator for neuronal polarity. Therefore, expression of 
other polarity markers within the prethalamic neurons, such as other 
components of the PAR3/6 complex and the kinesin motor protein KIF3A, 
which had been shown to display polarised distribution during the 
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establishment of neuronal polarity can be further tested. Notably, the antibody 
I used in the PAR3 analysis recognises the mammalian PAR3 protein (PARD3), 
which differs from the PARD3B protein. It was the mRNA level of the latter that 
was upregulated in the RNAseq data in the prethalamus when Pax6 was lost. 
Pard3b is the paralog B of the mammalian Par3 gene, whose protein cannot 
be recognised by the PAR3 antibody. By interacting with PARD6B, PARD3B 
can also mediate the specification of neuronal polarity. Therefore, it is also 
worth repeating the above experiments with antibodies for the PARD3B to find 
out if expression and distribution of this particular protein shows any difference 
in the Pax6-null prethalamic neurons. 
 
4.4.2 Statistical analysis for the intensity profile of AIS 
 
No statistical analysis was performed on the data sets of the AIS intensity 
profiles, due to the unique nature of these data sets. When measuring the 
intensity profiles, the readout for each neuron was a scatter plot. Each dot on 
that scatter plot contained one reading on the X-axis and one reading on the 
Y-axis, which were correlated. Additionally, all the dots on that plot were not 
independent of each other, because they resemble the intensity readout of 
each pixel on the same axon. What is more, 30 neurons from each embryo 
were measured. Therefore, the 30 scatter plots (intensity profiles) obtained 
were not independent of each other either. This further complicated the 
situation, and no present statistical tests can satisfy the criteria for such data 
sets. One of the very few publications that studied the AIS in the same way 
with measurements of intensity profiles used the Kruskal-Wallis test with 
Dunn’s correction for multiple comparisons (97). However, the Kruskal-Wallis 
test studies distributions, and if the samples being tested originate from the 
same distribution (186). Therefore, the data points themselves that make up 
such distributions should be independent of the others. However, this is not 
the case for the intensity profile data sets, as the intensity profile from one 
neuron is already a population of numerical data that shows certain trends of 
distribution, and these numerical data points are all related to each other.  
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One possible solution that can apply to such complicated data sets is to 
simulate how the intensity profiles of AIS behaves using mathematic models. 
However, within the time frame of this PhD, this was not managed. This is one 
of the most immediate follow-up experiments to do.  
 
4.4.3 High expression of PAR3, AnkG and voltage-gated sodium 
channels in the soma 
 
Instead of the tip of the neurite or the AIS, in my study, I found that PAR3, 
AnkG and voltage-gated Na+ channels showed the highest expression levels 
in the soma. Previous studies have repeatedly emphasised the importance of 
polarised expressions of PAR3 at the neurite tips in the establishment of 
neuronal polarity and concentrated expressions of AnkG in the formation of 
the AIS (81,82,184,185). The significance of the highest intensity of these 
proteins in the soma remains to be further determined. Interestingly, previous 
studies that used the same antibody as in my study to reveal the distribution 
of PAR3 also showed high level of PAR3 expression within the soma (184,185). 
These studies utilised hippocampal neurons prepared from E18 rat embryos, 
which were cultured for 2-3DIV, and showed strongest selective accumulation 
of PAR3 within the soma and at the tip of only one of the immature neurites of 
the neurons (184,185). However, the authors only emphasised the 
significance of PAR3 accumulation at the tip of only one neurite. They did not 
mention the possible meaning and function of PAR3 expression within the 
soma, let alone measured the level of PAR3 within the soma and compared 
that to the level of PAR3 expression at the tip of the neurites (184,185). It would 
be crucial to our understanding of the mechanism of action of the PAR3/6 
complex during establishment of neuronal polarity if we can further confirm 
whether the PAR3 proteins within the soma are as functional as the PAR3 
proteins at the tip of the neurites, when and how the PAR3/6 complex is 
assembled after the PAR3 proteins are produced in the soma, and how the 
PAR3/6 complex are selectively transported towards the putative axon. In 
addition to the high-PAR3-expressing neurite, these studies also found lower 
levels of PAR3 expression at the tip of other neurites, a scenario similar to 
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what I found in the cultured prethalamic neurons (184,185). In my study, 
instead of selective PAR3 accumulation at the tip of one of the neurites, I found 
the strongest selective PAR3 accumulation at the proximal end of the stem of 
one of the neurites. This discrepancy of PAR3 distribution during 
establishment of neuronal polarity might arise from different types of neurons 
(prethalamic neurons versus hippocampal neurons), different species of 
neurons (mouse versus rat), different maturation speed in culture of different 
neurons and also different starting timepoint of embryonic tissue in culture 
(E13.5 versus E18).  
 
In terms of high AnkG and voltage-gated Na+ channels expression within the 
soma, one possible explanation is that the prethalamic neurons were still 
developing and such proteins were still under production and sorting as the 
neurons become more polarised. A simple experiment that I can do to verify 
this is to stain for AnkG and voltage-gated sodium channels in embryonic, 
neonatal and postnatal mouse brain sections, and check if their expression 
and distribution differ in any ways in the prethalamus-derived neurons, such 
as neurons in the TRN.  
 
4.4.4 Improvement on future electrophysiology recordings 
 
Results from whole-cell patch clamp recording showed intriguing changes in 
the excitability of the Pax6-null prethalamic neurons. However, several 
improvements need to be applied in future experiments before I can draw any 
solid conclusion. First of all, the sample size was too small. The above results 
were obtained from one neuron per litter per genotype and a total of three 
litters were recorded (n=3). Second of all, the conditions of the neurons 
changed during recording, therefore within each protocol, I saw fluctuation of 
membrane potentials across cycles (Protocol 2, Figure 4.12A, B) and repeats 
(Protocol 3, Figure 4.12C, D). This greatly complicated the analysis of such 
recording and also impacted on the credibility of the results. In future 
experiments, a small negative current (-5pA) will be first applied to the neurons 
to stabilise their membrane potentials, and adjustments will be made during 
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the recording to make sure that the membrane potentials of the neurons are 
clamped at a certain voltage throughout the protocol. Third of all, I will further 
improve the culture conditions to improve the viability of the neurons. With the 
current cell culture protocol, I was able to keep the primary prethalamic 
neurons viable for as long as 13 DIV. However, as shown by Figure 4.9E, I 
and 4.10E, I, AnkG and voltage-gated Na+ channel staining, the AIS seemed 
to be disassembling at 9DIV, as the prethalamic neurons of the control 
genotype showed drastic decreases in AnkG and Na+ channel intensity in the 
AIS region. Additionally, electrophysiology recordings showed that the resting 
membrane potentials in the cultured prethalamic neurons were much more 
depolarised than what was normally recorded in other neurons (Figure 4.12E). 
These results indicated that the conditions of the neurons might not have been 
ideal or as healthy as their in vivo counterpart. In my dissociated cell culture, I 
plated the prethalamic neurons purposefully at a density of 20 cells/mm2, to 
make sure that the neurites of the neurons do not cross each other so that I 
can observe the entire morphology of the mature neurons. Previous protocols 
of dissociated thalamic cell cultures indicated that if the plating density is below 
3000 cells/mm2, the dissociated thalamic neurons were not healthy, and they 
died within a few days of cell culture (187). Therefore, in future experiments, I 
will try to improve neuron viability by first increasing the plating density. 
Additionally, it would also be interesting to see if the prethalamic neurons are 
able to form synapses and communicate with each other once the plating 






In this chapter, I analysed the ability of the prethalamic neurons to establish 
and maintain their neuronal polarities, in the presence and absence of Pax6. I 
found that the establishment of neuronal polarity, indicated by PAR3 
expressions and distributions within the neurons, was not impacted in Pax6-
null prethalamus. In terms of maintenance of neuronal polarity by the AIS, the 
Pax6-null prethalamic neurons can form single, functional AISs as they mature, 
and they can also fire action potentials upon depolarising current inputs. 
However, the AISs in the Pax6-null prethalamic neurons were slightly shorter 
in length and further away from the soma. Additionally, these AISs have higher 
expressions of AnkG and voltage-gated Na+ channels, which might have 
contributed to the lower rheobases and higher excitability recorded in the 








Chapter 5  
 
Pax6 inhibits the activities of Wnt 







5.1.1 Wnt signalling pathways 
 
The Wnt signalling pathways are crucial and versatile. During 
neurodevelopment, the functions of Wnt signalling pathways include 
patterning of the neural tube, promoting proliferation of neural progenitors, 
specifying cell fates, regulating the establishment of polarity and cytoskeletal 
remodelling during neuronal morphogenesis, etc. (32,188,189). Recent 
findings also unveil novel functions of Wnt signalling pathways in maturing 
neurons in postnatal brains, in which they control transcriptional activation of 
voltage-gated ion channels and regulate the molecular composition of the axon 
initial segment, thereby fine-tuning the electrophysiological properties of these 
neurons and having further impact on the functionality of the nervous system 
(99,190).  
 
WNTs are secreted glycoproteins with a conserved cysteine residue being 
palmitoylated. This unusual post-translational modification restricts long-range 
diffusion of the WNTs (99,188). Therefore, although acting as morphogens, 
the range of the effects of the WNTs usually is within the distance of a few 
cells.  
 
There are 19 WNTs and 9 Frizzled receptors expressed in the mouse genome. 
Depending on what downstream signalling cascades the WNTs initiate, they 
are classified into two categories: (1)- the canonical WNTs, including WNT1, 
WNT3A, WNT7B and WNT8B and (2) non-canonical WNTs, including WNT4, 
WNT5A and WNT11 (188,191,192). 
 
In the case of the canonical or Wnt/b-catenin pathway, binding of WNTs to the 
transmembrane Frizzled receptors and the co-receptor LRP5 (low-density 
lipoprotein receptor-related protein 5) or LRP6 further activates the scaffold 
protein Dishevelled (DVL). Activation of DVL inhibits the functions of glycogen 
synthase 3b (GSK-3b) and also induces the disassembly of the destruction 
 149 
complex composed of adenomatosis polyposis coli (APC), AXIN and GSK-3b. 
This subsequently leads to the accumulation of cytoplasmic b-catenin, which 
can then be translocated into the nucleus, where it binds to and activate the 
functions of the transcription factors T-cell specific transcription factor (TCF)/ 
lymphoid-enhancing factor (LEF) (188,189).  
 
Axin2 is a direct target of the Wnt/b-catenin pathway, whose transcription can 
be activated by the TCF/LEF transcription factors. Axin2 is a scaffold protein 
that together with APC and GSK3b, compose the destruction complex. The 
latter binds to and phosphorylate cytoplasmic b-catenin, resulting in 
ubiquitylation and degradation of b-catenin. Therefore, Axin2 is part of the 
negative feedback mechanism to limit the activities of canonical Wnt signalling. 
Lef1, on the other hand, is part of the positive feedback loop to boost the effect 
of canonical Wnt signalling locally, as it is a direct target and acts as a 
downstream transcriptional activator of Wnt/b-catenin pathway (193,194).  
 
In addition to transcriptional activation, the canonical Wnt signalling pathway 
can also initiate cytoskeletal remodelling as inhibition of GSK-3b can also 
activate multiple cytoskeletal effector proteins (188,195). In the absence of 
WNTs or the presence of antagonists for the Wnt signalling pathways, GSK-
3b phosphorylates the cytoplasmic b-catenin, resulting in the latter’s 
ubiquitylation and degradation (Figure 5.1a) (188,189).  
 
Similar to the canonical Wnt signalling pathway, the other two Wnt signalling 
pathways- the Planar cell polarity pathway (PCP pathway) and the 
WNT/calcium pathway also begin with the binding of the WNT ligands to the 
Fz receptors and activation of the DVL proteins (189). However, in the PCP 
pathway, activated DVL relays the signal through Rho GTPases (Rho or Rac 
or both). These Rho GTPases function to modify cytoskeletal structures 
directly or through activation of the c-Jun amino (N)-terminal kinase (JNK). The 
PCP pathway, therefore, has been found to direct cell and tissue polarity and 
dendritogenesis (Figure 5.1b) (196,197). On the other hand, in the 
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WNT/calcium pathway, activated DVL induces the intracellular release of 
Ca2+ and activation of protein kinase C (PKC), which can eventually result in 
changes of cell fate and cell movement (Figure 5.1c) (198). 
 
Wnt signalling pathways can be blocked at multiple levels. Wnt antagonists 
such as Cerberus, Wnt inhibitory factor 1 (WIF1), secreted Frizzled-related 
proteins (SFRPs) and Dickkopf-related proteins (DKKs) can inhibit the 
signalling relay from the very beginning, by either binding directly to the WNT 
ligands themselves or to the LRP5/6 co-receptors. SFRPs, for example, can 
bind to the secreted WNTs, rendering the latter unable to bind with the Fz 
receptors. Therefore, SFRPs are capable of inhibiting both canonical and non-
canonical Wnt signalling pathways. DKKs, on the other hand, is only capable 
of blocking the canonical Wnt signalling pathway by occupying the LRP5/6 co-
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proteins are members of 
the transforming growth 
factorβ family of secreted 
signalling molecules.
FGFs 
Fibroblast growth factors are 
secreted signalling molecules.
AP AND DV AXES
The anterior to posterior 
axis runs from the head 
to the tail of a vertebrate 
embryo. The dorsoventral 
axis runs from the back to 
the stomach of an embryo.
FOREBRAIN 
The most rostral structure of 
the neural tube. It is subdivided 
into the telencephalon, which 
gives rise to the cerebrum, 
hippocampus and olfactory 
lobes, and the diencephalon, 
which gives rise to the thalamic 
and hypothalamic regions.
Patterning of the nervous system
Anterior–posterior neural tube specification. In 1952, 
Nieuwkoop proposed a double-gradient model for the 
regulation of NEURAL TUBE patterning37. According to this 
model, after the acquisition of neural identity by ecto-
dermal cells, neural tissues are induced to acquire ante-
rior fates. Subsequently, posteriorizing factors induce 
posterior characteristics in anterior neural tissues. 
Finally, regional patterning regulates the formation of 
specific neural structures in the neural tube. Several 
posteriorizing factors, including bone morphogenetic 
proteins BMPs, fibroblast growth factors FGFs, retinoic 
acid, Nodal and WNTs, have been proposed to act 
directly or indirectly during early anterior–posterior AP 
specification of the neural tube, possibly by regulating 
cell fate and behaviour38. Studies using β-catenin-medi-
ated activation as a read-out show that an endo genous 
gradient of WNT signalling might specify cell fates 
during the formation of the neuraxis39,40.
Several lines of evidence indicate that the posteri-
orizing function of WNTs must be inhibited anteriorly 
to generate anterior neural structures (FIG. 2a). Ectopic 
expression of WNTs41,42 or components of the WNT 
pathway leads to the suppression of anterior fates and 
the induction of posterior neural markers39,43,44. 
Conversely, inhibition of WNT signalling by the loss 
of WNT8 function leads to the expansion of FOREBRAIN 
markers and defects in the posteriorization of the 
neuraxis45–47. Modulators, such as the secreted pro-
tein context-dependent acivator and inhibitor of 
WNT signalling (WISE), might enhance the effect of 
WNTs as posteriorizing signals48.
Studies have shown that anterior tissues release WNT 
antagonists that are crucial for specification of the ante-
rior neural tube. For example, the WNT antagonist 
DKK1 is expressed by the organizer at the onset of gas-
trulation49 and in the anterior axial mesoderm during 
late gastrulation49. Ectopic expression of DKK1 leads to 
enlargement of the head, whereas loss of DKK1 function 
induces microcephaly or loss of anterior structures50–52. 
In the Dkk1 mutant, posterior markers are unaffected, 
which indicates that DKK1 specifically affects head 
formation52. This function of DKK1 is mediated 
through its interaction with the LRP6 receptor53.
Other secreted WNT antagonists, such as Cerberus 
and Frizzled-related protein (FRZB1)54, are also 
involved in the patterning of the neural tube 
Overexpression of  Cerberus, which is expressed in the 
anterior endomesoderm, rescues the effect of ectopic 
expression of WNT 47,55. In contrast to DKK1, Cerberus 
Figure 1 | The three main branches of the WNT signalling pathway. a | The canonical or WNT/β-catenin pathway 
regulates cell fate decisions and possibly synaptogenesis. Binding of WNT to the Frizzled (FZ) and low-density lipoprotein 
receptor-related protein 5 (LRP5) or LRP6 receptor complex activates Dishevelled (DVL). Signalling through FZ requires 
G-protein activation. Activation of DVL results in the inhibition of glycogen synthase kinase 3β (GSK3β) and accumulation of 
β-catenin in the cytoplasm by inducing the disassembly of the destruction complex that is formed by adenomatosis polysis 
coli (APC), AXIN and GSK-3β. Subsequently, β-catenin translocates to the nucleus where it activates transcription mediated 
by T-cell specific transcription factor (TCF)/ lymphoid-enhancing factor (LEF). A pathway that diverges downstream of GSK3β 
has also been shown to control microtubule dynamics. b | In the planar cell polarity (PCP) pathway, FZ functions through 
G proteins to activate DVL, which, in turn, signals to Rho GTPases (Rho or Rac or both). Activation of Rac signals through the 
c-Jun amino (N)-terminal kinase (JNK). Activation of Rho GTPases induces changes in the cytoskeleton. This pathway has 
been implicated in cell and tissue polarity and, more recently, in dendritic arborization. c | In the WNT/calcium pathway, 
activation of DVL induces the release of intracellular calcium and activation of protein kinase C (PKC) and calcium/calmodulin-
dependent protein kinase II (CaMKII). The role of G proteins is poorly understood. This pathway has been implicated in cell fate 
and cell movement. NF-AT, nuclear factor of activated T cells.
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Figure 5.1 Schematic repres ntation of th  thr  branches of Wnt signalling 
pathways. Depending on the downstream signalling effects, the Wnt signalling pathways 
can be categorized into Canonical or WNT/b-cantenin pathway (a), planar cell polarity 
(PCP) pathway (b) and WNT/calcium pathway (c). (a) Activation of Canonical or WNT/b-
cantenin pathway relies on signalli g relay that results in stabilized b-cantenin, which t en 
enters the nucleus and activate the TCF/LEF transcription factors. The functions of WNT/b-
cantenin pathway have been implicated in cell fate decision, proliferation, etc. A divergent 
of this pathway, downstr am of GSK3b, has also been shown to affect cytoskeletal 
r modelling during neuronal morphog e is. (b) The PCP pathway controls cellular 
behaviours such as cell and tissue polarity, dendritogenesis by modulating cytoskeletal 
structures through Rho GTPases and/or JNK. (c) In the signalling relay of WNT/calcium 
pathway, activation of DVL induces the release of Ca2+ into the cytoplasm, which triggers 
the activities of protein kinase C (PKC) and calcium/calmodulin-dependent protein kinase 
II (CaMKII). This pathway has been implicated to function during cell fate determination and 
cell movement. Figure adapted from reference (185). 
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5.1.2 Activity of Wnt signalling in the prethalamus 
 
Although it has been established that canonical Wnt signalling is crucial for 
correct patterning and cell fate specification of the thalamus, little is known for 
its roles during prethalamic development. The minimal amount of evidence so 
far points to a scenario in which there needs to be a low Wnt activity 
environment for correct prethalamic development (32). This remains to be 
further confirmed. More importantly, if that is the case, why and how is that 
achieved? Just like the thalamus, the prethalamus directly abuts ZLI, which is 
the primary source of Wnt ligands within the diencephalon. How the thalamus 
and prethalamus display such a distinct difference in Wnt signalling activity 
remains unclear. Additionally, previous studies have only focused on the 
effects of canonical Wnt signalling in diencephalic development. The functions 
of the other Wnt signalling pathways remain to be elucidated as non-canonical 
Wnt ligands such as Wnt5a are also expressed in the ZLI.  
 
5.1.3 Aim of this chapter 
 
Pax6 displays a unique expression pattern in the developing diencephalon. It 
is expressed in the ventricular zone of the thalamus in a gradient, with the level 
of Pax6 increasing with distance from the ZLI (22). In the prethalamus, 
however, Pax6 is expressed in a homogeneous level in the ventricular zone. 
Besides, Pax6 is also expressed in a subset of prethalamic post-mitotic cells 
(22,60). Various evidence has shown differential expressions of Wnt and Wnt-
related genes in the prethalamus in mouse models when expression of Pax6 
was disturbed (39,42,202). In addition, RNAseq data in the lab showed that 
genes involved in the GO-term of Wnt signalling pathway were among the 
most highly up-regulated genes in the prethalamus when Pax6 is lost (58).  
 
Based on the above, in this chapter, I aim to: 
 
1. Determine innate Canonical Wnt activities in the prethalamus under 
control conditions 
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2. Determine the expression patterns of selected Wnt and Wnt-related 
genes in the prethalamus and how they change in response to the loss 
of Pax6 
3. Further investigate the potential mechanisms by which Pax6 might be 






5.2.1 Expression of specific Wnt and Wnt-related genes was 
dysregulated in the prethalamus in the absence of Pax6 
 
To have an idea of how the activity of Wnt signalling might have changed in 
the prethalamus when Pax6 is lost, I first cross-referenced with literature that 
identified components of the Wnt signalling pathways with the list of 
differentially expressed genes in out RNAseq data. What I found was that the 
expression of several Wnt ligands, Fzd receptors and Wnt effector genes was 
significantly upregulated whereas several Wnt antagonist genes were 
significantly downregulated in the prethalamus when Pax6 is lost (Table 5.1). 
Specifically, transcription of the Wnt3a gene showed a Log2-fold change (LFC) 
of 2.206, which ranked as the third most upregulated among the over 3000 
differentially expressed genes. On the other hand, the Wnt antagonist genes 
Sfrp2 and Dkk3 showed LFCs of -3.03 and -2.05 respectively, which were 
among the most downregulated genes in the RNA-seq data. Additionally, Wnt 
effector genes Axin2 (LFC 0.808), Lef1 (LFC 1.005) and Tcf7l2 (LFC 1.262), 
together with Frizzled receptor genes (Fzd5 LFC 0.927, Fzd10 LFC 0.846) and 
scaffold protein Dishevelled (Dvl3 LFC 0.723) all showed significantly 
upregulated expressions in the absence of Pax6 in the prethalamus. All these 
seemed to point to a general trend of upregulated canonical Wnt signalling in 





Table 5.1. Selective Wnt and Wnt-related genes showed significantly differential 




5.2.2 Activities of the Wnt/b-catenin pathway expand ventrally into the 
ventricular zone of the prethalamus when Pax6 is lost 
 
5.2.2.1 Prethalamus displayed low activity of Wnt/b-catenin 
pathway under normal conditions 
 
To test how the activities of canonical Wnt signalling are altered in the 
prethalamus when Pax6 is lost, and more importantly in which prethalamic 
areas these changes might have happened, we first turn to the TCF/Lef: H2B-
GFP reporter line to find out how active the canonical Wnt signalling is in the 
prethalamus under normal conditions. The reporter construct of the TCF/Lef: 
H2B-GFP line consists of six TCF/Lef binding sites and a minimal promoter 
followed by a GFP gene fused with the histone H2B gene. Therefore, it allows 
us to visualise Wnt/b-catenin signalling activity by expression of the nuclear-
localised GFP (203). 
 
Immunofluorescence staining detecting GFP and PAX6 showed their 
expressions in the diencephalon at E13.5 mutually exclusive. Pax6 is a known 
marker for the prethalamus. It is expressed in the ventricular zone of the 
prethalamus, where its dorsal boundary directly abuts the ZLI, and a subset of 
cells in the mantle zone (Figure 5.2A-D). GFP expression, on the other hand, 
showed the highest levels in the mantle zone of the thalamus and 
hypothalamus. However, expression of GFP was barely detectable in the 
prethalamus (Figure 5.2A-B, E-F). As the expression pattern of GFP and PAX6 
seemed complementary, these results indicated a low canonical Wnt 
environment in the prethalamus under normal condition, which is in 
concordance with what others have found using the BAT-gal reporter line or 






Figure 5.2 Activities of canonical Wnt signalling is low in the prethalamus, shown by 
the TCF/Lef:H2B-GFP reporter line. (A-F) Fluorescent immunohistochemistry detecting 
PAX6 (red) and GFP (green) in coronal sections of the TCF/Lef:H2B-GFP reporter mouse line 
at E13.5, sections were also counter-stained with DAPI (blue). (A, B) Merged channels for 
PAX6, GFP and DAPI, the two dashed lines demarcated the boundaries of the prethalamus 
based on PAX6 expression. The expression patterns of PAX6 and GFP seem mutually 
exclusive in the diencephalon. Single channels for PAX6 (C-D), and GFP staining (E-F). (C-
D) PAX6 expression is strong in the prethalamic area. (E-F) GFP expression reporting for 
canonical Wnt activity shows to be strong in the post-mitotic cells of thalamus and 
hypothalamus, but weak in the prethalamus. Embryos from 3 litters of TCF/Lef:H2B-GFP 
reporter mouse line were analysed, n=3. Abbreviations: PTh, prethalamus. Scale bars: 500μm 
(A, C, E), 250μm (B, D, F). 
TCF/Lef:H2B-GFP  PAX6  DAPI 
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5.2.2.2 Wnt3a expression expanded into the prethalamic 
ventricular zone when Pax6 is lost 
 
To find out where the significantly differentially expressed Wnt and Wnt-related 
genes are expressed in the diencephalon under normal conditions and upon 
acute Pax6 deletion, we performed in situ hybridisation to detect the presence 
of their mRNAs in coronal sections of the FP6CD1 mouse brain at E13.5. Due 
to the structural complexity of the developing diencephalon, without any 
regional markers, it would be difficult for us to pinpoint the exact locations of 
the finer diencephalic regions such as the ZLI and pTh-R. Therefore, for each 
gene tested, we also performed in situ hybridisation against Ngn2 in adjacent 
sections (Figure 5.3B). Ngn2 is a known marker for specific diencephalic 
regions- it is expressed in the ZLI, pTh-C and the mantle zone of pTh-C (24). 
Therefore, by comparing with Ngn2 expressions in adjacent sections, we will 
be able to locate where exactly the gene to test is expressed in the 
diencephalon. The expression patterns of each gene tested were examined in 
sections throughout the entire caudal-rostral axis of the diencephalon. 
Representative sections for the caudal, medial and rostral levels were selected 
for presentation (Figure 5.3A’). 
 
In the control embryos, the expression of Wnt3a showed the highest intensity 
in the ZLI. In the ventricular zone of the thalamus, Wnt3a is expressed in pTh-
R as well as pTh-C (Figure 5.3C-H). However, this expression seemed to 
display a gradient as its intensity decreases with distance from the ZLI (Figure 
5.3C-E). Wnt3a expression was also found in the mantle zone of the thalamus, 
but only at more rostral levels (Figure 5.3E, H). Notably, no expression of 
Wnt3a was observed in the prethalamus (Figure 5.3C-H). In the absence of 
Pax6, however, Wnt3a expression showed a distinct expansion into the 
prethalamic ventricular zone. The average level of Wnt3a expression seemed 
to have been elevated in the mantle zone of the prethalamus as well (Figure 
5.3I-N). Wnt3a expression in the ZLI and pTh-R also seemed to have 




Figure 5.3. Expression pattern of Wnt3a in coronal sections at caudal, medial and 
rostral levels of Pax6+/flox and Pax6flox/flox embryos at E13.5. High magnification images 
of (A) Wnt3a and (B) Ngn2 expression in medial sections of Pax6+/flox. Single arrows indicate 
the position of the ZLI. (F-H) Single arrows point to the highest intensity of Wnt3a expression 
in the diencephalon of Pax6+/flox. (L-N) Double arrows indicate expansion of Wnt3a 
expression into the prethalamic ventricular zone of Pax6flox/flox. (A’) Schematic 
representation of the sagittal view of the mouse neural tube. The vertical lines indicate the 
proximate location of the representation sections at the rostral, medial and caudal levels. 
One control and one Pax6-null embryo were obtained from each litter, three litters (n=3). 
(C-D) Black circles are bubbles created during mounting. PTh, prethalamus; ZLI, zona 
limitans intrathalamica. Scale bars: 500μm (C-E, I-K), 250μm (F-H, L-N) and 125μm (A-B). 
A’ 
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5.2.2.3 Readout genes for Wnt/b-catenin pathway showed 
upregulated expressions in the prethalamus in the absence of Pax6 
 
The expansion of Wnt3a expression into the prethalamic ventricular zone 
indicates potential upregulation of canonical Wnt activities in this region. To 
find out whether that was the case, we selected Axin2 and Lef1, two known 
readout genes for the canonical Wnt signalling that also showed upregulated 
expressions in the RNA-seq data and examined their expression patterns 
using in situ hybridisation. 
 
In control embryos, Axin2 was expressed in the ventricular zone of the 
thalamus, the ZLI, as well as the mantle zone of the ZLI (Figure 5.4A-B, C-H). 
Additionally, Axin2 expression was found in the ventricular zone of the dorsal-
most part of the prethalamus, abutting the ZLI (Figure 5.4G, double arrows). 
This expression appeared higher in the medial level of the diencephalon. In 
the absence of Pax6, Axin2 expression was elevated in the prethalamus 
(Figure 5.4I-N) and expanded even more ventrally to occupy almost the entire 
ventricular zone of the prethalamus (Figure 5.4M, double arrows). 
 
Similar to Wnt3a and Axin2, Lef1 expression in the control embryos seemed 
most robust in the ZLI (Figure 5.5A-B). However, in the thalamus, the level of 
Lef1 expression was low in pTh-R and pTh-C, but higher in the mantle zone of 
the pTh-C (Figure 5.5C-H). In the prethalamus, Lef1 is also found to be 
expressed in the ventricular zone of the dorsal-most prethalamic region (Figure 
5.5A-B, 5.5G, double arrows). Interestingly, Lef1 was also expressed in the 
ventricular zone and subventricular zone of the hypothalamus (Figure 5.5C-E). 
 
In the absence of Pax6, Lef1 expression was also found to have expanded 
ventrally, closing the gap of the Lef1-null region in the ventricular zone of the 
prethalamus observed in the control embryos (Figure 5.5I-N, 5.5M double 
arrows). Additionally, the low-Lef1 region, which was initially the pTh-R, have 
also expanded in the Pax6 mutant.  
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The above results showed that the ZLI was one of the primary sources of 
releasing ligands of the Wnt/b-catenin pathway, in concordance with previous 
studies. Detailed analysis of the expression patterns of Wnt3a, Axin2 and Lef1 
as above revealed differential expressions of these genes in different 
structures of the diencephalon- pTh-R and the ventral prethalamus display low 
canonical Wnt activity, whereas pTh-C and the dorsal ventricular zone of the 
prethalamus display high canonical Wnt activity. Acute deletion of Pax6 led to 
region-specific increased activities of canonical Wnt in the ventricular zone of 
the prethalamus.  
 
In contrast to the upregulated expressions of Wnt ligands and Wnt effector 
genes, several Wnt antagonist genes showed significantly downregulated 
expressions in the prethalamus when Pax6 is lost. Based on this information, 
we hypothesised that Pax6 inhibits the activity of Wnt signalling pathways by 
promoting the expressions of Wnt antagonists. To test this hypothesis, we 
examined the expression patterns of Wnt antagonists- Sfrp2 and Dkk3 by in 





Figure 5.4. Expression pattern of Axin2 in coronal sections at caudal, medial and rostral 
levels of Pax6+/flox and Pax6flox/flox embryos at E13.5. High magnification images of (A) 
Axin2 and (B) Ngn2 expression in medial sections of Pax6+/flox. Single arrows indicate the 
position of the ZLI in the sections. (F-H, L-N) Single arrows point at Axin2 expressions in the 
prethalamus of Pax6+/flox and Pax6flox/flox respectively. Double arrow in (G and M) indicates the 
area of Axin2 expression in the prethalamic ventricular zone. At least one control and one 
Pax6-null embryo were obtained from each litter, three litters were analysed (n=3). 
Abbreviations: PTh, prethalamus; ZLI, zona limitans intrathalamica. Scale bars: 500μm (C-E 
and I-K), 250μm (F-H and L-N) and 125μm (A and B). 
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Figure 5.5. Expression pattern of Lef1 in coronal sections at caudal, medial and rostral 
levels of Pax6+/flox and Pax6flox/flox embryos at E13.5. High magnification images of (A) Lef1 
and (B) Ngn2 expression in medial sections of Pax6+/flox.  Single arrows indicate the position 
of the ZLI in the sections. (C, F, I, L) Single arrows indicate the disappearance of the Lef1-
null gap between the prethalamus and the hypothalamus when Pax6 is lost. (F) Arrowhead 
points at the pTh-R with low Lef1 expression. (L) Bracket indicates the expansion of the pTh-
R. (G) Double arrows indicates the expression of Lef1 in the Pax6+/flox prethalamus. (M) 
Double arrow indicates the area of stronger and expanded Lef1 expression in the Pax6flox/flox 
prethalamus. At least one control and one Pax6-null embryo were obtained from each litter, 
three litters were analysed (n=3). Abbreviations: PTh, prethalamus; ZLI, zona limitans 
intrathalamica; Hyp, hypothalamus. Scale bars: 500μm (C-E and I-K), 250μm (F-H and L-N) 
and 125μm (A and B). 
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5.2.3 Wnt antagonists are expressed in the ventricular zone of the 
prethalamus, which were almost completely abolished when Pax6 is 
lost 
 
When looking into the RNA-seq data, Wnt antagonists Sfrp2 and Dkk3 were 
among the most highly down-regulated genes in the prethalamus when Pax6 
is lost. SFRP2 and DKK3 are both soluble inhibitors of Wnt signalling pathways. 
By binding directly to the Wnt ligands themselves, SFRP2 is thus able to inhibit 
the signalling relay of all three Wnt pathways. DKK3, on the other hand, 
functions to bind with the LRP5/6 co-receptor, therefore inhibits explicitly the 
activities of the canonical Wnt signalling pathway (192,199–201). 
 
In control embryos at E13.5, strong Sfrp2 expression was found in the 
ventricular zone of the prethalamus (Figure 5.6C-E, F-H double arrows), with 
its dorsal limit abutting the ZLI (Figure 5.6A-B). The intensity of this Sfrp2 
expression increased as it descended ventrally, but then dialled down as it 
reached and passed the ventral boundary of the prethalamus and 
hypothalamus (Figure 5.6F-H).  
 
In the absence of Pax6, Sfrp2 expression was almost completely lost in the 
ventricular zone of the prethalamus (Figure 5.6I-N). Interestingly, the 
expression of Sfrp2 seemed to have been upregulated in the ventricular zone 
of the thalamus at the medial level (Figure 5.6J). 
 
SFRP2 is a soluble inhibitor (204). Therefore, to better understand the range 
of its effects, I tried to further find out the range of its diffusion by studying the 
distribution of the protein itself. Due to technical difficulties, fluorescent 
immunohistochemistry detecting the SFRP2 protein could not be combined 
with fluorescence in situ hybridisation detecting the Sfrp2 mRNA. Therefore, 
these two experiments were done in parallel, in adjacent sections to compare 
the expression patterns of the Sfrp2 mRNA and SFRP2 protein. As shown in 
Figure 7, the distribution of the SFRP2 protein highly resembles the expression 
pattern of the Sfrp2 mRNA (Figure 5.7A-B). Expression of the Sfrp2 gene 
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seemed to be limited to only the cells in the ventricular zone of the prethalamus, 
so did diffusion of the SFRP2 protein (Figure 5.7A-B, 5.7A’, 5.7A’’, 5.7B’, 
5.7B’’). These results indicated that the effect of the SFRP2 protein was also 
short-ranged and limited to a distance of only a few cells from its source, which 
is similar to the diffusion mechanisms of the Wnt ligands as previous studies 
proposed (99,188). 
 
In addition to Sfrp2 expression, Dkk3 expression in the control embryos also 
showed the strongest staining in the ventricular zone of the prethalamus. The 
dorsal limit of Dkk3 expression seemed to be abutting the ZLI as well; however, 
at a much lower level than Sfrp2 expression in this area (Figure 5.8A-B). The 
intensity of Dkk3 expression also displayed a gradient, which increased with 
distance from the ZLI. The ventral limit of Dkk3 also seemed to have passed 
the prethalamic boundary and descended into the hypothalamus (Figure 5.8C-
D, 5.8F-H, double arrows).  
 
Interestingly, in the absence of Pax6, Dkk3 expression also suffered a drastic 
drop in its intensity, as its expression was merely detectable in the ventricular 
zone of the prethalamus.  
 
The overlapping expression patterns of Sfrp2, Dkk3 in the ventricular zone of 
the prethalamus in the presence of Pax6, and the region-specific upregulated 
activity of canonical Wnt signalling in this area in the absence of Pax6 






Figure 5.6 Expression pattern of SFRP2 in coronal caudal, medial and rostral 
diencephalic sections of Pax6+/flox and Pax6flox/flox embryos at E13.5. (A) SFRP2 and 
(B) Ngn2 expression in medial sections of Pax6+/flox. Single arrows indicate the position of 
the ZLI in the sections. (F-H) Double arrows indicate the expression of SFRP2 in the 
ventricular zone of the prethalamus of Pax6+/flox. At least one control and one Pax6-null 
embryo were obtained from each litter, five litters were analysed (n=5). Abbreviations: 
PTh, prethalamus; ZLI, zona limitans intrathalamica. Scale bars: 500μm (C-E and I-K), 





Figure 5.7. Comparison of expression patterns of Sfrp2 mRNA and SFRP2 protein in 
parallel sections. (A) Fluorescent in situ hybridization detecting Sfrp2 mRNA in 
combination with fluorescent immunohistochemistry detecting PAX6 protein in coronal 
section of the E13.5 mouse brain at medial level. (B) Fluorescent immunohistochemistry 
detecting SFRP2 and PAX6 protein in parallel section of (A). (A’, B’) Zoomed in images of 
the areas within the rectangular in (A) and (B), section in (A’) were stained to detect Sfrp2 
mRNA and PAX6 protein distribution; section in (B’) were stained to detect SFRP2 and 
PAX6 protein distribution. (A’’, A’’’, B’’, B’’’) Single channel images for (A’) and (B’). One 
control and one Pax6-null embryo were obtained from each litter, three litters were 




Figure 5.8. Expression pattern of Dkk3 in coronal caudal, medial and rostral 
diencephalic sections of Pax6+/flox and Pax6flox/flox embryos at E13.5. (A) Dkk3 and 
(B) Ngn2 expression in medial sections of Pax6+/flox. Single arrows indicate the position 
of the ZLI in the sections. (F-H) Double arrows indicate the expression of Dkk3 in the 
ventricular zone of the prethalamus of Pax6+/flox. (L-N) Single arrows point areas of low 
expression of Dkk3 in the prethalamus of Pax6flox/flox. At least one control and one Pax6-
null embryo were obtained from each litter, three litters were analysed (n=3). 
Abbreviations: PTh, prethalamus; ZLI, zona limitans intrathalamica. Scale bars: 500μm 
(C-E and I-K), 250μm (F-H and L-N) and 125μm (A and B). 
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5.2.4 Wnt5a expression is upregulated in the ventricular zone as well as 
a subset of post-mitotic cells of the prethalamus when Pax6 is lost 
 
In addition to Wnt3a, another Wnt gene- Wnt5a also showed upregulated 
expression in the prethalamus when Pax6 is deleted. WNT5a is normally 
considered as a non-canonical Wnt ligand. However, when co-expressed with 
Fzd5 receptor, it can also activate the canonical Wnt pathway (200,205). 
Additionally, previous studies have shown strong Wnt5a expression in the ZLI 
during diencephalic development (37,38,41). To determine the exact 
expression pattern of Wnt5a in our mouse model at this particular age of 
diencephalic development, we also performed in situ hybridisation to detect 
the expression of Wnt5a mRNA in coronal sections. 
 
In control embryos, Wnt5a is also expressed most strongly in the ZLI (Figure 
5.9A-B, 5.9C-E arrowhead). In the thalamus, Wnt5a is expressed in a rather 
homogeneous level in the ventricular zone (Figure 5.9C-E). Interestingly, 
Wnt5a is also expressed by a small group of post-mitotic cells in the 
prethalamus at the caudal and medial levels (Figure 5.9F-G, rectangle). 
Additionally, Wnt5a is also expressed in the ventricular zone of the 
hypothalamus, a group of post-mitotic cells in the subpallium, as well as the 
cortical hem.  
 
In the absence of Pax6, Wnt5a expression has expanded, not only ventrally 
into the ventricular zone of the prethalamus (Figure 5.9I-K, double arrows), but 
also laterally as more post-mitotic cells in the caudal and medial levels of 
prethalamus now express Wnt5a (Figure 5.9L-M, rectangle).  
 
To find out whether Wnt5a expressions in the post-mitotic cells of the 
prethalamus correlate with Pax6 expressions in this area, we performed in situ 
hybridisation against Wnt5a mRNA in combination with immunohistochemistry 
detecting the PAX6 protein. The PAX6 antibody used in these experiments 
detects the last 20 amino acids on the C-terminal of the PAX6 protein. Due to 
the presence of an internal initiation site, a truncated PAX6 protein with its C-
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terminal intact can still be produced after the floxed Pax6 exons had been 
excised from the genome (32). Hence, we can utilise this antibody to detect 
cells with active transcriptions for the Pax6 gene, regardless of whether the 
protein being produced will be complete and functional or not. 
 
Colour reaction of the Wnt5a in situ hybridization was performed with BCIP (5-
bromo-4-chloro-3-indolyl-phosphate) in conjunction with NBT (nitro blue 
tetrazolium), hence giving out the signal in blue, whereas colour reaction of the 
immunohistochemistry detecting PAX6 was performed with the DAB (3, 3 -
diaminobenzidine) HRP substrate, which produces a dark brown reaction 
product. As shown in Figure 5.10, in control embryos, the population of Wnt5a 
positive cells mainly resides in the very lateral mantle zone of the prethalamus. 
Expression patterns of Wnt5a and PAX6 are highly mutually exclusive as most 
of the Wnt5a-high cells express low levels of PAX6, and vice versa (Figure 
5.10C, arrows). Only a few cells co-expressing Wnt5a and Pax6 were found in 
the mantle zone of the prethalamus (Figure 5.10C, arrowheads). However, in 
the absence of Pax6, not only had this Wnt5a-positive population expanded 
within the mantle zone of the prethalamus, but cells within this population also 
expressed higher levels of Wnt5a. Additionally, more cells in this population 
were now co-express Wnt5a and PAX6 (Figure 5.10D, arrowheads). Adjacent 
sections were processed in parallel with immunohistochemistry detecting 
PAX6 using the antibody recognising the N-terminal of PAX6, which is absent 
in the truncated PAX6 in the mutant embryos (153). Figure 10E confirmed that 
within the mantle zone of the prethalamus in the Pax6flox/flox embryos, most 
of the cells had lost their PAX6 expression. There were still a few PAX6-
positive cells detected, possibly due to a variation of responses towards 
tamoxifen from different cells. Nonetheless, this does not affect the Pax6-null 
phenotype, and we can conclude from the above that loss of Pax6 induced 
increased expression of Wnt5a in the ventricular zone and mantle zone of the 
prethalamus, and the inhibition of Wnt5a expression by Pax6 in the mantle 




Figure 5.9. Expression pattern of Wnt5a in coronal caudal, medial and rostral 
diencephalic sections of Pax6+/flox and Pax6flox/flox embryos at E13.5 after in situ 
hybridization. (A) Wnt5a and (B) Ngn2 expression in medial sections of Pax6+/flox. Single 
arrows indicate the position of the ZLI in the sections. (F, G, L and M) Rectangles indicate 
the cell population expressing Wnt5a in the mantle zone of the prethalamus. (C-E) 
Arrowheads point the expression of Wnt5a in the ZLI in Pax6+/flox. (I-K) Double arrows 
indicate Wnt5a expression in the ventricular zone of the prethalamus of Pax6flox/flox. At least 
one control and one Pax6-null embryo were obtained from each litter, three litters were 
analysed (n=3). Abbreviations: PTh, prethalamus; ZLI, zona limitans intrathalamica. Scale 





Figure 5.10 Expression pattern of Wnt5a and Pax6 in coronal medial diencephalic 
sections of Pax6+/flox and Pax6flox/flox embryos at E13.5 after DAB 
Immunohistochemistry. (A-D) Wnt5a (blue) and Pax6 (brown) expression in the 
prethalamus. (C-D) Single arrows indicate Wnt5a-expressing cells in the mantle zone. 
Arrowheads point to overlapping Wnt5a-Pax6 cells in the mantle zone. (E) Wnt5a and 
Pax6 expression in the mantle zone of the prethalamus of Pax6flox/flox. At least one 
control and one Pax6-null embryo were obtained from each litter, three litters were 





The functions of Wnt signalling pathways are essential for the normal 
development of the forebrain. Recent studies have also revealed new roles of 
canonical Wnt signalling in directing the development of the diencephalon, with 
most emphasis on the thalamus. These studies have validated various 
thalamic developmental defects when canonical Wnt signalling was removed 
(28,29,32,36,38,41,43). However, the impacts of Wnt signalling pathways on 
the development of the prethalamus were seldom mentioned. It had been 
established, although, without much in-depth investigation, that inhibition of 
canonical Wnt signalling is required for the normal development of the 
prethalamus (32). However, this remained to be confirmed, and the underlying 
mechanisms are still poorly understood. RNAseq data in the lab showing 
differential expressions of genes revealed a general increase of activities of 
Wnt signalling pathways in the diencephalon, and especially in the 
prethalamus, after acute deletion of Pax6. However, as the diencephalon at 
this age of investigation is compacted with fine structures such as pTh-C, pTh-
R, ZLI etc., it was hard to draw any solid conclusions without knowing the 
specific expression patterns of particular genes involved in the Wnt signalling 
pathways. 
 
Based on this, in this chapter, we analysed the expression patterns of several 
Wnt and Wnt-related genes by in situ hybridisation, to find out how the 
activities of Wnt signalling pathways were affected in specific regions of the 
diencephalon in the presence and absence of Pax6. This has enabled us to 
elucidate the involvement of Wnt signalling pathways in prethalamic 
development and further shed light on the potential mechanisms of Pax6’s 
control over Wnt signalling pathways in this particular region. 
 
5.3.1 Working model: Pax6 inhibits the activities of Wnt signalling 




As shown above, canonical Wnt signalling is highly active in the thalamus but 
inert in the prethalamus under normal conditions (Figure 5.2). In the absence 
of Pax6, increased and expanded expressions of Wnt3a, Wnt5a, Lef1 and 
Axin2 were observed specifically in the ventricular zone of the prethalamus, 
along with a drastic decrease of expressions of Wnt antagonists Sfrp2 and 
Dkk3 in this region. These results have allowed us to propose a simple working 
model. As shown in Figure 5.11, in the ventricular zone of the prethalamus, 
Pax6 might be indirectly inhibiting the canonical Wnt signalling pathway by 
promoting the expressions of Wnt antagonists such as Sfrp2 and Dkk3. Indeed, 
previous studies have shown that Pax6 can directly bind to the promoter of 
Sfrp2 and activate its transcription, in order to inhibit canonical Wnt signalling 
during retinal development. Kim et al. had also shown the disappearance of 
Sfrp2 expression in the Sey/Sey mutant, the mouse model with the natural loss 
of function mutation of the Pax6 gene. Additionally, Pax6 was shown to be able 





Sfrp2 and Dkk3 can inhibit the activities of the canonical Wnt signalling by 
binding directly to the Wnt ligands themselves or to the LRP5/6 co-receptors, 





Figure 5.11. Diagram showing the proposed working model of Pax6’s inhibition on 
the canonical Wnt signalling in the ventricular zone of the prethalamus at E13.5. By 
directly promoting the expressions of Wnt antagonists such as Sfrp2 and Dkk3, Pax6 
thereby indirectly inhibit the activities of the canonical Wnt signalling in the ventricular zone 
of the prethalamus. 
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How the loss of this extracellular protein-protein interaction results in 
transcriptional activation of Wnt and Wnt-related genes remains to be 
elucidated. However, as shown in the case of the transcriptional activation of 
Wnt effector genes Axin2 and Lef1, it is reasonable to speculate that the 
canonical Wnt signalling in the ventricular zone of the prethalamus might be 
involved in positive feedback loops of transcribing genes that are themselves 
components of the signalling relay of this pathway. 
 
In summary, we propose that Pax6 indirectly inhibits the activities of the 
canonical Wnt signalling pathway through directly promoting the expressions 
of Wnt antagonists in the prethalamic ventricular zone. 
 
5.3.2 Activities of Wnt signalling pathways in the different regions of the 
developing diencephalon 
 
Our detailed analysis of the expression patterns of Wnt3a, Axin2 and Lef1 
have revealed differential expressions of these genes in different structures of 
the diencephalon- pTh-R and the ventral prethalamus display low canonical 
Wnt activities whereas pTh-C and the dorsal ventricular zone of the 
prethalamus display high canonical Wnt activities. These results were derived 
from the TCF/Lef: H2B-GFP reporter line as well as in situ hybridisation against 
Wnt and Wnt-related genes in the FP6CD1 line. Interestingly, the activities of 
canonical Wnt signalling on either side of the ZLI as we found was rather 
opposite to what was previously proposed. Both the pTh-R and the dorsal-
most prethalamus situate directly on either side of the ZLI, hence should be 
receiving a similar amount of WNT ligands. However, the most ventral-rostral 
thalamic region, the pTh-R, showed low Lef1 expression, whereas the most 
dorsal prethalamic region showed high Axin2 and Lef1 expressions.  
 
On either side of the ZLI, Pax6 expression was reported to be low, due to the 
mutual repression between Pax6 and Shh expressed by the ZLI (22). Low 
Pax6 expression in the ventricular zone of the dorsal-most prethalamus might 
explain why Sfrp2 and Dkk3 expressions were also lower in this particular 
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region, possibly as a result of lower levels of direct transcriptional activation of 
Pax6 over these genes. This might therefore further lead to elevated Axin2 and 
Lef1 expressions in this region. It would be interesting to find out how the 
derivative neurons from this region differ from the neurons generated in nearby 
prethalamic regions, in terms of cell identity and even electrophysiological 
properties.  
 
Whether the pTh-R indeed displays low canonical Wnt signalling remains to 
be confirmed, as, in our study, we only looked at the expression of Lef1. The 
pTh-R might express other members of the TCF/LEF families of transcription 
factors, such as Tcf7l2, to carry out the final steps of canonical Wnt signalling. 
However, we also observed the Lef1-null gap within the thalamic region 
widened in the absence of Pax6. This might be due to the expansion of pTh-R 
in Pax6-null mutants, which was in concordance with what was previously 
described (22). This indicated that the absence of Lef1 expression in the pTh-
R might be independent of Pax6. So far, the very limited evidence showed that 
deleting b-catenin in the ZLI and pTh-C at E10.5 and onwards does not affect 
the formation of the pTh-R. It does, however, results in an invasion of 
prethalamic and pTh-R markers in the mantle zone of pTh-C. On the other 
hand, deleting Shh expression under the same condition results in loss of pTh-
R markers such as Helt, Gata2, Ascl1 and Nkx2-2. Lastly, deleting both Shh 
and b-catenin although restored expression of pTh-R markers close to ZLI, it 
also led to the invasion of prethalamic and pTh-R markers in the mantle zone 
of pTh-C. These results indicate an essential role of canonical Wnt signalling 
in maintaining the development of pTh-C and Shh in maintaining the 
development of pTh-R in the presence of high levels of canonical Wnt 
signalling (36). Therefore, in terms of the formation and development of the 
pTh-R, Shh signalling might be playing a more determining role than the 
canonical Wnt signalling. If this is true, then the remaining questions would be, 
what signalling pathway contributed to this and what are their interactions with 
the canonical Wnt signalling. 
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As the mid-diencephalic organiser, the ZLI is known to release morphogens 
such as Shh and Fgfs, which further direct the development of the 
neighbouring tissues as the thalamus and prethalamus (2,32). Interestingly, 
our results revealed that in addition of being the primary source of releasing 
Wnt ligands, such as Wnt3a and Wnt5a, ZLI is also where the two readout 
genes for canonical Wnt signalling, Axin2 and Lef1, most intensively 
expressed. This result indicated that although the prevailing notion proposes 
that organisers do not respond to the morphogens expressed by themselves 
(2), ZLI at this age might be able to respond to its own canonical Wnt signals. 
If this is truly the case, it would be extremely intriguing to test how canonical 
Wnt signalling might interact with ZLI's production of other morphogens such 
as Shh and Fgfs, and how that might affect the responses of neighbouring 
tissues to any of these signalling pathways. 
 
Another interesting finding from this study was the expression of Wnt5a in the 
diencephalon. In the ventricular zone of the diencephalon, the expression 
pattern of Wnt5a highly correlates with that of Wnt3a’s. However, Wnt5a is 
also expressed in a subset of post-mitotic cells in the prethalamus, which 
display either no or low levels of Pax6 expression. In the absence of Pax6, not 
only more prethalamic post-mitotic cells started to express Wnt5a, but also at 
a higher level. The functions of Wnt5a in the prethalamus remain elusive, and 
without the information of expression patterns of specific receptor genes for 
the Wnt signalling pathways, it is difficult to speculate what they might be. 
WNT5a is normally considered as a non-canonical Wnt ligand. However, in the 
presence of FZD5, it can also act as a canonical Wnt ligand and induce 
anterior-posterior axis formation by activating the canonical Wnt signalling 
pathway (200,206). Based on the unique expression patterns of Wnt5a in the 
prethalamus, one intriguing idea to propose would be that Wnt5a plays 
different roles in the progenitor and post-mitotic cells in the prethalamus. 
Notably, this group of Wnt5a-positive post-mitotic cells resides lateral to the 
thalamocortical tract in the control embryos. However, the expansion of this 
group of cells upon Pax6 deletion places them directly in the path of the TCA 
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in the mutant embryos. Given Wnt5a’s involvement in the PCP pathway and 
directing axon guidance and neurite extension, it would be worthwhile to 
investigate further whether this elevated Wnt5a expression in the prethalamic 
post-mitotic cells also contribute to the misformation and misroute of TCA 
frequently observed in the Pax6 mutants (167).  
 
In this study, we did test the expressions of Fzd5, Fzd7 and Fzd10 by in situ 
hybridisation. However, the signals were not specific and clear enough for us 
to distinguish them from the background staining. Therefore, they were not 
included in this thesis, and other attempts are needed.  
 
5.3.3 Potential impact of upregulated Wnt signalling pathways on the 
development of the prethalamus (proliferation, the specification of 
cell fate and PCP pathways) 
 
As we showed that the ventricular zone of the prethalamus is protected from 
the canonical Wnt signalling under normal conditions, an important question 
to ask would be why this is the case and what defects would the prethalamus 
display when canonical Wnt signalling is activated in the prethalamic 
progenitor cells, as what we saw in our Pax6 conditional knock-outs.  
 
One possibility would be misspecification of cell fates of the prethalamic 
derivative neurons. As shown in the RNA-seq data, several prethalamic 
markers showed a drastic decrease of expressions, such as Isl1 (LFC -2.59), 
Gsx2 (LFC -2.15) and Six3 (LFC -1.3). In contrast, markers for epithalamus 
(Irx2, LFC 2.10; Robo3, LFC 1.93; Irx1 LFC 1.57), pTh-C and pTh-C derived 
post-mitotic cells (Gbx2, LFC 1.60; Irx3, LFC 1.24; Lhx2, LFC 0.70; Hs6st3, 
LFC 1.39; Rora, LFC 0.75), and pTh-R and pTh-R derived post-mitotic cells 
(Gata3, LFC 2.34; Sox14 LFC 2.39; Gata2 LFC 1.64) were upregulated in the 
prethalamus when Pax6 is lost (43,47). It would be interesting to see the exact 




Canonical Wnt signalling has been shown to promote cell proliferation in 
various systems (189). Given that the prethalamus has a more differentiated 
profile than the thalamus at the same age, we wonder whether the specific 
blockage of canonical Wnt signalling in the progenitor cells of the prethalamus 
could contribute to that. However, recently published work in the lab has shown 
that deletion of Pax6 led to more cell cycle exit and less proliferation in the 
prethalamus, which is opposite to what the thalamus displays under normal 
conditions (58). Nonetheless, it would be interesting to perform a time course 
analysis on the expressions of Sfrp2, Dkk3, as well as Wnt3a and the effector 
genes Axin2 and Lef1, to see if the expressions of the antagonists and 
changes of expressions of Wnt3a, Axin2 and Lef1 are always restricted to the 
ventricular zone of the prethalamus. We know that the palmitoylation of the 
Wnt ligands renders their inability to diffuse far. Thus, Wnt signalling is 
considered to be effective locally. This also seemed to be the case for the Wnt 
antagonists such as SFRP2. Therefore, an intriguing hypothesis to propose 
would be that prethalamic progenitors are protected from Wnt because they 
are within the range of effect of canonical Wnt secreted from the ZLI, but once 
they are protected from the canonical Wnt signalling, their post-mitotic 
derivatives would be ‘immune’ and thus unaffected by the canonical Wnt 
signalling. 
 
In addition to canonical Wnt signalling, the RNA-seq data also showed 
dysregulated expressions of components of the planar cell polarity pathways 
(196). For example, the Wnt ligands know to initiate the PCP pathway (Wnt5a, 
LFC 0.92; Wnt4, LFC 0.70), and transmembrane adhesive molecule 
maintaining the polarities (Vangl 2, LFC 0.54; Prickel1, LFC 0.68; Prickel2, 
LFC 1.16; Dishevelled 3, LFC 0.72; Celsr1, LFC 1.05; Celsr3, LFC 0.72); 
whereas Frizzled7 showed a -2.14 log2-fold change. The expression patterns 
of these genes and where their proteins are distributed in the prethalamus 
need to be determined, to unravel the location of action and disruption of the 





In this chapter, we analysed the expression patterns of several Wnt and Wnt-
related genes in the E13.5 mouse diencephalon in the presence and absence 
of Pax6. According to these, we proposed that in the developing prethalamus, 
Pax6 might be indirectly inhibiting the activities of the Wnt signalling pathways 








Chapter 6  
 
Pax6-null prethalamus develops a 
thalamus-like expression profile of 
voltage-gated ion channels and 






Although the thalamus and prethalamus both reside on either side of the ZLI, 
hence should receive the same dosages of morphogens released by this 
secondary organiser, the thalamus and prethalamus exhibit very different 
developmental profiles and produce neurons with very different morphologies 
and functions (12,32). The sharp difference of Pax6 expression in the thalamus 
and prethalamus makes it an excellent candidate to test whether Pax6 can 
cause this regionally different development of the thalamus and prethalamus. 
 
Thalamic neurons derived from the pTh-C are glutamatergic, which send out 
long axons that travel through the prethalamus and the ventral telencephalon 
to innervate the cortex (4,12). Prethalamus-derived neurons, on the other hand, 
are mostly GABAergic, which develop much shorter axons that only innervate 
the thalamic nuclei nearby (12,67). Previous studies have pointed out that 
downregulation of Pax6 expression in the thalamic post-mitotic cells correlates 
with the time of thalamic axon outgrowth and TCA formation (162). However, 
whether this downregulation of Pax6 directly causes the rapid outgrowth of 
TCA remains to be confirmed. Interestingly, my analysis on neuronal 
morphogenesis showed that, in the absence of Pax6, the prethalamic neurons 
were able to develop longer neurites, evidenced by both the total length of 
neurites and length of the longest neurite. This result indicated that at least in 
the prethalamic neurons, normal expression of Pax6 in the post-mitotic cells 
might function to limit axon outgrowth and elongation. When Pax6 is removed 
from the prethalamus, the prethalamic neurons can develop longer axons, 
raising the possibility that the morphologies of prethalamic neurons resembled 
that of the thalamic neurons in the absence of Pax6.  
 
In addition, in the absence of Pax6, we observed specific regional upregulation 
of activities of various Wnt signalling pathways in the prethalamus. Previous 
studies have identified the determining roles of canonical Wnt signalling in 
patterning, cell fate specification and transcriptional control of voltage-gated 
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ion channels in the developing thalamus. Could this ectopic expression of Wnt 
signalling moved the transcriptome profile of the prethalamus towards that of 
the thalamus?  
 
What is more, I also discovered that the Pax6-null prethalamic neurons 
displayed altered structures of the AISs, which were shorter in lengths and 
located further away from the soma. In the absence of Pax6, these AISs also 
exhibited higher expression levels of AnkG and voltage-gated Na+ channels. 
How do the expression levels of these AIS component genes in the 
prethalamus differ from that in the thalamus in the presence and absence of 
Pax6?  
 
The RNAseq data in the lab, which analysed the transcriptional changes of 
genes in the anterior cortex, the thalamus and the prethalamus upon acute 
deletion of Pax6, provided us with an unbiased starting point to answer the 
above questions. 
 
Therefore, in Chapter 6, by utilising the existing RNAseq data, I aim to: 
 
1. Test whether the Pax6-null prethalamus develops a thalamus-like 
expression profile of AIS component genes and voltage-gated ion 
channels  
 
2. Reveal the potential mechanisms- by assessing whether this is due to 
the loss of direct transcriptional control of Pax6 or upregulation of Wnt 





6.2 Materials and methods 
 
Heatmap of hierarchical clustering and principal component (PC) analysis 
were performed by Zrinko Kozić. RNAseq data were from reference (58); the 
gene list of putative TCF/LEF target genes was from reference (207). 
 
Identification of potential Pax6 target genes was also performed by Zrinko 








6.3.1 Pax6 deletion in the prethalamus made its expression profile of 
AIS component genes and voltage-gated ion channels thalamus-like 
 
To find out if deletion of Pax6 in the prethalamus would move its expression 
profile of AIS component genes and voltage-gated ion channels towards that 
of the thalamus, I first identified genes included in the GO terms of axon initial 
segment (GO:0043194), sodium channel activity (GO:0005272), potassium 
channel activity (GO:0005267) and calcium channel activity (GO:0005262). 
Then I identified the genes included in the above GO terms, which also showed 
significant dysregulation of expressions in any of the three pieces of tissues- 
the anterior cortex (ACtx), thalamus and prethalamus in our RNAseq data, to 
generate the overlapping genes (marked as red dots in Figure 6.1). After that, 
we carried out distance-based hierarchical clustering and principal component 
(PC) analysis specifically on these overlapping genes. 
 
22 genes were included in the GO term of axon initial segment. As shown in 
Figure 6.1A, in the prethalamus, 6 of them showed significant dysregulation of 
expression in our RNAseq data and the expression levels of all six genes were 
upregulated in the prethalamus in the absence of Pax6. A similar situation 
happened with genes in the GO term of sodium channel activity. A total of 75 
genes were included in this GO term, and 9 showed up in our RNAseq data, 
all of which showed significantly upregulated expression in the prethalamus 
when Pax6 was lost (Figure 6.1B). In terms of the GO term of potassium 
channel activity, a total of 160 genes were included in this GO term, and 27 of 
them showed significant dysregulation of expression in the prethalamus in our 
RNAseq data. Among these 27 genes, 24 of them were significantly 
upregulated, and 3 of them were significantly downregulated in the 
prethalamus following the loss of Pax6 (Figure 6.1C). The GO term of calcium 
channel activity included the highest number of genes among these four GO 
terms. 194 genes were included in this GO term, and 25 of them showed 
significantly dysregulated expressions in the prethalamus in our RNAseq data. 
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The expression levels of 24 genes were significantly upregulated, whereas the 
expression of only 1 gene was significantly downregulated in the Pax6-null 
prethalamus (Figure 6.1D). These results also highlighted an intriguing 
phenomenon that although Pax6 is expressed by three tissues, the 
prethalamus is the only one where these genes were almost exclusively 
upregulated, which could be due to the postmitotic actions of Pax6. 
 
As shown in Figure 6.2A, 6.2C, 6.2E, and 6.2G, the heatmap of hierarchical 
clustering of the genes in the above four GO terms that were present in our 
RNA-seq data showed that, regardless of genotype, all six anterior cortical 
samples clustered together and separated from the diencephalic samples. PC 
analysis using the same set of genes showed the same trend, as cortical 
samples always clustered together and separated from the diencephalic 
sample along the axis of maximum variation, which represented 60%, 75%, 
72% and 72% of the variance respectively for the above four GO terms (Figure 
6.2B, 6.2D, 6.2F and 6.2H). These results revealed the drastic differences the 
anterior cortex and the diencephalon displayed in terms of expression profiles 
of AIS component genes and voltage-gated ion channels, and the loss of Pax6 
did not change such differences.  
 
Among the diencephalic samples, distance-based hierarchical clustering 
showed that the thalamic samples also always cluster together for all four GO 
terms, regardless of genotype (Figure 6.2A, 6.2C, 6.2E and 6.2G). PC analysis 
showed the same trend, as thalamic samples always clustered together and 
separated from the prethalamic control samples along the axis of the second 
highest variation, which represented 23%, 9%, 12% and 9% of variance 
respectively for the above four GO terms (Figure 6.2B, 6.2D, 6.2F and 6.2H). 
This indicated that within the diencephalon, the thalamic and prethalamic 
neurons also displayed rather different expression profiles of AIS component 
genes and voltage-gated ion channels, and the loss of Pax6 had little effect on 
the expression profiles of these genes in the thalamus. Such result was also 
in concordance with what was shown in Figure 6.1A-D. For all the genes that 
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were involved in these four GO terms, the thalamus had the least amount of 
them that showed significantly dysregulated expressions in the absence of 
Pax6. 
 
However, when Pax6 was removed from the prethalamus, there was a general 
trend of the prethalamic expression profiles of the genes in these GO-terms to 
become thalamus-like. This was more obvious in the GO terms of axon initial 
segment and calcium channel activity. As shown in Figure 6.2A and 6.2G, 
Pax6-null prethalamic samples were clustered with the thalamic control and 
Pax6-null samples, and only at the third level in the dendrogram did the Pax6-
null prethalamic samples separated from the thalamic samples. PC analysis 
showed the same results, as the Pax6-null prethalamic samples had moved 
(having as a reference the position of control prethalamic samples) from one 
end of the axis of the second highest variation and mixed with the thalamic 
samples (Figure 6.2B and 6.2H). Genes involved in the other two GO terms- 
sodium channel activity and potassium channel activity of the Pax6-null 
prethalamic samples - still clustered better with the control prethalamic 
samples in the distance-based hierarchical clustering (Figure 6.2C and 6.2E). 
Their PC analysis showed that same results, as they clustered first with their 
control counterparts. Nevertheless, the variances of expressions of genes in 
both of these GO terms displayed by the thalamus and prethalamus were 
smaller when Pax6 was removed from the prethalamus, as Pax6-null 
prethalamic samples in these two GO terms showed a trend of moving towards 
the thalamic samples (they were situated closer to the thalamic samples than 
the prethalamic controls) (Figure 6.2D and 6.2F).  
 
These results showed that following the loss of Pax6, the variances of 
expression profiles of the AIS component genes and voltage-gated ion 
channels in the thalamus and prethalamus became smaller. This indicates that 
the Pax6-null prethalamus developed a thalamus-like expression profile for 




Figure 6.1 Overlapping genes which are involved in the four GO terms of axon initial 
segment (A), sodium channel activity (B), potassium channel activity (C) and calcium 
channel activity (D) that were also significantly dysregulated in the anterior cortex, 
prethalamus and thalamus in the RNAseq data. All the black dots in the background for 
each piece of tissue represented all the genes, whose expressions were significantly 
dysregulated in the absence of Pax6. Each red dot represented one gene that was involved 
in that specific GO term, but also showed significant dysregulation in any of the three pieces 
of tissues in the absence of Pax6. (A) 6 overlapping genes were seen in the GO terms of axon 
initial segment; (B) 9 overlapping genes were seen in the GO terms of sodium channel activity; 
(C) 27 overlapping genes were seen in the GO terms of potassium channel activity and (D) 25 






Figure 6.2 Pax6 removal from the prethalamus minimises the variance of 
expression profiles of AIS component genes and voltage-gated ion channels 
among the diencephalic tissue. Heatmap of hierarchical clustering of RNAseq data 
on genes annotated by the “axon initial segment” GO term (GO:0043194), (A); “sodium 
channel activity” GO term (GO:0005272), (C); “potassium channel activity” GO term 
(GO:0005267), (E); and “calcium channel activity” GO term (GO:0005262), (G). 
Principle component (PC) analysis on the same RNAseq data as in (A), (C), (E) and (G). 
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6.3.2 Increased canonical Wnt activity in the Pax6-null prethalamic cells 
did not produce a shift towards a thalamic profile in the expression 
profiles of the putative TCF/LEF-target genes  
 
Various studies have reported the importance of the transcriptional control 
exerted by canonical Wnt signalling during the development of the thalamus 
(32,36,38,43). In Chapter 5, we found that the activity of canonical Wnt 
signalling was significantly upregulated in the ventricular zone of the 
prethalamus, which could potentially have altered the expression profiles of 
the prethalamic cells and made them thalamus-like. 
 
To test this possibility, I utilised a data set that specified the 428 putative 
TCF/LEF target genes expressed in the adult thalamus (207). We crossed this 
data set with our RNAseq data, identified the overlapping genes and 
processed them for distance-based hierarchical clustering and PC analysis to 
compare how their expression changed across the three pieces of tissues in 
the presence and absence of Pax6. 
 
As shown by Figure 6.3A, expression profiles of these putative TCF/LEF target 
genes clustered better within tissues, regardless of genotypes. PC analysis 
showed the same trend, as samples from the same tissues clustered better 
(Figure 6.3B). The variances of expression profiles of these genes between 
anterior cortex and the diencephalon (as observed in the axis explaining 62% 
of the variance) were still much higher than the variances displayed between 
the thalamus and prethalamus (axis of 22% variance). Although in the absence 
of Pax6, the expression profiles of these genes in the prethalamus showed a 
slight shift towards the thalamus, these results indicated that the loss of Pax6 
did not alter the expression profiles of these genes to the extent that the 
prethalamus was becoming thalamus-like as observed before (i.e., for calcium 













Figure 6.3 Expression profiles of putative TCF/LEF target genes did not show 
inter-regional changes in the absence of Pax6. (A) Heatmap of hierarchical 
clustering of RNAseq data on putative TCF/LEF target genes. (B) Principal 
component (PC) analysis on the same RNAseq data as in (A). 
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6.3.3 Loss of transcriptional control by Pax6 and upregulated canonical 
Wnt signally together made the Pax6-null prethalamic expression 
profiles of AIS component genes and voltage-gated ion channels 
thalamus-like 
 
As a master regulator gene, Pax6 sits high in the hierarchy of gene regulatory 
networks and functions to control the transcriptions of numerous genes 
(128,140). To find out if the shift of expression profiles of AIS and calcium 
channel activity in the Pax6-null prethalamus, which had become thalamus-
like, was due to the loss of direct transcriptional control of Pax6 in the 
prethalamic cells, we first tried to identify putative Pax6 target genes within the 
genes included in these GO terms.  
 
Putative Pax6 target genes should present one or more Pax6 binding peaks in 
their sequences. The sequences of these Pax6 binding peaks were discovered 
and verified by a previous ChIP-seq study using forebrain and lens chromatin 
from mice (150). The association of Pax6-peaks to the selected genes was 
carried out using RefSeq annotation. These selected genes were the ones 
involved in any of the above four GO-terms, which also showed significantly 
dysregulated expressions in the prethalamus in our RNAseq data. The result 
showed that 2 of the 6 genes belonging to the axon initial segment GO term 
showed one or more Pax6 binding peaks. Only 1 of the 9 genes belonging to 
the sodium channel activity GO term was a putative Pax6 target gene, as it 
had one Pax6 binding peak. 11 of the 27 genes belonging to the potassium 
channel activity GO term showed one or more Pax6 binding peaks, whereas 
11 out of 25 of the genes belonging to the calcium channel activity showed 
one or more Pax6 binding peaks.  
 
As mentioned above, the prethalamic expression profile of genes in the GO 
term of axon initial segment had shifted to become thalamus-like in the 
absence of Pax6. Interestingly, AnkG, the master regulator gene of AIS 
formation, was found to be one of the putative Pax6 target genes as two Pax6-
binding peaks (Pax6_337 and Pax6_338) were discovered within its gene 
sequence (Figure 6.4A). AnkG expression in the control prethalamus sample 
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was the lowest among the three tissues (Figure 6.4B). In the absence of Pax6, 
the expression level of AnkG in the prethalamus increased drastically and 
surpassed that in the control thalamus (Figure 6.4B).  
 
Although the Pax6-null prethalamic expression profile of genes in the GO term 
of calcium channel activity had also become thalamus-like, only one calcium 
channel component gene, Cacna2d3, was shown to be a putative Pax6 target 
gene. Cacna2d3 encodes the small subunit of a2d3 of the subfamily 2 (Cav2) 
of high-voltage-activated calcium channels (208). α2δ subunits are traditionally 
considered to be auxiliary subunits that enhance channel trafficking, increase 
the expression of functional calcium channels at the plasma membrane and 
influence the channels’ biophysical properties (209). Previous studies have 
shown that Cacna2d3 knockout mice showed a deficiency in pain perception 
and sensory cross-activation, i.e. the activation of a cortical sensory region by 
input from another modality due to reorganisation in the brain such as after a 
sensory loss (208). Cacna2d3 was the only gene belonging to the calcium 
channel activity GO term, whose expression level was downregulated in our 
RNAseq data. More interestingly, the expression level of Cacna2d3 was the 
highest in the prethalamus among the three tissues in the control embryos. In 
the absence of Pax6, its expression level dropped to approach that in control 
thalamic tissues (Figure 6.4C). 
 
Voltage-gated calcium channels are formed as a complex of α1 subunits, 
which forms the Ca2+ conducting pore, and other different subunits such as 
α2δ, β1-4, and γ. Based on the specific α1 subunits, the voltage-gated calcium 
channels can be divided into high-voltage-activated (HVA) and low-voltage-
activated (LVA) calcium channels (210). The α2δ subunits as mention above 
associate only with HVA calcium channels (208,209). The T-type low-threshold 
Ca2+ channels, which mediate low-threshold calcium spikes and rebound 
firing, are typical representatives of the LVA calcium channels (209,210). 
Interestingly, the expression of the Cacna1g gene was one of the most 
upregulated in the Pax6-null prethalamus among the genes in the GO term of 
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calcium channel activity. The Cacna1g gene encodes the α1 subunit of a T-
type, low-voltage activated calcium channel (209,210). As shown in Figure 
6.4D, the expression levels of Cacna1g were low in control cortex and 
prethalamus. However, in the absence of Pax6, the expression level of 
Cacna1g in the prethalamus increased dramatically and was at similar levels 
to that in the control and Pax6-null thalamus. No Pax6 binding sites were found 
associated with the Cacna1g gene. However, Cacna1g is a known canonical 
Wnt target gene and it is highly expressed in the thalamic neurons of the 
mouse and rat adult brain (190,207).  
 
These results indicated that the shift of Pax6-null prethalamic expression 
profiles of genes involved in axon initial segment and calcium channel activity 
towards thalamus-like might be due to a combined effect of loss of 








Figure 6.4 Changes of expression levels of putative Pax6 and canonical Wnt target 
genes in the anterior cortex, the prethalamus and thalamus in the absence of Pax6. (A) 
RefSeq annotation showed two Pax6-binding peaks, Pax6_337 and Pax6_338 within the 
AnkG (also known as Ank3) gene. Noted that neither of these binding sites are within the 
promotor region. (B) Expression levels of AnkG in the anterior cortex, the prethalamus and 
thalamus. The expression level of AnkG in the prethalamus under control condition was the 
lowest among the three pieces of tissues. In the absence of Pax6, its expression level had 
increased and surpassed that in the thalamic samples. (C) Cacna2d3 is another putative Pax6 
target gene with one Pax6-binding peaks. Expression of Cacna2d3 under the control condition 
was the highest in the prethalamus among the three tissues. In the absence of Pax6, the 
expression level of Cacna2d3 had dropped to approach the expression levels in the thalamic 
tissues. (D) Cacna1g is a canonical Wnt target gene, whose expression were highest in the 
thalamus under control condition. In the absence of Pax6, the expression levels of Cacna1g 





In this chapter, by utilising the existing RNAseq data, we proved that the 
prethalamic expression profiles of genes in the GO terms of axon initial 
segment and calcium channel activity had become thalamus-like in the 
absence of Pax6. Such results supported our hypothesis that the distinct 
expression patterns of Pax6 in the thalamus and prethalamus helped to 
maintain the regional variances between these two pieces of tissues in certain 
ways during development. Additionally, we identified novel putative Pax6 
target genes, such as AnkG, Cacna2d3 and genes encoding for subunits of 
the voltage-gated potassium channels. These genes are strongly associated 
with neuronal differentiation and function and their expression levels contribute 
to the characteristics of the electrophysiology profiles of the neurons. These 
findings revealed potential novel functions and direct transcriptional control of 
Pax6 in the postmitotic neurons of the prethalamus, and also mechanisms 
underlying regional differential development. 
 
Another exciting finding generated by the distance-based hierarchical 
clustering and PC analysis was the sharp variances of expression profiles of 
the genes in the GO terms of axon initial segment and voltage-gated ion 
channels between the cortex and the diencephalon. Besides, Pax6 did 
probably not play a role in creating such differences as the loss of Pax6 did 
not change these expression profiles in the anterior cortex in any significant 
way. Therefore, an intriguing question to ask would be, if the differential 
expression of Pax6 underlies the distinct expression profiles of the axon initial 
segment and calcium channel activity between the thalamus and prethalamus, 
which transcription factors directed such different expression profiles between 
the cortex and diencephalon?  
 
Another critical question to ask is why is it essential for a cortical neuron to be 
so different from a diencephalic neuron, and a thalamic neuron from a 
prethalamic neuron, in terms of the expression of genes that shape their 
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electrophysiological characteristics? Moreover, how does that contribute to 
neural circuitry formation and the functionality of the nervous system?  
 
Take the thalamic and prethalamic neurons as examples. Previous studies 
have indicated that all thalamic neurons can fire in both the tonic and bursting 
mode, whereas prethalamus-derived neurons can fire either only in tonic mode 
or in both modes (67,103). However, as most of the studies analysed the 
electrophysiology properties of only one type of neuron, it was difficult to 
compare precisely how differently the neurons from the thalamus and 
prethalamus respond to external stimuli. From our RNAseq data, we could see 
that the control prethalamus at E13.5 expressed rather low levels of axon initial 
segment component genes and various genes encoding for voltage-gated ion 
channel subunits. The presence of Pax6 in the prethalamic post-mitotic cells 
thus seemed to restrict the expression of these genes. In the absence of Pax6, 
the expressions of axon initial segment component genes, subunits for 
voltage-gated Na+ and K+ channels and T-type low-threshold Ca2+ channels 
were upregulated, indicating that these Pax6-null prethalamic cells are 
probably more excitable and can adapt more to the burst firing mode. It would 
be exciting if I can verify this with in vivo electrophysiological recording.  
 
Additionally, it will also be extremely intriguing to observe how Pax6-null mice 
with more excitable prethalamus-derived neurons behave. With my current 
experimental setup, it was not possible to generate Pax6-knockout mice 
postnatally. This was mainly due to the devastating effects of the loss of Pax6 
in proliferating cells (E9.5). However, pilot experiments have shown that if I 
double the concentration of tamoxifen and apply that to the pregnant FP6CD1 
females at E13.5 by oral gavage, the embryos will survive beyond P0. Mice 
generated this way could be optimal for us to study more about the functions 
of Pax6 in post-mitotic neurons, and how its absence might impact the 
excitability of the prethalamic neurons, the functionality of the nervous systems 





In this chapter, we discovered that in the absence of Pax6, the prethalamic 
expression profiles of genes in the GO terms of axon initial segment and 
calcium channel activity had become thalamus-like, due to the loss of 






The functions of Pax6 in the developing prethalamus 
 
In this study, I was able to characterise various defects in the developing 
mouse prethalamus when Pax6 is lost. On the cellular level, acute deletion of 
Pax6 resulted in increased axon and neurite elongation of the prethalamic 
neurons. On the subcellular level, absence of Pax6 resulted in alteration of the 
structure and components of the axon initial segments of the prethalamic 
neurons. On the tissue level, loss of Pax6 resulted in upregulated canonical 
Wnt activity specifically in the ventricular zone of the prethalamus. On the 
transcriptome level, loss of Pax6 caused the prethalamic expression profiles 
of AIS components and voltage-gated Ca2+ channels to become thalamus-
like. 
 
By combining these results with the information from the RNAseq data, I 
propose that in normal conditions, Pax6 plays the following roles during 
prethalamic development. By directly or indirectly inhibiting the expression of 
cytoskeletal effector genes, Pax6 functions to restrict axon and neurite 
elongation during neuronal morphogenesis of the prethalamic neurons. By 
directly controlling the transcription of genes such as AnkG and Cacna2d3, 
and indirectly controlling the transcription of various subunits of voltage-gated 
Na+, K+ and Ca2+ channels, Pax6 might thus control the formation and 
structure of the AIS and have further impacts on the electrophysiological 
properties of the prethalamic neurons. In the ventricular zone of the 
prethalamus, by activating the expressions of Wnt antagonist genes Sfrp2 and 
Dkk3, Pax6 probably shields the prethalamic ventricular zone from the activity 
of canonical Wnt signalling. Active canonical Wnt signalling is essential for the 
normal development of the thalamus. In the postnatal thalamic neurons, 
canonical Wnt signalling also functions to control the expressions of voltage-
gated ion channels, neurotransmitter receptors, synaptic vesicle proteins and 
so on. Many of the genes involved in these processes are exclusive to the 
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thalamic neurons. I have reported how the transcriptome profile of some of 
those genes in the prethalamus moves towards that of the thalamus in the 
absence of Pax6. This could be due to the combined effects of loss of 
transcriptional control by Pax6 and upregulated activity of the canonical Wnt 
signalling. In any case it indicates that Pax6 is crucial for specifying some 
characteristic of postmitotic prethalamic cells, especially those that make them 
different from thalamic neurons.  
 
My results not only revealed novel functions of the transcription factor Pax6 in 
post-mitotic cells of the prethalamus, but also provided a plausible mechanism 
































Figure 7.1 Transcriptional control of Pax6 and its various functions during prethalamic 
development. On the left is a schematic representation of the coronal view of half of the neural 
tube. The expression pattern of Pax6 is marked with regions of different colors. Pax6 
expression in the thalamus is restricted to the ventricular zone, which displays a gradient that 
increases with distance from the ZLI. The ZLI is marked with a thin blue wedge. Pax6 
expression in the prethalamus can be found in both the ventricular zone, and a subset of 
neurons in the mantle zone. The ventricular zone and the mantle zone are separated by a 
dash line. The intensity of Pax6 expression varies in the ventricular zone and the mantle zone, 
as the latter displays higher levels of Pax6 expression than the ventricular zone. Therefore, 
the presence of Pax6 in the mantle zone is presented by bolder letters than that in the 
ventricular zone. In the post-mitotic prethalamic cells, Pax6 can either directly or indirectly 
control the expressions of cytoskeletal effector genes. Many of these genes found in our 
RNAseq data, which show significantly dysregulated expression in the prethalamus when 
Pax6 is lost, can enhance axon and neurite elongation. Pax6 might also be able to directly 
bind to AnkG and Cacna2d3, or indirectly control the expressions of subunits of voltage-gated 
Na+ and K+ channels. All these genes can affect the structures of the AIS and the 
electrophysiological properties of the prethalamic neurons. In the prethalamic ventricular zone, 
where the level of Pax6 expression is slightly lower than that in the prethalamic mantle zone, 
Pax6 directly regulates the expressions of Sfrp2 and Dkk3, which function to antagonise the 
canonical Wnt activity in the prethalamus. The expressions of Pax6, together with all these 
direct and indirect target genes, compose the unique prethalamic transcriptome profile 
(represented by the pink rectangle). The thalamic transcriptome profile (represented by the 
light blue rectangle) overlaps with the pink rectangle as some genes are expressed by both 
tissues during development. In the absence of Pax6, the prethalamic transcriptome profile 
shifts and becomes thalamus-like, especially for genes involved in the GO terms of axon initial 





With the results obtained in this thesis, I have achieved my original aim for 
this study, which was to shed light on the functions of Pax6 in the 
prethalamic post-mitotic cells. However, questions remain. Firstly, what are 
the mechanisms that maintain the expression and functions of Pax6 in the 
prethalamic post-mitotic cells? Secondly, the prethalamic post-mitotic cells 
express Pax6 at a higher level than the progenitor cells. How is this achieved 
and why is this the case? Thirdly, in a previous study, Zhang et al. found that 
in adult ocular tissues (cornea, lens and retina), the ratio of Pax6 transcript 
and Pax6(5a) transcript had decreased from 8:1, as observed in the 
embryonic tissues, to 1:1. Recent publication in the lab showed that the in 
the embryonic prethalamus, the average ratio of Pax6 against Pax6(5a) is 
around 9:1. Is there also a change of ratio between the Pax6 isoforms when 
prethalamic progenitor cells become post-mitotic? Fourthly, my previous 
attempts to delete Pax6 only in the post-mitotic cells had proven that the 
expression of Pax6 in the post-mitotic cells were much more persistent than 
that in the progenitor cells. For example, with the same animal model, 
administration of tamoxifen at E9.5 would result in Pax6 deletion in 80-90% 
of all the cells at around E11.5. However, Pax6 expression in the prethalamic 
post-mitotic cells was still present at postnatal day 0 (P0) if I administrate 
tamoxifen at E13.5. The underlying mechanisms for this remain elusive.  
 
These are all questions worth pursuing, the answers to which will help us 
better understand the mechanisms of brain development controlled by the 
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